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Overview 
 
In the first part of this thesis, an introduction of the main characteristics of the 
primary-progressive form of multiple sclerosis (PPMS) (Chapter I), and of the 
acquisition and post-processing of the conventional and quantitative magnetic 
resonance imaging techniques employed in the studies presented in this thesis 
(Chapter II), will be presented. In the second part of this thesis, several 
advanced imaging techniques will be employed to answer the following two key 
questions on PPMS: 1) Is there is a spatial and temporal link between the 
pathological processes occurring in the normal appearing white matter (WM) 
and in the grey matter (GM) of patients with PPMS?; 2) Which regions of WM 
and GM abnormalities significantly contribute to clinical progression and 
cognitive dysfunction over time in patients with PPMS?  
 To answer the first question, I first used tract-based spatial statistics (TBSS) 
and voxel-based morphometry (VBM), to explore the spatial relationship 
between the damage occurring in the normal-appearing WM and GM in patients 
with early PPMS (Chapter III). Then, I moved onto exploring the temporal 
relationship linking the pathological changes affecting the two compartments, 
employing magnetization transfer imaging (MTI) and diffusion-based 
tractography (Chapter IV). 
 To answer the second question, I first looked at the prognostic role of WM 
lesion location in a study conducted on a large population of patients with well-
established PPMS who were followed-up for ten years in five different European 
centres (Chapter V). Then, using a novel approach which combines MTI and 
TBSS, I explored the regions of short-term accrual of microstructural damage in 
patients with early PPMS (Chapter VI). Finally, I moved onto examining the 
relative contribution of WM and GM damage to long-term motor and cognitive 
disability in PPMS (Chapter VII).  
In the final Chapter, I will summarise the results of the studies presented in this 
thesis, provide an answer to the two key questions on PPMS, and propose 
future directions for research. 
 3
 
 
 
 
Acknowledgements 
 
 
The work presented in this thesis was carried out in the Department of Brain 
Repair and Rehabilitation, UCL Institute of Neurology, which received a 
proportion of funding from the Department of Health’s NIHR Biomedical 
Research Centres funding scheme and from the Multiple Sclerosis Society of 
Great Britain and Northern Ireland. My PhD was funded by fellowships I was 
awarded from the ENS, the AISM/FISM, and the MAGNIMS/ECTRIMS, and I 
would like to thank all these organisations for their generous support. 
 
I am extremely grateful to my principal supervisor, Dr Olga Ciccarelli, for guiding 
me with tireless enthusiasm and motivation through the whole process of my 
research and writing up of this thesis. Over these years she has supported me 
in every single aspect of my life, and I could not have asked for a more 
inspirational mentor, for a more caring friend, and for a better auntie for my son. 
I would also like to warmly thank my second supervisor, Professor Alan J 
Thompson, from whom I learnt a great deal on identifying my goals and keeping 
focused on them, on dealing with academic writing and oral communications, 
and on enhancing emotional intelligence. 
 
I would like to thank Dr Claudia Wheeler-Kingshott and Dr Mara Cercignani for 
sharing with me their deep knowledge of MRI physics (as well as countless 
meals chit-chatting in Italian, and fun nights out during conferences), and for 
making London a second home for me. I am also very grateful to Dr Declan 
Chard and Dr Ahmed Toosy, for helping me over the years in dealing with 
challenging clinical cases and with the even more challenging reviewers’ 
comments to my papers. I wish to thank Professor David H Miller for his 
thoughtful comments to my papers and to my abstracts, and Dr Daniel Altmann, 
for his great input on the statistical part of my studies. I would also like to extend 
my gratitude to all the researchers who shared with me the infinite “chicken and 
egg project”, which has finally come to an end, and is presented in Chapter IV. I 
 4
 
 
 
 
would like to warmly thank Dr Marco Battaglini, whose help was essential for 
carrying out the study presented in Chapter V, for finding our way out of the 
forest in Kauai, and for managing to submit our abstract for the last ECTRIMS 
conference exactly thirty seconds before the deadline.  
 
A special thank goes to my friends and colleagues Dr Zhaleh Khaleeli, Dr Tom 
Jenkins, Dr Carmen Tur, Dr Nikos Gorgoraptis, and more recently Dr Amber 
Michelle Hill and Dr Khaled Abdel-Aziz, who at different times shared with me 
the small office on the 7th floor of Queen Square House, the Tuesdays in clinic, 
many nights out, my 30th birthday in New York, my pregnancy, the joys and the 
pains of my research, and all that made my years in London the most fun and 
unforgettable period of my life.  
 
Many other people contributed directly or indirectly to my research, and I am 
very grateful to all of them for their valuable input and great support. In 
particular, I would like to mention the patients and the healthy volunteers who 
took part in the studies presented in this thesis, all the MRI physicists, the 
students of the Fellows’ room, Ms Tracey Gibson, Ms Rowena Kemp, Ms Marie 
Braisher, Ms Tina Holmes, Ms Taira Bibi, Ms Navaeeda Naaem, Dr Elisabetta 
Cittadini, Ms Arianna Sanesi, Dr Antonella Ivaldi and all my wonderful friends in 
Rome, London and Paris.  
 
My research would not have been possible without the help of my mother and 
my father, whose unconditioned love and infinite support sustained me 
throughout this long journey. Finally, I would like to thank my little Enrico, who 
was born just before I started writing this thesis, for always succeeding in 
getting a smile out of me with his irresistible laugh. Every page of this work is 
dedicated to him. 
 
 5
 
 
 
 
Publications associated with this thesis’ work 
 
 
Papers: 
 
Bodini B, Khaleeli Z, Cercignani M, Miller DH, Thompson AJ, Ciccarelli O. 
Exploring the relationship between white matter and grey matter damage in 
early primary-progressive multiple sclerosis: an in vivo study with TBSS and 
VBM. Human Brain Mapping. 30(9):2852-61, 2009. 
 
Bodini B, Battaglini M, De Stefano N, Khaleeli Z, Barkhof F, Chard D, Filippi M, 
Montalban X, Polman C, Rovaris M, Rovira A, Samson R, Miller D, Thompson 
A, Ciccarelli O. T2 lesion location really matters: a 10 year follow-up study in 
primary progressive multiple sclerosis. Journal of Neurology, Neurosurgery and 
Psychiatry. 82(1):72-7, 2011.  
 
Dalton CM, Bodini B, Samson RS, Battaglini M, Fisniku LK, Thompson AJ, 
Ciccarelli O, Miller DH, Chard DT. Brain lesion location and clinical status 20 
years after a diagnosis of clinically isolated syndrome suggestive of multiple 
sclerosis. Multiple Sclerosis. 82(9):1022-4, 2011.  
 
Tozer DJ, Chard DT, Bodini B, Ciccarelli O, Miller DH, Thompson AJ, Wheeler-
Kingshott CA. Linking white matter tracts to associated cortical grey matter: a 
tract extension methodology. Neuroimage. 59(4):3094-102, 2012. 
 
Bodini B, Cercignani M, Khaleeli Z, Miller DH, Ron M, Penny S, Thompson AJ, 
Ciccarelli O. Corpus callosum damage predicts disability progression and 
cognitive dysfunction in primary-progressive MS after five years. Human Brain 
Mapping. Feb 13, 2012; [Epub ahead of print] 
 
Bodini B, Cercignani M, Toosy A, De Stefano N, Miller DH, Thompson AJ, 
Ciccarelli O. A novel approach with “skeletonised MTR” measures tract-specific 
 6
 
 
 
 
microstructural changes in early primary-progressive multiple sclerosis. Human 
Brain Mapping, in press. 
 
Bodini B, Chard D, Altmann D, Tozer D, Miller DH, Thompson AJ, Wheeler-
Kingshott C, Ciccarelli O. White matter damage precedes and possibly causes 
later grey matter changes in early primary-progressive MS, in preparation. 
 
Bodini B, Battaglini M, Eshaghi A, Gasperini C, Pozzilli C, Thompson AJ, De 
Stefano N, Ciccarelli O. Longitudinal microstructual and structural changes in 
relapsing and primary-progressive MS: lessons from the early phase, in 
preparation.  
 
Book chapter: 
 
Bodini B, Ciccarelli O. Diffusion MRI in neurological disorders. In: Imaging 
brain pathways - Diffusion MRI: from quantitative measurement to in-vivo 
neuroanatomy. Publisher: Academic (Elsevier), 2008. Editors: Heidi Johansen-
Berg and Tim Behrens, University of Oxford. 
 
Prize:  
 
Bodini B. Corpus callosum damage predicts disability progression and 
cognitive dysfunction in primary-progressive MS after five years. Award for the 
best poster, Queen Square Symposium poster competition, London, 2010.  
 7
 
 
 
 
Table of contents 
 
 
Title page                         1 
Declaration                         2 
Overview                             3 
Acknowledgements                     4 
Publications associated with this thesis’ work              6 
Table of Contents                      8 
List of Tables                          17 
List of Figures                          19 
List of Formulas                         22 
List of Abbreviations                       23 
 
 
Chapter I 
The primary-progressive form of multiple sclerosis          26 
 
1.1  Primary-progressive multiple sclerosis            27 
1.1.1 Multiple sclerosis and its primary-progressive form: overview and  
epidemiological data                    27 
1.1.2   Genetic and environmental influence on the aetiology of PPMS    29 
    1.1.2.1 Genetic factors                   29 
    1.1.2.2 Environmental  factors                30 
1.1.3  Clinical presentation and disease course            31 
1.1.4  Pathology of PPMS: differences and similarities with other forms  
of MS                         33 
     1.1.4.1 Pathological hallmarks of MS              33 
     1.1.4.2 White matter and grey matter pathology in PPMS      35 
1.1.5  Diagnosing PPMS: a longstanding challenge           38 
1.1.6  Failures and hopes in the therapy of PPMS           40 
     1.1.6.1 Failures                     40 
 8
 
 
 
 
1.1.6.2 Hopes                      43 
 
1.2  Imaging primary-progressive multiple sclerosis        44  
1.2.1  Studies on lesions and atrophy                45 
1.2.1.1 WM and GM Lesions                 45 
1.2.1.2 Atrophy                      46 
1.2.2  Studies using MTI and DTI                 48 
1.2.2.1 Magnetisation transfer imaging (MTI)           48 
1.2.2.2 Diffusion tensor imaging (DTI)             49 
1.2.3  Lessons from the early phase: the London experience 
on early PPMS                      52 
 
1.3   Two key unanswered questions on PPMS:  
rationale for this thesis                  53 
 
 
Chapter II 
Principles of MRI, DTI, MTI, and imaging analysis           55 
 
2.1  Principles of MRI                     56 
2.1.1  Physics of MRI                      56 
2.1.2  From the spin-echo phenomenon to the generation of signal     58 
2.1.3  Spatial encoding                     61 
2.1.4  Generation of tissue contrast                 64 
2.1.5  From MR signal to image reconstruction            65 
 
2.2  Conventional imaging sequences              67 
2.2.1  Fast spin-echo (FSE) sequence                67 
2.2.2  Gradient echo (GE)                    67 
2.2.3  Inversion recovery (IR)                   68 
2.2.4  Echo planar imaging (EPI)                  68 
 
2.3  Diffusion tensor imaging (DTI)               69 
2.3.1  The phenomenon of diffusion: basic principles          70 
 9
 
 
 
 
2.3.2  Effects of diffusion on the MRI signal              71 
2.3.3  The pulsed field gradient sequence              71 
2.3.4  Diffusion-weighted images and Apparent Diffusion  
Coefficient maps                     73 
2.3.5  Diffusion tensor and its indices                75 
2.3.6  Artifacts in the acquisition of diffusion-weighted images       78 
 
2.4  Magnetisation transfer imaging (MTI)             79 
2.4.1  Basic principles of MTI                   79 
2.4.2  Magnetisation transfer ratio (MTR)               81 
 
2.5  Imaging Analysis                    82 
2.5.1  Post-processing of conventional images            82 
2.5.1.1 Voxel-based morphometry (VBM)            82 
2.5.1.2 Lesion Probability Mapping (LPM)            85 
2.5.2  Post-processing of DTI  and MTI images            87 
2.5.2.1 Methodological considerations             87 
2.5.2.2 Tract-based spatial statistics (TBSS)           88 
2.5.2.3 White Matter tractography               91 
 2.5.2.4 Linking WM tracts to associated cortical GM:  
    a tract-extension methodology             93 
2.5.2.5 “Skeletonised MTR”: a novel approach to explore 
microstructural WM changes              95 
 
2.6 Conclusions                      96 
 
 
Chapter III 
 
Exploring the relationship between white matter and  
grey matter damage in PPMS                   97 
 
3.1 ` Introduction                      98 
 
 10
 
 
 
 
3.2  Methods                      100 
3.2.1  Subjects                      100 
3.2.2  Image acquisition and analysis              101 
3.2.2.1 Dual-echo images, lesion load, and creation of  
a mean lesion mask               101 
3.2.2.2 Diffusion-tensor imaging and TBSS analysis       102 
3.2.2.3 T1-weighted volumetric images and SPM2-VBM  
analysis of GM                 103 
 3.2.2.4 Anatomical correspondence and quantitative  
    relationship between NAWM and GM abnormalities   104 
3.2.2.5 Correlation between NAWM and GM abnormalities  
and disability                  104 
 
3.3  Results                      105 
3.3.1  Reduced FA of NAWM tracts               105 
3.3.2  GM atrophy                     106 
3.3.3  Anatomical correspondence between NAWM and GM  
abnormalities                    108 
3.3.4  Quantitative relationship between anatomically related NAWM  
and GM abnormalities                 108 
3.3.5  Correlation between NAWM and GM abnormalities and disability 109 
 
3.4  Discussion                     110 
3.4.1  NAWM and GM abnormalities              110 
3.4.2 Anatomical and quantitative relationship between NAWM  
damage and GM atrophy                110 
3.4.3  Contribution of NAWM and GM abnormalities to disability    112 
 
3.5  Conclusions                    113 
 
 
 
 
 
 11
 
 
 
 
Chapter IV 
 
Exploring the temporal relationship between white and grey matter 
pathology in early PPMS                   115 
 
4.1  Introduction                    116 
 
4.2  Methods                      117 
4.2.1  Subjects                      117 
4.2.2  Image acquisition                   118 
4.2.2.1 Brain imaging                 119 
4.2.2.2 Spinal cord imaging               120 
4.2.3  Image analysis                    120 
4.2.3.1 White matter lesions               120 
 4.2.3.2 Generation of the DTI template, reconstruction  
    of tracts and tract  extension in standard space     120 
 4.2.3.3 MTR map calculation and transformation of extended  
    tracts into native space              123 
 4.2.3.4 Segmentation of extended tracts in native space  
    and extraction of  WM and GM MTR values      123 
   4.2.3.5 Cord cross-sectional area             125 
4.2.4  Statistics                      125 
4.2.4.1 Comparison of WM and GM MTR between  
patients and controls               125 
4.2.4.2 Evolution of NAWM, WML and GM values over time  
in patients                   126 
4.2.4.3 Cross-sectional relationship between NAWM and  
GM values at each time-point           126 
4.2.4.4 Temporal relationship between tract-specific NAWM  
and GM values: the “primary WM damage” and  
the “primary GM damage” model          126 
4.2.4.5 The role of lesions: post-hoc analysis on the correlation 
 between   baseline lesion MTR and later NAWM and  
GM MTR                   127 
 12
 
 
 
 
4.3  Results                      128 
4.3.1  Comparison of WM and GM MTR between patients and controls 128 
4.3.2  Evolution of NAWM, WML and GM damage over time in patients 129 
4.3.3 Cross-sectional relationship between NAWM and GM damage 
 at each time-point                   130 
4.3.4  Temporal relationship between tract-specific NAWM and  
GM damage                     131 
4.3.4.1 “Primary WM damage” model           131 
4.3.4.2 “Primary GM damage” model            131 
4.3.4.3 Comparison between the “primary WM damage” and  
the “primary GM damage” model          132 
4.3.4.4 The role of lesions: correlation between baseline  
lesion MTR and  later WM and GM MTR       132 
 
4.4  Discussion                     133 
 
4.5  Conclusions                    137 
 
 
Chapter V 
 
The role of focal WM damage in predicting clinical progression  
over 10 years                       139 
 
5.1  Introduction                    140 
 
5.2  Methods                      142 
5.2.1  Patients                      142 
5.2.2  MRI acquisition                    143 
5.2.3  MRI processing                    143 
5.2.3.1 Lesion probability map (LPM)           143 
5.2.3.2 Cord cross-sectional area             145 
5.2.4  Statistical analysis                   145 
5.2.4.1 Correlation between lesion location and time to event   145 
 13
 
 
 
 
5.2.4.2 Predictors of progression rate           146 
 
5.3  Results                      146 
5.3.1  T2 and T1 lesion probability maps             146 
5.3.2  Correlation between lesion location and time to event      147 
5.3.3  Predictors of progression rate              148 
 
5.4  Discussion                     149 
 
5.5  Conclusions                    153 
 
 
Chapter VI 
 
Short-term microstructural changes in white matter tracts  
in early PPMS                       155 
 
6.1  Introduction                    156 
 
6.2  Methods                       157 
6.2.1  Patients                      157 
6.2.2  Image acquisition                   158 
6.2.3  Image post-procesing                 159 
6.2.3.1 Lesions                    159 
6.2.3.2 From “skeletonised” FA, AD, RD, to “skeletonized MTR”  159 
6.2.4  Statistical analysis                   160 
6.2.4.1 Assessment of clinical progression over one year    160 
6.2.4.2 Changes in skeletonised FA, AD, RD and MTR  
over one year                 160 
6.2.4.3 Correlation between changes in FA, AD, RD and  
MTR, and clinical changes over one year       161 
6.2.4.4 Post-hoc analysis                162 
 
6.3  Results                      163 
 14
 
 
 
 
6.3.1  Clinical progression over one year             163 
6.3.2  Changes in skeletonised FA, AD, RD, and MTR over one year  164 
6.3.3 Correlation between changes in FA, AD, RD, and MTR,  
and clinical changes over one year            166 
6.3.4  Post-hoc analysis                   169 
6.3.4.1 The role of lesions                169 
6.3.4.2 The role of total GM MTR             170 
6.3.4.3 Correlation between FA changes and MTR decrease  
in regions that showed correlation between MTR changes and  
clinical function                    170 
 
6.4  Discussion                     170 
 
6.5  Conclusions                    176 
 
 
Chapter VII 
 
The relative contribution of WM and GM damage to long-term  
disability progression and cognitive dysfunction         177 
 
7.1  Introduction                    178 
7.2  Methods                       180 
7.2.1  Study design                     180 
7.2.2  Neuropsychological assessment             181 
7.2.3  Processing of clinical and cognitive data          182 
7.2.4  Image acquisition and post-processing           183 
7.2.5 Investigation of predictors of physical deterioration and cognitive 
dysfunction                     184 
7.2.5.1 White matter FA analysis             184 
7.2.5.2 Grey matter volumetric analysis           185 
 
7.3  Results                      185 
7.3.1  Patients’ clinical and neuropsychological assessment      185 
 15
 
 
 
 
7.3.2  White matter FA as predictor               186 
7.3.3  Contribution of WM lesions               189 
7.3.4  Grey matter volume as predictor             190 
 
7.4  Discussion                     190 
 
7.5  Conclusions                    195 
 
 
Chapter VIII 
 
Conclusions and future directions               196 
 
8.1  The answer to the two key questions on PPMS       197 
 
8.2        Future directions                      199 
 
Appendix I Different cohorts of patients and controls included             202 
     In the studies presented in this thesis 
 
References                        204 
 
 16
 
 
 
 
List of tables 
 
 
CHAPTER I 
 
Table 1.1 Diagnostic criteria for PPMS according to the 2010 Revisions to 
the McDonald Criteria 
 
Table 1.2  Ongoing clinical trials on patients with PPMS  
 
 
 
CHAPTER III 
 
Table 3.1 Patients’ and healthy controls demographic, clinical and 
radiological characteristics 
 
Table 3.2 Regions showing a lower GM volume in patients compared with 
healthy controls 
 
Table 3.3 Regions where GM atrophy was significantly correlated with FA 
reduction in adjacent NAWM in patients 
 
 
 
CHAPTER IV 
 
Table 4.1 Demographic and radiological characteristics of patients and 
healthy controls at study entry 
 
Table 4.2 Each tract-cortex pair’s mean MTR in NAWM and GM in patients, 
and in WM and GM in healthy controls, at baseline and year 2 
 
Table 4.3 Comparison of mean MTR between patients and healthy controls 
adjusted for age and gender, at baseline and year 2 
 
Table 4.4 Mean MTR change in the NAWM and GM of all the tract-cortex 
pair over the follow-up 
 
Table 4.5 Standardised regression coefficients and p-values for each tract-
cortex pair’s “primary WM model” regression adjusted for baseline 
GM area’s MTR 
 
Table 4.6 Standardised regression coefficients and p-values for each tract-
cortex pair’s “primary GM model” regression adjusted for baseline 
NAWM MTR 
 
 17
 
 
 
 
Chapter V 
 
Table 5.1 Demographic, clinical and radiological characteristics of the 
patients studied in each centre, at study entry 
 
Table 5.2 Acquisition parameters for T2-w/PD and T1-w sequences 
performed in each centre at study entry 
 
Table 5.3 Number of lesional voxels and corresponding lesion loads 
extracted from the tracts containing regions that showed an 
association between lesion location and time to event 
 
 
 
Chapter VI 
 
Table 6.1 Clinical test scores at baseline and year one 
 
Table 6.2 Tract-specific FA and MTR values obtained from skeletonized 
images in patients at baseline and one-year follow-up 
 
 
 
Chapter VII 
 
Table 7.1 Patients’ clinical, radiological and demographic characteristics at 
baseline 
 
Table 7.2 Neuropsychological test results and comparisons of patient and 
control groups 
 
Table 7.3 White matter regions showing a significant association between 
lower FA at baseline and neuropsychological scores at five years 
 
 
 
Appendix I 
 
Table AI  Patient and healthy control groups included in the studies 
presented in this thesis 
 18
 
 
 
 
List of Figures 
 
 
CHAPTER I 
 
Figure 1.1  Disease course of different types of MS 
 
Figure 1.2  Cortical demyelination in RRMS 
 
Figure 1.3  Inflammation and axonal injury in NAWM of patients with PPMS 
 
Figure 1.4  Cortical demyelination in PPMS 
 
Figure 1.5 Areas of significant GM atrophy in cognitively impaired PPMS 
 
Figure 1.6 Regions of increased GM mean diffusivity in patients with PPMS 
compared with controls 
 
 
 
CHAPTER II 
 
Figure 2.1      Proton behavior in an external magnetic field 
 
Figure 2.2 T1 recovery and T2 decay 
 
Figure 2.3 Free induction decay 
 
Figure 2.4 Dual spin echo sequence diagram 
 
Figure 2.5 Gradient echo EPI pulse sequence and EPI  k-space sampling 
 
Figure 2.6 Stejskal-Tanner Pulse Field Gradient (PFG) sequence  
 
Figure 2.7 Diffusion-weighted MR images 
 
Figure 2.8 ADC and DWI maps 
 
Figure 2.9 Mean diffusivity and fractional anisotropy maps 
 
Figure 2.10 Diffusion ellipsoid 
 
Figure 2.11 Free and bound proton resonance frequencies 
 
Figure 2.12 MTR map of an MS patient 
 
Figure 2.13 Mean FA skeleton of a group of patients with PPMS 
 19
 
 
 
 
 
Figure 2.14 Deterministic algorithms 
 
Figure 2.15 The tract-extension method 
 
 
 
CHAPTER III 
 
Figure 3.1 Regions of significant difference in FA between patients and 
controls 
 
Figure 3.2 Regions of significant difference in GM volume between patients 
and controls 
 
Figure 3.3 Regions of anatomical and quantitative correlation between 
NAWM tracts and GM atrophy in patients 
 
 
 
CHAPTER IV 
 
Figure 4.1 Reconstructed tracts and corresponding cortical targets in 
standard space 
 
Figure 4.2 Bilateral cortico-spinal tract and associated cortical voxels in a 
single patient 
 
 
 
CHAPTER V 
 
Figure 5.1 T2 and T1 lesion probability maps 
 
Figure 5.2 Regions where a higher probability of a voxel being lesional on 
T2-w images was associated with a shorter time to event 
 
 
 
CHAPTER VI 
 
Figure 6.1 WM tracts showing a significant increase in radial diffusivity over 
the follow-up 
 
Figure 6.2 Regions of significant reduction in skeletonized MTR over one 
year 
 
Figure 6.3 Areas of association between a reduction in axial diffusivity and 
reduction in NHPT scores over the follow-up 
 
 20
 
 
 
 
Figure 6.4 Areas of association between an increase in radial diffusivity and 
a reduction in NHPT scores over the follow-up 
 
Figure 6.5 Areas of association between an increase in radial diffusivity and 
a reduction in PASAT scores over the follow-up 
 
Figure 6.6 Areas of correlation between the decrease in skeletonized MTR 
and the changes in NHPT score over the follow-up 
 
Figure 6.7 Significant MTR changes over one year and probabilistic 
distribution of new/enlarged lesions over the same follow-up 
period in patients 
 
 
 
CHAPTER VII 
 
Figure 7.1 Regions of skeleton whose FA at study entry was associated with 
progression of disability over five years 
 
Figure 7.2 Regions of association between FA values at study entry and 
cognitive scores at five years 
 
Figure 7.3 White matter regions showing an association between lower 
baseline FA and neuropsychological scores at five years when a 
threshold of significance of p<0.05 was used 
 
Figure 7.4 The callosal area, whose FA at baseline significantly correlated 
with executive function scores at five years 
 
 21
 
 
 
 
List of formulas 
 
 
CHAPTER II 
 
Formula 2.1      Larmor equation 
 
Formula 2.2      Fick’s first law of diffusion 
 
Formula 2.3      Diffusion tensor 
 
Formula 2.4      Stejskal and Tanner equation  
 
Formula 2.5      Diffusion weighting factor 
 
Formula 2.6      Diagonalisation of the diffusion tensor 
 
Formula 2.7      Mean diffusivity 
 
Formula 2.8      Fractional anisotropy 
 
Formula 2.9      Magnetic transfer ratio 
 
 
 
 22
 
 
 
 
List of abbreviations 
 
 
AD     Axial diffusivity 
ADC     Apparent diffusion coefficient 
CC     Corpus callosum 
CNS     Central nervous system 
CSF     Cerebro-spinal fluid 
CST     Cortico-spinal tract 
DIR     Double inversion recovery 
DTI     Diffusion tensor imaging 
DWI     Diffusion-weighted imaging 
EDSS    Expanded Disability Status Scale 
EPI     Echo planar imaging 
FA     Fractional anisotropy 
FID     Free Induction Decay 
FLAIR    Fluid attenuation inversion recovery  
FOV     Field of view 
FSE     Fast spin-echo 
FSPGR    Inversion-prepared fast spoiled gradient recall 
GCC     Genu of the corpus callosum 
GE     Gradient echo 
GM     Grey matter 
IFOF    Inferior fronto-occipital fasciculus 
IR      Inversion recovery 
 23
 
 
 
 
LEAP    Lesion automated pre-processing 
LPM     Lesion probability map 
MD     Mean Diffusivity 
MRI     Magnetic resonance imaging 
MS     Multiple sclerosis 
MSFC    Multiple Sclerosis Functional Composite 
MTI     Magnetisation transfer imaging 
MTR     Magnetisation transfer ratio 
NAGM    Normal appearing grey matter 
NAWM    Normal appearing white matter 
NHPT    Nine-Hole Peg Test 
PASAT    Paced Auditory Serial Addition test 
PD-w    Proton density weighted  
PPMS    Primary-progressive multiple sclerosis 
RF     Radio frequency 
RD     Radial diffusivity 
ROI     Region of interest 
RRMS    Relapsing-remitting multiple sclerosis 
SD     Standard deviation 
SE     Spin-echo 
SLF     Superior longitudinal fasciculus 
SNP     Single nucleotide polymorphism 
SPM     Statistical parametric mapping 
SPMS    Secondary-progressive multiple sclerosis 
T1-w     T1-weighted  
T2-w     T2-weighted  
 24
 
 
 
 
 25
TBSS    Tract-based spatial statistics 
TE     Echo time 
TI      Inversion time 
TR     Repetition time 
TWT     Timed Walk Test 
VBM     Voxel-based morphometry 
WM      White matter 
 
  
 
 
 
The primary-progressive form 
of multiple sclerosis 
 
 
 
 
 
 
Chapter I 
 26
Chapter I: Introduction to primary-progressive MS  
 
 
 
In this first Chapter, the characteristics of the primary-progressive form of 
multiple sclerosis will be discussed. This chapter is divided into three parts. The 
first part is a review of epidemiology, aetiology, clinical presentation, diagnostic 
criteria, and  therapy of this form of disease. The second section is a summary 
of this patient group main features that conventional and advanced imaging 
techniques have allowed to unveil. The final section of this Chapter describes 
the rationale for this thesis.  
 
1.1 Primary-progressive multiple sclerosis 
 
1.1.1 Multiple sclerosis and its primary-progressive form: overview and 
epidemiological data 
 
Multiple sclerosis (MS) is a chronic neurological disease of the central nervous 
system (CNS) that primarily affects young adults, with a prevalence of between 
1 in 500 and 1 in 1500 of the population in Europe, North America, and 
Australasia (Miller and Leary, 2007). It is an inflammatory demyelinating 
disease, which is characterised by the presence of typical white-matter (WM) 
lesions in the brain and spinal cord, although the importance of the 
neurodegenerative component of this disease is being increasingly 
acknowledged.  
 
MS incorporates  different subtypes of disease, each one characterised by a 
different course. The main clinical subtypes of MS were defined 20 years ago 
as relapsing-remitting (RRMS) and chronic progressive MS. The former is 
characterised by episodes of acute clinical deterioration (relapses), followed by 
periods of partial or complete recovery (remissions); the latter is characterised 
by a gradual, progressive deterioration in neurological functions over months or 
years. Most cases of chronic progressive MS start as RRMS (the so-called 
secondary progressive form, SPMS). According to epidemiological studies, 
most patients with RRMS eventually develop SPMS, entering a phase of 
progressive deterioration. However, in a subgroup of patients with MS, the 
disease course is characterised by a steady neurological deterioration from 
onset; this particular, rarer form of MS, has been labelled primary-progressive 
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(PPMS). About 10% of patients with PPMS have relapses (Andersson et al., 
1999).  Since 1996, there has been a formal classification of MS clinical 
subgroups according to clinical course, that includes RRMS, SPMS, and PPMS, 
which has become widely accepted (Lublin and Reingold, 1996) (Figure 1.1).  
 
       
 
 
 
 
 
 
 
 
 
 
Primary-progressive multiple sclerosis
Secondary-progressive multiple sclerosis
Relapsing-remitting multiple sclerosis
Time 
D
is
a
b
ility
Figure 1.1. Graph representing the disease course of different types of multiple sclerosis. 
 
 
A primary-progressive presentation is seen in approximately 10% of patients 
with MS (Koch et al., 2009). Most patients with PPMS come from areas where 
MS is common, such as North America and Europe, but an increasing number 
of studies have shown that this form of disease is also present in other parts of 
the world, such as South America and Africa (Idris et al., 2009; Ferreira 
Vasconcelos et al., 2010). In addition to its particular disease course, the PP 
form differs from the other subtypes of MS in other aspects. Symptom onset in 
patients with PPMS tends to occur at an older age compared with the RR form 
of disease (mean 40 years versus 30 years). In contrast to RRMS, where MS 
occurs between two and three times more frequently in women, there is no 
gender predominance in PPMS (Miller and Leary, 2007).  
 
 28
Chapter I: Introduction to primary-progressive MS  
 
 
 
1.1.2 Genetic and environmental influence on the aetiology of PPMS 
 
1.1.2.1 Genetic factors 
To date, most studies have not reported evidence for genetic associations with 
the clinical forms of MS or the severity of the disease course (Ramagopalan et 
al., 2008; Jensen et al., 2010; Sawcer et al., 2011).  
 
An association between the DR2 haplotype DRB1*15:01 in the class II region of 
the major histocompatibility complex on the short arm of chromosome 6 and the 
risk of developing MS, has been found both in patients with RRMS and PPMS 
(Barcellos et al., 2003; Miller and Leary, 2007; Ramagopalan et al., 2010). 
Moreover, an association with PPMS has been reported with other HLA 
haplotypes, such as DR4 - DQ8, DR7-DQw9 and DRw8-DQw4 haplotypes, and 
with DR3 (Ramagopalan et al., 2008). Data from a study conducted in a cohort 
of patients with PPMS showed a significant difference in the severity of the 
disease between HLA DRB1*1501-positive and negative patients, with the 
former deteriorating more quickly over time (Vasconcelos et al., 2009). 
 
Over the years, genes outside the major histocompatibility complex with modest 
effect in MS have been identified, including interleukin-7 receptor α (IL7RA), 
interleukin-2 receptor α (IL2RA) and tumor-necrosis-factor receptor superfamily 
member 1A (TNFRSF1A) (Ramagopalan et al., 2010). A significant association 
with disease susceptibility was also found for chromosome 10 open reading 
frame (C10orf27), in a study conducted on 571 patients with RRMS and PPMS, 
and on healthy controls (Goertsches et al., 2008). Modestly powered studies 
found some evidence of an increased risk of developing the PP form of disease 
in patients with the Apolipoprotein E ε4 allele (Cocco et al., 2005), the Cytotoxic 
T Lymphocyte Antigen 4 G49 (Maurer et al., 2002), and the interleukin-4 E1(33) 
TT (Kantarci et al., 2003). An interesting study found an underexpression of the 
interleukin 7 receptor (IL7R, which is crucial for T cell maturation and 
proliferation) gene in patients with PPMS compared with those with SPMS, 
suggesting that IL7R may be a potential therapeutic target for PPMS. More 
recently, a study has confirmed the previously documented association between 
the perforin 1 gene and MS, and has reported that a subgroup of patients with 
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PPMS, mainly males, were characterized by not only a low perforin expression 
in peripheral blood cells, but also deficient expression in additional genes that 
code for proteins involved in cell killing by CD8+ T cell and NK cells, with 
mechanisms similar to perforin (Camina-Tato et al., 2010).  
 
Recently, a genome-wide association study that included patients with MS from 
Europe, United States of America, Australia and New Zealand, replicated 
almost all of the previously suggested associations and identified further novel 
susceptibility loci, within genes such as VCAM1, CD65 or IL12B (Sawcer et al., 
2011). Among the susceptibility genes proposed in this study, TMEM39A, IL12B 
and CBLB have been subsequently validated in another study on a large 
population of Spanish patients (Varade et al., 2012).  
 
Finally, a recently published study on 590 Finnish patients investigated the 
association of specific single nucleotide polymorphisms (SNPs) in the genes of 
the melatonin pathway, and the risk of developing progressive MS. The Authors 
found an association between polymorphisms of the melatonin pathway genes 
and the risk of developing PPMS, as well as the risk of severe disability in 
PPMS (Natarajan et al., 2012).  
 
1.1.2.2 Environmental  factors 
Epidemiological studies clearly demonstrate a prominent role for environmental 
factors in determining the disease risk for MS (Ramagopalan et al., 2010). 
There is strong evidence that Epstein-Barr virus (EBV) infection precedes MS 
onset and there is a dose dependent relationship between the risk of MS and 
the level of EBV specific antibodies (Lucas et al., 2011). A study conducted in 
100 subjects, including 25 PPMS patients, showed that the pattern of serologic 
response to EBV was different between clinical subgroups, which may imply a 
different immunologic response to primary infection with EBV; this may 
determine/influence the clinical phenotype of the disease (Farrell et al., 2009) 
 
Several retrospective and prospective studies have demonstrated an 
association between smoking and susceptibility to MS (Jafari and Hintzen, 
2011). In particular, cigarette smokers have a higher risk of developing MS 
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compared with those who never smoke (Ascherio and Munger, 2007). 
Interestingly, a study conducted in 1465 MS patients, which included 63 
patients with PPMS, found that the probability of a PP course of MS was 
significantly higher in current smokers or ex-smokers than that of an initially 
relapsing form of disease (Healy et al., 2009). This result is in line with data 
showing the neurotoxic effects of components of cigarettes, and the association 
of tobacco smoke components (such as cyanides) with demyelination in animal 
studies (Jafari and Hintzen, 2011).  
 
Within temperate regions , MS incidence and prevalence increase with latitude, 
while living below 35° latitude for the first 10 years of one’s life reduces this risk 
by approximately 50% (Ramagopalan et al., 2010). The association between 
sunlight exposure and vitamin D levels is a potential explanation for the 
association between MS incidence and latitude (van der Mei et al., 2003). It has 
been extensively documented that past sunlight exposure is inversely related to 
MS susceptibility, and higher vitamin D levels protect against MS (Munger et al., 
2006). However, in a recent study comparing Vitamin D serum levels in patients 
with RRMS, PPMS and healthy controls, it was found that, differently from the 
RRMS group, where a significant reduction in Vitamin D levels compared to 
healthy controls was observed, in patients with PPMS the Vitamin D levels were 
similar to those observed in healthy individuals (Correale et al., 2011). A 
possible explanation for this finding is the different effect that Vitamin D could 
have on the pathogenic processes mediating brain damage in RRMS and 
PPMS. 
 
1.1.3 Clinical presentation and disease course 
 
The most common clinical presentation in patients with PPMS is a gradual and  
progressive, spastic paraparesis (usually lower limb asymmetric weakness and 
stiffness) (Cottrell et al., 1999), whilst in patients with RRMS the most frequent 
initial presentation is characterized by visual and sensory disturbances (Miller et 
al., 2012). Other (less frequent) presentations of PPMS include visual loss and 
cerebellar or brainstem disturbance. Usually, the clinical picture gradually 
deteriorates over months or years. However, in some cases symptoms can 
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remain stable for long periods. Urinary urgency and retention, bowel 
disturbances (including constipation and, less frequently, faecal urgency), as 
well as sexual dysfunction, are also common in PPMS.  
 
Cognitive impairment is very frequent in MS, affecting up to 65% of patients, 
and is usually more common in the progressive forms of the disease (Amato et 
al., 2006). It has been well documented that cognitive dysfunction in PPMS is 
present in about 30% of patients, affecting a number of domains, including 
memory, attention/speed of information processing, and executive function  
(Camp et al., 1999; Camp et al., 2005; Ukkonen et al., 2009). Studies 
comparing the pattern and severity of cognitive impairment in different MS 
subtypes have reported more severe impairment in patients with progressive 
forms of MS than in those with RRMS (Huijbregts et al., 2004; Huijbregts et al., 
2006), but only subtle differences in the pattern of neuropsychological deficit 
and in the severity of cognitive dysfunction have been seen between patients 
with PPMS and SPMS (Foong et al., 2000). 
 
PPMS carries the worst prognosis of all MS subtypes. However, the speed of 
disability accumulation varies considerably among patients with this form of 
disease (Miller and Leary, 2007). Studies on the long-term natural history of 
patients with PPMS have shown that the speed of disability accumulation, as 
measured by the number of years taken to reach 6.0 on the Expanded Disability 
Status Scale (EDSS) (Kurtzke, 1983), varies considerably between different 
cohorts. In particular, while earlier studies reported a rapid disease progression 
(7.1 years to EDSS 6.0 in the Lyon cohort and approximately 8.5 years in the 
London, Ontario cohort) (Cottrell et al., 1999; Confavreux and Vukusic, 2006), 
data from the British Columbia MS cohort showed a much slower disease 
course (Tremlett et al., 2005); Koch et al. found that patients in this cohort took 
14 years to reach EDSS 6.0 (Koch et al., 2009). Interestingly, a very recent 
study on the British Columbia MS cohort showed that 9.2% of PPMS patients 
showed a natural and innate improvement of ≥ 0.5 in EDSS over one year of 
follow-up (Tremlett et al., 2012). 
 
Few clinical predictors of disease course have been identified in natural history 
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studies conducted on patients with PPMS. It has been shown that  patients 
presenting at onset with involvement of three or more systems had a faster 
clinical deterioration over time compared with those with less than three 
systems involved (Cottrell et al., 1999). A worse prognosis has also been 
identified in patients presenting with cerebellar or brainstem symptoms 
(Tremlett et al., 2005). There is some evidence that in this form of disease the 
clinical decline is faster in men than in women (Cottrell et al., 1999; Confavreux 
and Vukusic, 2006) and in patients presenting with a faster rate of initial 
progression (Cottrell et al., 1999; Tremlett et al., 2005). More recently, in the 
British Columbia cohort, sensory symptoms at presentation and a younger age 
at disease onset were associated with a longer time to reach EDSS 6.0 (Koch 
et al., 2009). Two MAGNIMS (Magnetic Resonance Imaging in MS) multi-center 
studies, found that a shorter disease duration at baseline, male sex, and a more 
severe clinical disability at study entry, as measured by EDSS and timed-walk 
test (Cutter et al., 1999), were all independent predictors of a worse long-term 
clinical outcome in the large cohort of PPMS patients (Sastre-Garriga et al., 
2005b; Khaleeli et al., 2008b). 
 
1.1.4 Pathology of PPMS: differences and similarities with other forms of MS 
 
1.1.4.1 Pathological hallmarks of MS 
The pathological hallmarks of MS include inflammation, demyelination, 
remyelination, gliosis, neurodegeneration, which affect the WM and the GM 
both focally and diffusely (Lassmann et al., 2012). In particular, MS is 
characterised by multiple foci of inflammation (lesions) in the white matter, 
consisting of perivascular lymphocytic infiltrates, loss of oligodendrocytes and 
demyelination (Reynolds et al., 2011). Within the demyelinated lesions there is 
prominent astrogliosis. A degree of axonal damage has been reported to occur 
in active, inflammatory, demyelinating  lesions (Trapp et al., 1998). In addition, 
demyelination is also present in both in the deep and cortical GM and is 
associated with neuronal loss (Bo et al., 2003; Geurts and Barkhof, 2008; 
Magliozzi et al., 2010). Recently, Lucchinetti and colleagues have studied 
cortical tissue from 138 patients with clinically isolated syndromes and early 
RRMS obtained with diagnostic stereotactic biopsy targeting WM lesions; they 
 33
Chapter I: Introduction to primary-progressive MS  
 
 
 
demonstrated that even in the early stage of MS, cortical demyelinating lesions 
are frequent, and strongly associated with meningeal inflammation (Lucchinetti 
et al., 2011) (Figure 1.2). They also reported that the majority of the examined 
GM lesions were associated with inflammatory infiltrates. This is in contrast to 
previously reported data on the lack of lymphocytic infiltration, complement 
deposition and blood-brain barrier disruption in GM lesions (Geurts and 
Barkhof, 2008). In this respect, it is important to underline that the biopsy 
specimens under investigation in the study by Lucchinetti et al. originated from 
patients with atypical clinical and radiological presentations, and therefore the 
results may not generalise to typical MS cases (Lucchinetti et al., 2011). 
Cortical lesions are mainly localised in the subpial cortical layers in progressive 
MS, and  active lesions are associated with activated microglia. Moreover, rims 
of activated microglia have been recently found at the border of cortical lesions 
in a subset of patients with more active WM inflammation and a worse disease 
course (Kooi et al., 2012).These data suggest that GM tissue damage may be 
driven by a soluble factor produced by meningeal inflammatory aggregates, 
which would cause tissue damage in the cortex either directly or indirectly 
through microglial activation (Howell et al., 2011; Lassmann et al., 2012).  
 
Outside the macroscopically visible lesions, within the so called normal-
appearing white matter (NAWM) and grey matter (NAGM), diffuse pathology 
has been demonstrated, consisting of axonal damage and loss (Kutzelnigg et 
al., 2005), microglial activation (Howell et al., 2010), changes at the nodes of 
Ranvier (Howell et al., 2011), and neuronal loss (Magliozzi et al., 2010). It has 
been shown that some degree of remyelination in demyelinated lesions may 
occur, but it is variable in extent (Patrikios et al., 2006; Patani et al., 2007). 
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Figure 1.2  On the left, bioptic tissue showing a cortical demyelinating lesion in patients with 
early RRMS; on the right, the arrows indicate an area of intracortical demyelination, in which 
neurons are visible (inset) (Adapted from Lucchinetti et al., 2011). 
 
 
 
1.1.4.2 White matter and grey matter pathology in PPMS 
In a post-mortem study comparing the different subtypes of MS, it was found 
that the focal WM lesion load in PPMS was the lowest of all MS forms 
(Kutzelnigg et al., 2005). Moreover, while the most extensive inflammatory 
reaction was found in focal WM plaques in all disease subtypes, there was a 
mild, but diffuse inflammatory reaction in the NAWM of patients with progressive 
MS (Figure 1.3), which was significantly less pronounced in patients with 
RRMS. This inflammatory reaction was characterised by a diffuse infiltration of 
the tissue by T-lymphocytes, and by perivascular aggregates of mononuclear 
cells, and was associated with prominent microglial activation. Axonal damage 
and degeneration were present throughout the WM, although there was some 
increase around demyelinated plaques (Figure 1.3). Patients with progressive 
disease showed significantly more diffuse axonal injury in the NAWM compared 
with patients with acute or relapsing disease. Finally, no significant correlation 
was found between the focal lesion load and microglia activation or axonal 
injury in the NAWM, supporting the concept that diffuse WM pathology may 
develop independently from focal lesions in progressive MS (Kutzelnigg et al., 
2005; Reynolds et al., 2011).  
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Figure 1.3  On the left, inflammation in the NAWM in PPMS (immunocytochemistry for CD8+ 
cells); on the right, diffuse axonal injury, reflected by axonal swellings and end bulbs in the 
NAWM of a PPMS patient (immunocytochemistry for neurofilament). (Adapted from Kutzelnigg 
et al, 2005). 
 
 
On the other hand, in another histological study looking at the interdependence 
of inflammation, neurodegeneration and disease course, a highly significant 
association between inflammation and axonal injury was seen in the global MS 
population as well as in PPMS alone, supporting a close association between 
inflammation and neurodegeneration in all lesions and subtypes of MS (Frischer 
et al., 2009). 
 
When comparing the cortico-spinal tract pathology of patients with PPMS with 
that of SPMS, Tallantyre et al. found that PPMS patients had a similar degree of 
axonal loss to SPMS patients, but presented a lower extent of demyelination in 
the WM. Therefore, PPMS patients presented a more pronounced axonal loss 
than SPMS patients within similarly demyelinated lesions (Tallantyre et al., 
2009). 
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Figure 1.4 Cortical demyelination in PPMS. On the left, schematic illustration of pathological 
findings in a PPMS brain. In green: focal demyelinated plaques in the white matter; in red: 
cortical demyelination; in blue: demyelinated lesions in the deep grey matter; dark blue dots: 
inflammatory infiltrates in the brain; light blue dots: inflammatory infiltrates in the meninges. 
(Adapted from Kutzelnigg et al, 2005). 
 
 
With regard to GM pathology, Kutzelnigg et al. demonstrated that demyelination 
in the cerebral cortex was significantly greater in patients with progressive MS 
than in those with relapsing MS. Demyelination mainly affected the subpial 
layers of the cerebral cortex, was associated with mononuclear inflammatory 
infiltrates in the meninges, and was significantly correlated with global 
inflammation and microglial activation in the NAWM (Kutzelnigg et al., 2005) 
(Figure 1.4). Recently, Choi et al. investigated the extent of WM perivascular 
and meningeal inflammation on post-mortem brain tissue from 26 cases of 
PPMS; they found that cases showing an increased level of meningeal 
inflammation exhibited a more extensive demyelination and neurite loss in the 
cortical grey matter, and were also those with a more severe disease course 
(i.e. shorted disease duration and younger age at death) (Choi et al., 2012). The 
Authors also reported a lack of tertiary lymphoid-like structures in PPMS brains. 
 
When comparing GM pathology between patients with PPMS and SPMS, 
studies report different results. While early studies found that the degree of 
cortical GM demyelination was similar between PPMS and SPMS, or higher in 
PPMS than in SPMS (Bo et al., 2003; Kutzelnigg et al., 2005), Tallantyre et al. 
showed that the extent of GM demyelination was significantly lower in patients 
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with the PP form of the disease when compared with SPMS (Tallantyre et al., 
2009). The formation of ectopic follicles in the cerebral meninges has been 
investigated in progressive MS and, while in a proportion of SPMS cases the 
presence of ectopic follicles was demonstrated, they were not seen in PPMS 
cases (Magliozzi et al., 2007). 
 
In a post-mortem study in brains of all subtypes of MS (including 11 cases of 
PPMS), remyelination was seen in all forms of MS. This process consists of an 
increased number of oligodendrocytes within WM lesions, that results in a 
myelin density, which is intermediate between fully demyelinated lesions and 
healthy brain tissue. It has been demonstrated that remyelination can be 
extensive also in patients with long standing disease (Patani et al., 2007), and 
appears to be more prominent in the cortex than in the WM (Albert et al., 2007). 
Interestingly, when comparing patients with PPMS and with SPMS with regard 
to remyelination, Bramow et al. found that the proportion of remyelinated 
shadow plaques was higher in the former than in the latter form of disease 
(Bramow et al., 2010). 
 
1.1.5 Diagnosing PPMS: a longstanding challenge 
 
Diagnosing MS is a process that includes clinical and paraclinical laboratory 
assessments to demonstrate dissemination of lesions in space (DIS) and time 
(DIT) and to exclude alternative diagnoses. The Poser committee in 1983 
formalised the diagnostic criteria for MS (Poser et al., 1983), which were based 
on clinical evidence of dissemination in time and space. For the first time, 
paraclinical evidence (a new lesion on MRI or altered evoked potentials) was 
accepted to replace clinical evidence. For a laboratory supported diagnosis, 
intrathecal syntesis of immunoglobulin G had to be detected in the 
cerebrospinal fluid (CSF) analysis. These criteria did not address appropriately 
the diagnostic difficulties posed by the PP form of MS, as in this subtype of 
disease the clinical picture is gradually deteriorating, and often affects one 
single system, at least in the early stages.  
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Thompson’s criteria for diagnosing PPMS addressed this issue, defining three  
levels of diagnostic certainty (definite, probable, and possible) based on clinical 
findings, abnormal CSF, abnormalities on MRI of the brain and spinal cord, and 
visual evoked potentials (Thompson et al., 2000). To achieve a diagnosis of 
definite PPMS, in addition to a documented history of at least one year of 
clinical progression, evidence of intrathecal synthesis of immunoglobulin G 
together with one of the following three MRI criteria was required: (1) nine brain 
lesions, (2) two spinal cord lesions, (3) four to eight brain lesions and one spinal 
cord lesion. In all the studies presented in this thesis, the patients with PPMS 
have been recruited following Thompson’s criteria. These criteria were largely 
integrated in the international diagnostic criteria for MS in 2001 (McDonald et 
al., 2001).  
 
In 2005, Polman’s revisions of McDonald’s criteria simplified the original 
Thompson’s criteria for PPMS, as positive CSF analysis was no longer 
mandatory for a definite diagnosis of PPMS (Polman et al., 2005). In particular, 
a diagnosis of PPMS could be achieved with a negative lumbar puncture, when 
both the spinal cord and brain MRI meet the criteria. Reviewing all the 
diagnostic algorithms proposed over the years, it has been recently reinforced 
the added value of a positive CSF analysis for the diagnosis of PPMS 
(Montalban et al., 2009b). In 2010, the International Panel of Diagnosis of MS 
formulated the 2010 Revisions to the McDonald Criteria (Polman et al., 2011). 
In these revised criteria, an attempt to harmonise MRI criteria for all forms of 
MS has been made, while considering the special diagnostic needs for PPMS 
(see Table 1.1) In particular, a diagnosis of PPMS can be made when there is 
one year of disease progression associated with dissemination in space (DIS) 
of asymptomatic lesions in the brain and in the spinal cord, or with DIS of 
lesions either in the brain or the spinal cord and a positive CSF. 
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C. Positive CSF (evidence of oligoclonal bands and/or elevated IgG index) 
B. Evidence for DIS in the spinal cord based on >2 T2b lesions in the cord 
A. Evidence for DIS in the brain based on >1 T2b lesions in at least 1 area 
characteristic for MS (periventricular, juxtacortical, or infratentorial) 
2. Plus 2 of the 3 following criteriaa: 
1. One year of disease progression (retrospectively or prospectively determined) 
PPMS may be diagnosed in a subject with: 
a  If a subject has a brainstem or spinal cord syndrome, all symptomatic lesions are excluded from the 
 criteria 
b Gadolinium enhancement is not required 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.1 Diagnostic criteria for PPMS according to the 2010 Revisions to the McDonald 
Criteria  
 
 
Very recently, a study from Kelly et al. compared the sensitivity of the diagnostic 
criteria for PPMS with particular reference to spinal cord criteria and the utility of 
the CSF oligoclonal bands (Kelly et al., 2012). The Authors found that the 
sensitivity of Thompson’s criteria (Thompson et al., 2000) was 64%, while that 
of McDonald’s 2010 revisions was 77%. They concluded that an alternative 
criterion requiring two of: (i) one or more lesions in two of three regions typical 
for demyelination on brain MRI; (ii) one T2-w spinal cord lesion typical for 
demyelination on spinal cord MRI; (iii) presence of CSF oligoclonal bands; 
would increase the diagnostic sensitivity for PPMS.  
 
1.1.6 Failures and hopes in the therapy of PPMS 
 
1.1.6.1 Failures 
The treatment of patients with RRMS has made great progress over recent 
years, as new and effective disease-modifying and immunosuppressive drugs 
have been licensed or are in the final phases of clinical trials (Wiendl and 
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Hohlfeld, 2009). The same cannot be said for patients with PPMS, for whom no 
disease-modifying drug has been shown to be effective in slowing the clinical 
deterioration over time (Fitzner and Simons, 2010). The largest placebo-
controlled trial conducted so far on this subtype of disease involved 943 patients 
with PPMS, and evaluated the immunomodulatory drug, glatiramer acetate (GA) 
(Wolinsky et al., 2007). This clinical trial had to be prematurely interrupted, as 
an interim analysis showed no effect on disease progression after two years. 
After the termination of the clinical trial, a post-hoc analysis showed a possible 
effect of GA in slowing disease progression in a subgroup of PPMS patients 
(i.e., male patients who showed more rapid progression when untreated). 
 
Two small, single-centre placebo-controlled trials have been conducted in 
London and in Barcelona to test the efficacy of another immunomodulatory 
drug, interferon beta (IFN beta) in PPMS (Leary et al., 2003; Montalban, 2004). 
Both trials failed to demonstrate a reduced clinical progression in patients 
treated with the active medication. More recently, a phase II, placebo-controlled, 
single-center trial with IFN beta-1b in PPMS, showed statistically significant 
differences in the Multiple Sclerosis Functional Composite score (MSFC) 
(Cutter et al., 1999) and in T1 and T2 lesion volumes (Montalban et al., 2009a) 
between the placebo and the treatment arm which were favoring the treatment. 
 
A small, phase II trial with mitoxantrone, an immunosuppressant agent, was 
conducted in patients with PPMS, using 12mg/m2 of mitoxantrone or placebo 
every  3 months for 24 months. No benefit on time to sustained progression was  
demonstrated in patients on treatment versus those on placebo (Stuve et al., 
2004).  
 
Cladribrine, a synthetic deoxyadenosine analog, is an oral immunomodulatory 
agent that produces targeted, sustained reduction of T and B lymphocytes. This 
drug has been tested in patients with SPMS and PPMS, and failed to show a 
reduction in disease progression in both groups. However, there was sustained 
reduction in the number and volume of Gadolinium-enhancing lesions on MRI 
(Rice et al., 2000). 
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More recently, the B cell depleting monoclonal antibody rituximab, that showed 
an impact on disease activity in RRMS (Hauser et al., 2008) and neuromyelitis 
optica (Bedi et al., 2011), was tested in PPMS. In total, 439 PPMS patients 
received two 1,000 mg intravenous rituximab or placebo infusions every 24 
weeks, through 96 weeks (4 courses). There was no effect on the primary 
endpoint (time to confirmed disease progression) in the group treated with 
rituximab, but a post-hoc subgroup analysis suggested that selective B-cell 
depletion may affect disease progression in younger patients, particularly those 
with inflammatory lesions (Hawker et al., 2009).  
 
Several explanations have been proposed to justify the failure of all the clinical 
trials in PPMS (Fitzner and Simons, 2010). One possible reason is that the 
immunomodulatory and immunosuppressive drugs tested may not be able to 
target the inflammatory cells in progressive MS, as there could be a 
compartmentalization of the inflammatory cells inside the blood-brain barrier, 
which is not sufficiently permeable to most drugs. Also, specific inflammatory 
components that seem to be of particular relevance in the pathogenesis of 
progressive MS, such as cells belonging to the innate immune system 
(activated microglia and dendritic cells), are not the main targets of current 
therapies.  
 
However, other reasons may have contributed to the failure of the reported 
clinical trials. Firstly, as PPMS is a relatively uncommon form of disease, patient 
cohorts are usually rather small, and therefore drawing meaningful conclusions 
from available data is often challenging. Secondly, the time frames of the 
clinical trials performed so far could be too short to observe clinically meaningful 
treatment effects in PPMS, considering the need for progression-based-only 
primary outcome measures in these patients. Finally, without reliable prognostic 
markers of progression, recruitment is unselected (i.e. not stratified according to 
the risk of progression), and it is very difficult to identify treatment effects in 
patients with a low risk of progressing rapidly. Therefore, the studies presented 
in Chapters V-VIII aim at looking for reliable (radiological and clinical) markers 
of clinical progression in PPMS, which in future may be used to recruit in clinical 
trials patients who are more likely to respond to treatments. 
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1.1.6.2 Hopes 
Several clinical trials testing the efficacy of various drugs on slowing clinical 
progression in PPMS are currently ongoing, and a summary of the tested 
compounds, their mechanism of action, and the study design and status is 
provided in Table 1.2. 
 
Fingolimod, a sphingosine 1-phosphate receptor agonist which, in addition to an 
effect on lymphocyte migration, has been shown to affect the maturation of 
dendritic cells (Brinkmann, 2009), is currently being assessed in PPMS patients 
(see Table 1.2). A modulation of the activation state of microglial cells may be 
obtained with Minocycline, a traditional antibiotic with profound anti-
inflammatory and neuroprotective effects, which is now considered for treating 
PPMS (Chen et al., 2011).  
 
Several studies in experimental autoimmune encephalomyelitis, the animal 
model of MS, have provided encouraging data on the neuroprotective effects of 
drugs that in future could be used in the treatment of PPMS (Fitzner and 
Simons, 2010; Fox et al., 2012).  
 
With regard to symptomatic treatment of PPMS, two phase III studies involving 
patients with all forms of MS have recently demonstrated that fampridine (4-
aminopyridine), a potassium channel blocker, has a significant effect in 
improving walking speed (one third of the patients improved of about 25% their 
walking speed) (Goodman et al., 2009; Goodman et al., 2010). 
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Idebenone Syntetic analogue of coenzyme 
Q10, is a potent antioxidant, 
protecting cell membranes and 
mitochondria from oxidative 
damage 
Phase I/II  Recruiting 
Masitinib Selective tyrosine kinase inhibitor 
that targets the survival, 
differentiation, and degranulation of 
mast cells, thus indirectly controlling 
their array of proinflammatory and 
vasoactive mediators 
Phase III Recruiting 
FTY720 
(Fingolimod) 
Modulates sphingosine-1-
phosphate (S1P) receptors and has 
strong immunoregulatory features  
Phase III Ongoing, but not 
recruiting 
Ocrelizumab Recombinant humanised antibody 
selectively targeting CD20+ B cells  Phase III  
Recruiting 
 
Hydroxyurea Inhibiting the synthesis of 
deoxynucleotides essential for viral 
transcription, suppresses the 
replication of Epstein-Barr virus 
Phase II Recruiting 
 
Natalizumab Monoclonal antibody that inhibits 
leukocyte migration across the 
blood-brain barrier 
Phase II Completed 
 
Erythropoietin Selective oral tyrosine kinase 
inhibitor, effectively inhibits the 
survival, migration and activity of 
mast cells 
Phase II Recruiting 
Drug Action Study Design Status 
 
 
Table 1.2 Ongoing clinical trials on patients with PPMS in December  2012 (source: U.S. 
National Institutes of Health). 
 
 
1.2  Imaging primary-progressive multiple sclerosis  
 
PPMS presents unique characteristics that are different from the other subtypes 
of disease (Thompson, 2004; Miller and Leary, 2007). Despite the irreversible 
accumulation of neurological disability, patients with PPMS  have a relatively 
low lesion load and lesion activity, as detected on T2-weighted, T1-weighted, 
and Gadolinium-enhanced brain scans (Thompson, 2004). One explanation for 
the dissociation between the clinical picture and the radiological features, 
defined as the “clinico-radiological paradox” (Barkhof, 2002), has been provided 
by data obtained with advanced MRI techniques (Miller and Leary, 2007), which 
have allowed the  detection of abnormalities  occurring outside visible lesions, 
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thus contributing towards a more complete understanding of the mechanisms 
that underlie clinical progression in MS (Rocca et al., 2012a). This section is 
divided in three parts. In the first part, a summary of the main findings of the 
studies conducted on lesions (in the WM and in the GM) and on atrophy will be 
provided; in the second part, a review of previously published investigations, 
which used the advanced MRI techniques applied in the studies presented in 
this thesis (i.e. diffusion tensor imaging (DTI), and magnetization transfer 
imaging (MTI)), will be presented. In the third part, the main findings of the 
studies conducted in our cohort of patients with early PPMS will be 
summarized.  
 
1.2.1 Studies on lesions and atrophy 
 
1.2.1.1 WM and GM lesions 
With regard to active lesions, it has been shown that in the early phase of 
progression, MR-visible inflammation is more frequent than in the later stages of 
the disease; however, this early inflammation does not seem to have a 
significant impact on the subsequent accumulation of clinical disability (Ingle et 
al., 2005; Khaleeli et al., 2010). T2-weighted lesions have been shown to have 
a small predictive value on the rate of clinical progression over 15 years in 
PPMS (Mostert et al., 2010). On the other hand, they have been found to have 
a complementary role with grey matter metrics in predicting clinical deterioration 
over time in PPMS (Tur et al., 2011a). T2-weighted lesions can be seen in both 
the brain and spinal cord; in the latter, diffuse (mild) hyperintensity, only weakly 
correlated with clinical disability scores, are often seen in PPMS (Lycklama et 
al., 2003).  
 
The application of approaches, such as lesion probability mapping (LPM), 
described in the Chapter II of this thesis, has allowed researchers to explore the 
spatial location of T2-weighted and T1-weighted lesions in PPMS. Using LPM, it 
has been demonstrated that lesions are more frequently localized in the 
superior and posterior regions of the corona radiata in PPMS than in RRMS (Di 
Perri et al., 2008). 
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The application of double inversion recovery (DIR) sequences, diffusively used 
in MS to visualize cortical lesions in-vivo (Geurts et al., 2005; Calabrese et al., 
2007; Geurts et al., 2011; Geurts et al., 2012), has shown that 80% of patients 
with PPMS have lesions in the cerebral cortex. Comparing the spatial location 
of cortical lesions in different patient groups, it has been found that there is no 
difference between PPMS and RRMS in their distribution across brain lobes, 
nor in their frequency and volume. However, the maximum probability of the 
occurrence of cortical lesions was demonstrated to be twice as high in PPMS 
than in RRMS patients (Calabrese et al., 2010). Importantly, in PPMS, the 
number and extent of cortical lesions correlated with clinical progression over 
two years (Calabrese et al., 2009). These data have been recently confirmed in 
a 5-year perspective study which included 44 patients with PPMS (Calabrese et 
al., 2012). 
 
1.2.1.2 Atrophy 
Global and fractional brain volume loss, as well as spinal cord atrophy, are 
visible on MRI scans from the earliest stage of PPMS (Sastre-Garriga et al., 
2004; Rocca et al., 2012a), and have been shown to progress relentlessly over 
time in this  patient group (Sastre-Garriga et al., 2005a; De Stefano et al., 2010; 
Laule et al., 2010). GM atrophy, as measured by MRI, probably reflects a 
combination of demyelination, neuroaxonal degeneration, and glial damage, but 
the relative contribution of each of these processes to cortical volume loss has 
yet to be conclusively established (Wegner et al., 2006; Pomeroy et al., 2008; 
Geurts et al., 2009). 
 
Comparing patients with PPMS and SPMS, the Amsterdam group has recently 
reported that patients with PPMS have a higher GM volume, but a similar low 
WM volume, when compared with patients with SPMS (Roosendaal et al., 
2011). This study also confirmed the presence of a relationship between GM 
atrophy and T2 lesion volume, that had been already reported in a previous 
study of a cohort of RR and PPMS patients (De Stefano et al., 2003). 
 
The application of voxel-based morphometry (VBM, see Chapter II for technical 
details) (Ashburner and Friston, 2000), has allowed the localization of areas of 
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volume loss in patients with this form of disease. In particular, atrophy of the 
thalamic region has been demonstrated in PPMS in several studies (Sepulcre et 
al., 2006; Ceccarelli et al., 2009). In one of these studies, Sepulcre et al. 
demonstrated a loss of GM in the putamen, caudate, thalami, and cortical and 
infratentorial areas as the disease evolved over one year (Sepulcre et al., 
2006). This study found a correlation between bilateral thalamic atrophy and T2 
lesion load, confirming a previous observation of a correlation between regional 
GM volume loss (in the bilateral central sulci, left angular gyrus, and head of the 
left caudate nucleus) with focal WM damage (T1 lesion volume) (Pagani et al., 
2005b). In the study presented in the Chapter III of this thesis I extended these 
data, exploring whether there was a link between regional GM volume loss, as 
measured using VBM, and regional WM damage localized outside focal lesions 
in PPMS.  
 
Brain and cervical cord atrophy in PPMS have been shown to be clinically 
relevant and more pronounced in patients with motor disability (Rovaris et al., 
2008). Moreover, the reduction of brain volume over two years has been 
demonstrated to predict long-term disease progression in a large, multicenter 
study, involving centers from the MAGNIMS consortium (Khaleeli et al., 2008b). 
Correlations between the localization of areas of GM volume loss and cognitive 
functional scores are of particular interest in this form of disease. Riccitelli et al. 
have recently demonstrated a significant GM loss in the anterior cingulated 
cortex and in the right superior temporal gyrus in cognitively impaired versus 
cognitively preserved PPMS patients (Riccitelli et al., 2011) (Figure 1.5).  
 
 
 
Figure 1.5 This picture shows the distribution of regions of significant GM atrophy (voxels in 
blue) and T2-visible lesions (voxels in red) in cognitively impaired versus cognitively preserved 
patients with PPMS (Adapted from Riccitelli et al, 2011).  
 
 
Interestingly, Anderson et al. have found that hippocampal atrophy occurs both 
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in patients with RRMS and PPMS, but an association of hippocampal volume 
with memory performance was observed only in patients with PPMS (Anderson 
et al., 2010). Finally, a very recent study performing a voxel-wise analysis of 
cervical cord volume in patients with different subtypes of MS, found significant 
cord atrophy in PPMS, which correlated with clinical disability and motor 
impairment (Rocca et al., 2012b). 
 
1.2.2  Studies using MTI and DTI 
 
1.2.2.1 Magnetisation transfer imaging (MTI) 
As discussed in detail in the second Chapter of this thesis, MTI provides an 
index, called magnetization transfer ratio (MTR), which reflects the extent of the 
magnetization exchange between the pool of free protons in tissue water and 
the pool of protons bound to macromolecules. MTR values are reduced in 
damaged brain tissues, and post-mortem studies have shown that reduced 
MTR correlate with the degree of demyelination and axonal loss in MS (van 
Waesberghe et al., 1999; Schmierer et al., 2004). Early studies have 
demonstrated that MTR values of lesions visible on T2-weighted images are 
significantly lower compared to those of the surrounding tissue in patients with 
PPMS (Gass et al., 1994; Leary et al., 1999). Both region-of-interest (ROI) and 
histogram-based analyses (see Chapter II for details) have shown reduced 
MTR in the NAWM of patients with PPMS when compared with healthy controls 
(Gass et al., 1994; Leary et al., 1999; Rovaris et al., 2008), and demonstrated 
that the damage in the NAWM is more severe in patients with the progressive 
form of MS than in those with RRMS (Filippi et al., 1999; Tortorella et al., 2000) 
However, when comparing the MTR values of the NAWM between patients with 
SPMS and PPMS, no significant difference was found (Rovaris et al., 2001). 
Interestingly, Rovaris et al. demonstrated that NAWM MTR values are only 
weakly correlated with T2- and T1-visible lesion load (Rovaris et al., 2001). This 
result is in line with the data emerging from post-mortem studies and discussed 
in the Pathology section of this Chapter, by confirming in vivo that NAWM 
damage could not derive exclusively from the Wallerian degeneration of axons 
transected in lesions, but also develops independently of focal and macroscopic 
WM damage.  
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With regard to the GM, several studies have demonstrated a significant 
reduction of MTR in PPMS compared with healthy controls, and correlations 
between lower MTR and greater clinical disability (Cercignani et al., 2001a; 
Dehmeshki et al., 2003; Ramio-Torrenta et al., 2006). A recent cross-sectional 
study focusing on the relationship between GM damage and cognitive 
impairment in this form of disease, has shown that GM MTR appears to be 
strongly correlated with overall cognitive dysfunction; this result highlights the 
role of abnormal GM integrity in determining cognitive impairment in PPMS (Tur 
et al., 2011b).  
 
MTI has also been employed to investigate the damage in the cervical cord of 
patients with PPMS. In particular, an early study from the Amsterdam group 
found that a composite measure derived from a combination of cervical spine 
MTR and cross-sectional area (a measure of the spinal cord volume loss), 
correlated significantly with clinical disability, as measured by the EDSS 
(Nijeholt et al., 2000). Comparing SPMS with PPMS, the Milan group found that 
cord MTR histogram metrics were significantly worse in the former group 
(Rovaris et al., 2001). In the same study, by combining the cross-sectional area 
at the C2 level with the MTR histogram peak height, a significant correlation 
with disability was found.  
 
1.2.2.2 Diffusion tensor imaging (DTI) 
As discussed in detail in Chapter II, DTI allows quantitative (and in vivo) 
measurements of brain tissue microstructure. Among the DTI-derived 
measures, mean diffusivity (MD), which reflects the magnitude of diffusion, and 
fractional anisotropy (FA), which is a measure of tissue integrity and 
organization, have been widely employed to explore tissue damage in MS. Data 
from post-mortem analysis of MS brains showed that an increased MD and a 
lower FA correlate with a more pronounced degree of demyelination and, to a 
lesser extent, axonal loss (Schmierer et al., 2007; Moll et al., 2011). 
 
In an early study that included patients with PPMS, Ciccarelli et al., using ROIs, 
found a significantly reduced anisotropy and a trend toward increased diffusivity 
 49
Chapter I: Introduction to primary-progressive MS  
 
 
 
in both infratentorial and supratentorial NAWM of patients compared with 
controls. In the same study, the mean diffusivity in infratentorial NAWM 
correlated strongly with disease duration (Ciccarelli et al., 2001). When the 
lesional and WM diffusion metrics were compared between the different forms 
of MS, including PPMS, no significant differences were found (Droogan et al., 
1999). This result was confirmed by Cercignani et al., who detected no 
difference between different MS subgroups in MD and FA histograms obtained 
from normal-appearing brain tissues and T2 visible lesions (Cercignani et al., 
2001b). Different studies have investigated the relationship between NAWM 
DTI-derived metrics damage and T2 lesion load, and have found only a partial 
correlation between these variables (Rovaris et al., 2005). This supports the 
concept that the damage in the NAWM could not entirely depend upon 
retrograde degeneration of axons transected in T2 visible lesions. 
 
DTI has also been employed to explore the GM of patients with PPMS. Bozzali 
et al. demonstrated that GM diffusion-derived metrics were abnormal in patients 
with MS, including a subgroup of PPMS, when compared with healthy controls, 
and that GM changes were more pronounced in patients with a progressive 
course than in patients with RRMS (Bozzali et al., 2002). Rovaris et al. showed 
that DTI abnormalities of the GM worsen over one year (Rovaris et al., 2005), 
and that GM diffusion abnormalities at baseline predict disability progression 
over five years (Rovaris et al., 2006). Mesaros et al. have recently found that 
the changes in DTI-derived metrics in the thalamus over fifteen months predict 
the long-term accumulation of disability in PPMS (Mesaros et al., 2011). 
 
The voxel-wise analysis of DTI metrics has allowed the exploration of regional 
changes in PPMS in an unbiased way (see Chapter II for details). The Milan 
group, using a voxel-based approach, found abnormalities in DTI measures in 
brain areas associated with motor and cognitive functions (Ceccarelli et al., 
2009) (Figure 1.6).  
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Figure 1.6 This picture shows statistical parametric mapping (SPM) regions (color-coded for t 
values) with increased GM mean diffusivity in PPMS patients compared with controls (Adapted 
from Ceccarelli et al., 2009) 
 
 
An interesting voxel-wise approach that allows the detection of regional 
changes in FA along the main white matter tracts is tract-based spatial statistics 
(TBSS) (Smith et al., 2006), which is described in detail in the next Chapter. We 
have used this method for the first time in patients with early PPMS, as 
described in Chapter III, VI and VIII. In particular, in the study presented in 
Chapter III, we employed TBSS to compare the NAWM of early PPMS patients 
with healthy controls. In the study presented in Chapter VI, we combined TBSS 
and MTR to explore short-term WM changes in the same patients. Finally, in 
Chapter VIII we investigated whether WM FA at baseline predicts disability 
progression and cognitive dysfunction after five years in the same cohort of 
PPMS.  
 
DTI has also been employed to investigate the damage in the spinal cord of 
patients with PPMS. MD and FA have been shown to be abnormal in patients 
with PPMS compared with healthy controls (Agosta et al., 2005). The Milan 
group studied the spinal cord of a group of MS patients, including 15 patients 
with PPMS, for two-years, and showed an increase in average MD and a 
decrease in average FA over the follow-up period. Moreover, while the increase 
in MD was independent of clinical course, the decrease in FA was more 
pronounced in PPMS than in patients with other forms of MS (Agosta et al., 
2007).  
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1.2.3  Lessons from the early phase: the London studies in early PPMS 
 
PPMS provides a useful model to study the mechanisms of progression in MS, 
as fixed disability progresses from disease onset and cannot be related to 
relapse activity. The important information obtained in the studies reported in 
the previous  sections of this Chapter relate to patients with well established 
PPMS. However, data from natural history studies show that most patients 
attain high levels of disability in the first years after disease onset, while in the 
following years the accrual of disability slows down (Cottrell et al., 1999). 
Therefore, it is important to investigate patients with PPMS as early as possible 
in the course of disease, to explore the mechanisms underlying clinical 
progression which are responsible for the most clinically active phase of this 
form of disease. For this purpose, a cohort of 50 patients with PPMS in the early 
phase of disease (i.e. within five years of clinical onset) has been recruited in 
our Unit in London and followed-up for five years with clinical assessments and 
conventional and non-conventional MRI imaging. Here we summarise the main 
findings obtained from our studies in this unique cohort of patients, to give the 
clinical and radiological background to the studies presented in the Chapter III, 
IV, VI, and VII of this thesis. 
  
Cross-sectional data on the London PPMS cohort, using different non-
conventional imaging techniques, showed that brain abnormalities and volume 
loss are present since the early stages of the disease, affect both the GM and 
the WM, and are clinically relevant (Sastre-Garriga et al., 2004; Sastre-Garriga 
et al., 2005a; Ramio-Torrenta et al., 2006). Localised GM damage was 
described in a study by Khaleeli et al., who found a significant reduction of MTR 
in the right pre- and left pre- and post-central gyri, right middle frontal gyrus, left 
superior frontal gyrus, bilateral superior temporal gyri, left insula, right insula 
and visual cortex, and thalamus bilaterally, when compared with controls. In the 
same study, a correlation was found between the MTR values in the cortical 
areas of the motor network and the EDSS score, and between the MTR values 
of the cognitive network and the Paced Auditory Serial Attention Test (PASAT) 
scores (Khaleeli et al., 2007b). In addition to cortical regions, regional GM 
atrophy has been shown to affect also deep GM (Sepulcre et al., 2006).  
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Longitudinal studies in the same cohort showed that NAWM MTR predicts 
clinical progression over one year (Khaleeli et al., 2007a), while GM MTR, 
proposed as a potential surrogate marker of clinical progression, predicts 
clinical deterioration over three years (Khaleeli et al., 2008a) . A recent study 
has extended the follow-up to five years and showed that the combination of 
GM MTR and T2-weighted lesion load measured at baseline significantly 
predicts clinical progression after five years (Tur et al., 2011a). The relevance of 
GM MTR in predicting long-term clinical evolution in PPMS is further supported 
by Penny et al., who showed that a lower baseline GM MTR predicts a poorer 
performance on neuropsychological tests assessing attention, speed of 
information processing and executive function after five years (Penny et al., 
2010). In summary, these studies reported a significant contribution of NAWM 
and GM pathology, as reflected by MTR changes, to clinical and cognitive 
impairment, but did not localise the regions that significantly contributed to the 
findings, as histogram metrics were derived from the whole GM and NAWM. 
 
1.3   Two key unanswered questions on PPMS: rationale for this thesis 
 
Against the background presented in this Chapter, this thesis focuses on 
addressing the following two questions, fundamental to the pathogenesis of 
progression in PPMS: 
 
(1) Is there is a spatial and temporal link between the pathological 
processes occurring in the NAWM and in the GM of patients with PPMS? 
In other words, is GM damage secondary to axonal degeneration and 
demyelination in connected WM tracts or alternatively, does it represent 
the initial target of the disease process that leads to subsequent axonal 
degeneration in the WM? 
 
(2) Which regions of WM abnormalities (within lesions and NAWM) and 
GM damage significantly contribute to clinical progression and cognitive 
deterioration? 
 
The subsequent Chapters of this thesis will try to answer these two questions. 
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After Chapter II, which provides a description of the conventional and advanced 
MRI techniques applied in this thesis, the first question is addressed. In 
particular, in Chapter III, the spatial relationship between the damage occurring 
in the WM outside visible lesions and in the GM in patients with early PPMS is 
described, while the temporal relationship between NAWM and GM damage in 
the same cohort of patients will be presented in Chapter IV. 
Chapters V-VII address the second question. In particular, the role of lesional 
WM damage in predicting clinical progression in patients with well established 
PPMS will be discussed in Chapter V. In Chapter VI, short-term changes in WM 
tract integrity, and their clinical relevance in patients with early PPMS, are 
explored. Finally, in Chapter VII, the contribution of early damage in WM and in 
GM to long-term clinical deterioration and cognitive dysfunction in this form of 
disease is investigated. 
 
  
 
 
 
Principles of MRI, DTI, MTI, 
and notes on imaging analysis 
 
 
 
 
 
 
CHAPTER II 
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This Chapter provides an overview of the physics principles of magnetic 
resonance imaging (MRI), and an introduction to the conventional and 
quantitative MRI techniques, diffusion tensor imaging (DTI) and magnetisation 
transfer imaging (MTI), and to the post-processing methods employed in the 
clinical studies presented in the subsequent Chapters of this thesis.  
 
2.1  Principles of MRI 
 
MRI generates images non-invasively with high spatial resolution. Since MRI 
does not emit ionizing radiation, it allows repeated in vivo imaging of an 
individual without the potential risk of neoplasia. MRI has been applied in many 
branches of science, but this discussion will focus on its application to brain 
imaging (Deoni, 2011). 
 
2.1.1 Physics of MRI 
 
As two thirds of the human body is made up of water, human tissue is rich in 
water hydrogen atoms. These are at the origin of the nuclear MR signal used to 
generate conventional MR images.  
 
The nucleus of a hydrogen atom consists of a single proton surrounded by only 
one electron. In quantum mechanics, atomic nuclei such as protons have a 
fundamental property, defined spin, which is a type of angular momentum that 
results from the sum of the spins of the constituent particles. Protons have a 
positive electrical charge, and rotating around their own axis, they produce a 
small magnetic field. In presence of an externally applied magnetic field (B0), all 
the nuclear spins tend to align with the magnetic field, showing a peculiar 
motion called precession, which is characterised by the circular movement of 
the spin axis forming a cone shape (Figure 2.1).  
 
The precession frequency is described by the Larmor equation: 
 
 00 B   (2.1) 
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where ω0 is the Larmor frequency given in Hz or rad s-1, B0 is the strength of 
the externally applied magnetic field given in Tesla, and γ is the gyromagnetic 
ratio, given in Hz/Tesla. The Larmor equation states that the precession 
frequency is proportional to the external magnetic field, and this relationship is 
determined by the gyromagnetic ratio, which is different for different nuclei. For 
hydrogen,   is 42.6 MHzT-1. Therefore, in an MRI scanner with a magnetic field 
of 1.5 Tesla, such as the one used for all the studies presented in this thesis, 
the hydrogen nuclei precess at a frequency of around 64 MHz.  
 
 
 
 
Figure 2.1. Proton behavior in an external magnetic field. The left side of the figure describes 
the precession movement. The right side of the picture shows that, when an external magnetic 
field B0 is applied to spinning protons with random orientations, their magnetic moments tend to 
align in a parallel or anti-parallel orientation with respect to B0. The big arrow represents the net 
magnetisation (M) of the spinning protons. 
 
 
Quantum mechanics tells us that the spin of each proton may have two different 
energy levels, which determine its alignment to the external magnetic field. In 
particular, at the low energy level a spin is aligned with the magnetic field, 
whereas at the high energy level the vector is anti-parallel to the field (Figure 
2.1). At equilibrium, the population of anti-parallel spins is almost equivalent to 
that of parallel spins. However, there is a small population difference, due to the 
fact that the low energy state (parallel to the field) slightly dominates the high 
energy state.  
 
This equilibrium magnetisation can be represented as a vector (M) pointing in 
the direction of the magnetic field (defined as the z-axis). The equilibrium 
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magnetisation cannot be measured, because it lies in the same direction as the 
main magnetic field. To measure the tissue magnetisation, we need to perturb 
the system and observe its return to equilibrium. This can be achieved by 
applying electromagnetic radiation to the system.  In order to interact with the 
system, this radiation must be supplied at the Larmor frequency, and usually a 
radio frequency (RF) pulse is used. From a quantum mechanical point of view, 
the pulse provides the energy required for the transition of some of the spins in 
the low energy level to the high energy level. A more intuitive way of explaining 
this phenomenon can be derived from classical physics. Like every 
electromagnetic wave, the RF pulse has a magnetic field component, B1. 
Assuming that the B1 field is perpendicular to B0, the net magnetisation M will 
start precessing around B1 as well as around B0. In order to simplify the 
description of the system, we can introduce a reference frame that rotates at the 
same angular frequency (the Larmor frequency) as the magnetisation. In this 
system, at equilibrium the net magnetisation M appears stationary. 
 
2.1.2   From the spin-echo phenomenon to the generation of signal  
 
During an RF excitation, the combined precession around both fields 
corresponds to a simple rotation towards the x-y plane. The angle by which M is 
rotated depends on the duration and the amplitude of the pulse, and it is called 
the flip angle. For example, a  90° pulse rotates completely M from the z to the 
x-y plane. 
When the RF pulse is switched off, the spins return to equilibrium, releasing a 
signal that is detected by a coil that acts as an antenna, as described below. 
The spin-echo (SE) phenomenon was described by Erwin Hahn in his 1950 
paper (Hahn, 1950), and was further developed by Carr and Purcell who 
pointed out the advantages of a 180° refocusing pulse (Carr and Purcell, 1954).  
 
In the basic SE sequence, a RF 90° pulse (of magnitude given by the “flip 
angle”) applied along the y axis of the rotating frame (i.e. perpendicular to B0), 
flips M into the horizontal (x-y) plane. This process produces a transverse 
magnetisation, because it causes protons 1) to perform a transition to a higher 
level of energy and 2) to precess in phase at the resonance (Larmor) frequency.  
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When the RF pulse is switched off, protons start losing phase coherence and 
the transverse magnetisation disappears.  This process is called transverse 
relaxation or spin-spin relaxation, as it is caused by the interaction between the 
proton and other magnetic entities, such as other nuclear or electronic spins.  
 
At the same time, protons start returning to a lower level of energy, and the 
longitudinal magnetisation returns to its original size in the direction of the 
magnetic field. This process is called longitudinal relaxation or spin-lattice 
relaxation, and is due to the spins releasing the energy obtained from the RF 
pulse to the surrounding lattice, and returning to their original equilibrium state 
(Bloch, 1946).  
 
Two time constants describe these processes: 1) T2, which is the time constant 
for decay of the transverse magnetisation in a homogeneous static magnetic 
field; 2) T1, which is the time constant for the recovery of the longitudinal 
magnetisation. As transverse relaxation is faster than longitudinal relaxation, T2 
is always shorter than T1 (Figure 2.2).  
 
Different tissues, because of their different chemical constitutions and different 
physical states, will have different relaxation times.  
 
Figure 2.2. T1 recovery and T2 decay. The time needed for 63 % of the longitudinal 
magnetisation to recover after being flipped into the magnetic transverse plane by a 90° RF 
pulse is defined as T1 (left side of the figure); at a time equal to T2 after the occurrence of the 
transverse magnetisation, there has been a decay of the detectable signal to 37% of its original 
value (right side of the figure). 
 
 
After a 90° pulse, local magnetic inhomogeneities in B0 cause protons to 
resonate at slightly different frequencies at slightly different positions within 
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each voxel. This determines a faster dephasing than would be expected from 
spin-spin interactions alone, and therefore transverse magnetisation (and 
induced signal) is lost exponentially. This type of signal is called a Free 
Induction Decay (FID) signal, and is characterised by a reduction in intensity 
with time and by a constant frequency (Figure 2.3). The time constant of this 
decay is called T2*, and is always shorter than T2.  In simple words, T2* 
incorporates T2 effects, but also some other causes of spin dephasing, such as 
field inhomogeneity, local susceptibility, etc. These latter effects can be 
compensated by using a 180° (refocusing) pulse, thus generating a SE. 
 
In order to understand this, we can think that phase coherence is lost because 
different spins precess at slightly different frequencies, i.e., some will precess 
faster and others slower. After a given interval a 180° RF pulse is applied along 
the y axis. This second pulse reverses completely the phase of the protons. 
Spins will continue to precess at the same angular frequency; however, now 
their respective positions have been reversed. After an interval identical to the 
one between the 90° and the 180° pulse, they will be in phase again, producing 
a spin-echo signal (Hahn, 1950). Following the spin echo, coherence is again 
lost as the protons continue to resonate at slightly different frequencies due to 
non-uniformities in the main magnetic field. If another 180° pulse is applied, 
coherence can again be established for a second spin echo. Multiple spin echo 
signals can be produced if the original 90° pulse is followed by multiple 180° 
pulses (spin echo train) (Carr and Purcell, 1954). The main difference between 
T2 and T2* relaxation is that the T2* processes can be refocused, whereas the 
T2 processes cannot, as they result from random fluctuations in the Larmor 
frequency at the molecular level.  
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Figure 2.3. Free Induction Decay (FID). FID is the signal decay due the inhomogeneity of the 
local magnetic field, which in turn depends on 1) the non-uniformity of the external magnetic 
field due to imperfections in the windings of the coil itself and 2) the differences in magnetic 
susceptibility between adjacent regions. In a perfect magnetic field, the value of T2* can 
approach that of T2.  
 
 
2.1.3 Spatial encoding 
 
Spatial information is derived by three gradient coils which generate magnetic 
field gradients along three orthogonal axes that can be referred to as z, x, and y 
(Figure 2.4): 
 
1) Slice select gradient (GSS, Gslice, “z”) 
2) Phase encoding gradient (GPE, Gphase, “y”) 
3) Frequency encoding (or readout) gradient (GFE, Gread, “x”) 
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Figure 2.4. Dual spin echo sequence diagram, showing when the different gradients are 
applied. In the case of a dual spin echo sequence, a 90° excitation pulse is applied, followed by 
a 180° pulse refocusing pulse. This creates a spin echo which is the measured signal. A 
subsequent 180° refocusing pulse within the TR time generates a successive echo at a different 
TE.  
 
 
For a two-dimensional (2D) image, frequency encoding is applied in one 
direction and phase encoding in the other. For a three-dimensional (3D) image, 
the slice selection is not employed, frequency encoding is applied in one 
direction and phase encoding in the other two. The 3D approach allows higher 
spatial resolution and higher signal-to-noise ratio compared with 2D scanning, 
but is characterised by a relatively long scan time.  
 
The first step of spatial encoding consists in selecting the slice plane. To do 
this, the slice select gradient (GSS) is applied in the direction of the z axis, 
perpendicular to the desired slice plane. As a result, the protons localized at 
different physical positions along this direction precess at a slightly different 
Larmor frequency around the direction of B0. In other words, adding this 
gradient to B0, the protons of the selected slice will present a specific resonance 
frequency proportionate to GSS, according to the Larmor equation. A 90° RF 
pulse (selective pulse) is simultaneously applied, with the same frequency as 
that of the protons in the selected slice, and only those protons will be excited 
62 
Chapter II: Introduction to MRI, DTI and MTI 
 
 
 
and will contribute to the formation of a transverse magnetisation. At time 
t=TE/2 a 180° pulse is applied which rephases the protons that are getting out 
of phase and, at time TE, an echo is produced. As none of the protons located 
outside the selected slice plane are excited, they will not emit a signal. The RF 
bandwidth and the amplitude of the GSS determine the slice thickness, and 
sequential excitations select different slices to cover the tissue under 
investigation.  
 
The second step in spatial encoding consists in applying a phase encoding 
gradient (GPE), which is applied in the direction of the y axis (orthogonal to the 
GSS) after the 90° pulse and before acquisition in order to induce different 
phases to the echo signal. While it is applied, it modifies the spin resonance 
frequencies, inducing dephasing, which persists after the gradient is interrupted. 
This results in the protons at different positions in the gradient having 
accumulated different phases. In particular, the protons in the same row, 
perpendicular to the gradient direction, will all have the same phase. This phase 
difference lasts until the signal is recorded. On receiving the signal, each row of 
protons will be slightly out of phase, and this translates in their signals being 
more or less out of phase. In order to decipher the phase information, it is 
necessary to repeat this step with increasing phase encoding amplitude, so that 
spins at certain position will be characterised a unique combination of phases. 
Therefore, in order to obtain an image, the sequence of pulses and gradients 
required to generate an echo is repeated many times at regular intervals (as 
explained in section 2.1.4). The number of repetitions is equal to the number of 
rows in the image. In other words, for a spin echo sequence with « n » rows, we 
make « n » acquisitions each with a different phase encoding gradient. 
 
The final step in spatial encoding is characterised by the application of a 
frequency encoding gradient (GFE) along the x direction when the signal is 
received. This last gradient applied during the signal acquisition, results in 
protons within the same column to precess with identical Larmor frequency, 
thus allowing the identification of their spatial location. The acquisition 
bandwidth determines the width of the acquisition window and together with the 
GPE it determines the in-plane resolution along the frequency or read-out 
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direction (Figure 2.4). The image matrix refers to the number of frequency 
encodes multiplied by the number of phase encodes. 
 
2.1.4 Generation of tissue contrast 
 
In order to characterize the contrast in a SE image, it is necessary to define the 
repetition time (TR) and the echo time (TE). We have seen that excitation (90° 
RF pulse) must be repeated several time in order to produce an image. TR is 
defined as the time between two successive excitations, i.e. from one 90° RF 
pulse to the next (Hahn, 1950). In order to have a full magnetisation recovery, it 
is necessary to allow a long relaxation time (equal to 5 times T1) before exciting 
the sample again. Changing TR, the contrast between tissues with different T1 
relaxation times changes. For example, in the case of a short TR, the 
longitudinal magnetisation of a specific tissue with a long T1, which has to be 
flipped in turn by the second pulse, has not the time to recover totally, and it 
produces a smaller transverse magnetisation with a consequent lower signal. 
On the other hand, in case of a very long TR, all tissues will have recovered 
their longitudinal magnetisation. 
 
The TE is defined as the time between the 90° RF pulse and the collection of 
the MR signal (Figure 2.4). In the case of a spin echo signal, TE is twice the 
time between the 90° and the 180° pulse. Changing TE, the contrast between 
tissues with different T2 relaxation times changes. This is because different 
tissues have different T2 relaxation time times and therefore they will be more 
or less dephased using a certain TE. In particular, with a short TE, the 
difference in signal intensity between two tissues with different T2 is very small, 
and both tissues can hardly be distinguished. Conversely, in the case of a long 
TE, the differences in signal intensity between tissues that have different T2 
times, becomes evident. In order to produce images where the contrast is 
predictable, the TR and TE are selected to weight the image towards one 
contrast mechanism and away from the other (Westbrook, 2009), producing 
different degrees of contrast (intensity differences) between tissues. In 
particular, changing TR and TE we can obtain different types of sequences: 
 
64 
Chapter II: Introduction to MRI, DTI and MTI 
 
 
 
1) T1-weighted imaging (T1-w), which is characterised by short TE and short 
TR, is able to detect differences between tissues due to their difference in 
T1 relaxation times. Indeed, to reduce T2 effects, TE must also be short. In 
such images, fat (short T1) is bright, whereas water (longer T1) is dark. 
 
2) T2-weighted imaging (T2-w), which is characterised by long TE and long TR, 
is able to detect differences between tissues due their difference in T2 
relaxation times. T1 effects are diminished selecting a long TR, hence 
allowing full T1 recovery between successive excitations. In these images, 
fat (short T2) is dark and water (longer T2) is bright. Because many 
pathological processes (such as demyelinating lesions) increase water 
content and the mobility of water protons, they can often appear bright on 
T2-WI. 
 
3) Proton-density weighted imaging (PD-w), which is characterised by short TE 
and long TR, is sensitive to detect differences in signal related to different 
proton density. These images are useful for showing pathological changes.  
 
In the brain, the cerebro-spinal fluid (CSF) has high water content and has long 
T1 and T2. The white matter (WM) is highly structured and has short T1 and T2. 
Grey matter (GM) is less structured than the WM, but contains more 
macromolecules than CSF, and therefore has intermediate T1 and T2.  
 
2.1.5 From MR signal to image reconstruction 
 
The acquired MR echo containing the frequency- and phase-encoded spatial 
information necessary to construct an image is entered in what is referred to as 
k-space, a space that organizes spatial frequency information of an object 
(Gallagher et al., 2008). The signal acquisition is sampled along trajectories 
within k-space, which was described for the first time in 1983 by Tweig (Tweig, 
1983) and Ljunggren (Ljunggren, 1983).  
 
The k-space is defined by the space covered by phase and frequency encoding 
data. Within the k-space, a line of data corresponds to the digitized MR signal at 
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a particular phase encoding level. The position in k-space is directly related to 
the gradient across the object being imaged. By changing the gradient over 
time, the k-space data are sampled in a trajectory through Fourier space. In 
particular, the application of frequency encoding gradient moves the trajectory 
along the x axis, whereas the application of phase encoding gradient moves the 
trajectory along the y axis. During a single TR, data corresponding to a phase 
encoding step is stored, but more than one slice can be sampled with the same 
phase encoding gradient per TR. By convention, high spatial frequencies, 
required to describe rapid spatial variations of the object, such as sharp edges, 
are mapped at the periphery of k-space, whereas low spatial frequencies, 
required to reconstruct the overall form of the image, are mapped near the 
centre. The range of spatial frequencies in k-space is inversely proportional to 
the spatial resolution of the image. Many different k-space sampling schemes 
can be used and each of them has practical or theoretical advantages. For 
example, a small number of k-space trajectories are used to allow rapid 
acquisition of MR images, at the price of a lower resolution.  
 
Subsequently, a Fourier transform of k-space decomposes the frequency- and 
phase-encoded spatial information, into a set of amplitudes at specific 
frequencies, which provide the image intensity at particular positions, resulting 
in the image we see (Gallagher et al., 2008).  
 
The signal to noise ratio (SNR) is defined as the ratio of the amplitude of the 
MR signal to the amplitude of the background noise. SNR is relevant in 
determining the final quality of the image produced, and can be affected by the 
magnetic field strength, proton density, coil type and position, TR, TE, flip angle, 
number of signal averages, bandwidth and pixel volume.  
 
The field-of-view (FOV) refers to the size of the area to be studied and is 
proportional to the acquisition bandwidth and inversely proportional to the 
readout gradient.  
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2.2 Conventional imaging sequences 
 
This section outlines the main features of the conventional imaging sequences 
that have been employed in the clinical studies presented in the subsequent 
Chapters of this thesis.  
 
2.2.1 Fast spin-echo (FSE) sequence 
 
This is a much faster variant than the conventional SE sequence described 
above. In SE sequences, only one phase encode is performed during each TR. 
FSE performs the same total number of phase encodes, therefore maintaining 
resolution, but more than one phase encode is performed for each TR. A train 
of 180° refocusing pulses is employed, with each pulse producing one echo. 
The number of pulses and resulting echoes is referred to as the echo train 
length. Therefore, several lines of k-space can be filled for every TR instead of 
one per TR as in SE. Because k-space is filled more rapidly, scan time is 
reduced. FSE allows different TEs and therefore PD and T2 weighted imaging 
can be acquired from one sequence. FSE has the advantages of shorter scan 
times, high resolution imaging, and increased T2 weighting, and has been used 
in the studies presented in this thesis to acquire PD and T2 weighted images.  
 
2.2.2 Gradient echo (GE) 
 
In gradient recalled echo sequences, instead of the180° pulse used in SE 
sequences, a bipolar gradient pulse  is used to generate an echo. A RF 
excitation pulse is followed by a relaxation period and a gradient reversal is 
used to produce rephasing of the spins. A transverse component of 
magnetisation is created. Often in GE imaging protocols a flip angle other than 
90° is employed, hence only part of the longitudinal magnetisation is flipped to 
the transverse plane. The transverse magnetisation is dephased using a 
superimposed magnetic field gradient of known amplitude and duration. By 
reversing this magnetic field, the dephasing caused by the applied gradient is 
reversed, and a gradient echo is generated. Scan times are short, as GE 
sequences have shorter TEs and TRs than SE. After the RF pulse is withdrawn, 
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the loss of signal due to transverse relaxation (i.e. dephasing of spins) is 
produced immediately as a result of inhomogeneities in the local magnetic field. 
Therefore, the GE image intensity depends on T2* rather than on T2. Since 
dephasing of spins increases with increasing TE, GE imaging is acquired with 
very short TE (a few milliseconds) in order to reduce signal loss. GE imaging 
with short TR is used for rapid in vivo MRI to reduce scan time and motion 
artifacts (van der Meulen et al., 1985; Haase et al., 1986).  
 
A spoiled GE is a sequence in which the transverse magnetization is spoiled at 
the end of each TR interval, before each RF excitation pulse, resulting primarily 
in T1 contrast images. An inversion-prepared fast spoiled gradient recall 
sequence (FSPGR), characterised by a single inversion RF pulse (see next 
section) followed by a spoiled and short TR gradient echo train acquiring the 
entire k-space, has been employed in all the studies presented in this thesis to 
acquire high-resolution T1-weighted images.   
 
2.2.3 Inversion recovery (IR) 
 
Inversion recovery (IR) sequences begin with a 180° pulse that inverts the net 
magnetisation M. When the pulse is removed, the net magnetisation starts to 
relax back to B0. A 90° pulse at time interval TI (time from inversion) is then 
applied. A further 180° pulse refocuses the spins in the transverse plane to 
produce an echo. The TI is the main factor that determines the weighting in IR 
sequences.  
 
Fast IR is a combination of IR and FSE and allows short scan times. A 
commonly used IR sequence in multiple sclerosis is FLAIR (fluid attenuation 
inversion recovery), which uses long TIs to null signal from CSF, thus producing 
CSF-suppressed images. Indeed, this sequence increases the delineation of 
periventricular lesions seen in multiple sclerosis.  
 
2.2.4 Echo planar imaging (EPI) 
 
EPI is a single-shot ultra-fast imaging sequence proposed by Mansfield in 1977 
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(Mansfield and Pykett, 1977), which collects all data required to fill all the lines 
of k-space from a single echo-train in one TR. The main echo is generated 
either by 180° rephasing pulses (spin echo EPI) or by gradient reversal 
(gradient echo EPI) (Figure 2.5). Images can be acquired in 50-80 ms and axial 
slices of the whole brain are feasible in 2-3s. EPI is particularly useful in 
functional MRI, cardiac imaging, and perfusion/diffusion imaging. EPI is 
sensitive to image artefacts and distortions, such as geometric distortions, 
which occur in regions where the magnetic field homogeneity is poor (frontal 
and temporal regions). In the studies presented in Chapter III, IV, VI, and VII, a 
spin-echo EPI sequence has been employed to acquire diffusion-weighted data.  
 
  
 
Figure 2.5. Gradient echo EPI pulse sequence and EPI  k-space sampling. 
 
 
 
2.3  Diffusion tensor imaging (DTI)  
 
In this section, we will examine the basic principles of DTI, which has been 
employed in the studies presented in Chapters III, IV, VI and VII of this thesis, to 
explore the microstructural damage in patients with PPMS. Indeed, DTI can 
provide unique insights of tissue structure in vivo, using the information 
provided by the water diffusion. In particular, when a tissue is affected by 
pathology, the measures of diffusion change, and this is the reason why DTI 
has proven very useful in studying in vivo brain pathological damage. 
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2.3.1 The phenomenon of diffusion: basic principles 
 
Diffusion is the random motion of molecules in any fluid system, including 
biological tissue, known as Brownian motion. When there is a gradient in the 
concentration (C) of a fluid, there is a macroscopic flux of fluid molecules from 
areas of high concentration to areas of low concentration, described by Fick’s 
first law of diffusion: 
   
             F = - D  x
C


 (2.2) 
 
where F is the diffusion flux, D is the diffusion coefficient, and ∂C / ∂x is the 
concentration gradient (the negative sign accounts for the flux direction being 
opposite to the increasing concentration)(Wheeler-Kingshott and Barker, 2003). 
 
Conversely, when the concentration is uniform, diffusion can only be 
described statistically, by measuring the probability that a molecule travels a 
given distance in a given time. In an isotropic medium, such probability has a 
Gaussian distribution and all the molecules are free to diffuse in any direction 
without restrictions (Wheeler-Kingshott and Barker, 2003). In biological 
tissues, molecular mobility may not be the same in all directions. This 
anisotropy may result from the presence of obstacles that limit molecular 
movements in some directions, such as cell membranes and other 
intracellular and extracellular structures. In this context, different directional 
components of diffusion must be analysed separately, and the diffusion 
process can be described by a 3x3 tensor matrix. The diffusion tensor (DT) is 
characterised by 9 elements (Basser et al., 1994). However, it is symmetric 
about the diagonal, and therefore only six elements have to be measured to 
estimate the full DT. The on-diagonal elements are DTxx, DTyy, DTzz, which 
represent molecular mobility along axes x, y, and z, respectively. The 
remaining elements (DTxy, DTxz, and DTyz) are off-diagonal and indicate 
how strongly random displacements are correlated in the x, y and z 
directions. 
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                                           DTxx     DTxy     DTxz   
                               DT =    DTyx     DTyy     DTyz                     (2.3) 
                                           DTzx     DTy      DTzz 
 
 
2.3.2  Effects of diffusion on the MRI signal 
 
Diffusion of protons can affect the MR signal (Wheeler-Kingshott and Barker, 
2003). In particular, in a given tissue, there is a delay between the excitation 
and the refocusing of the magnetisation, during which spins are diffusing 
because of thermal agitation. In absence of motion or diffusion of water 
molecules, the dephasing that occurs after the first pulse is exactly rephased 
after the 180° pulse. If, instead, there is a random motion of the spins between 
dephasing and rephasing, then the refocusing of the spins is incomplete. As a 
consequence, there is a loss in the transverse magnetisation and a reduction in 
the signal amplitude. Diffusion effects are always present, but, as they are very 
small, they do not contribute substantially to signal attenuation in a standard 
spin-echo sequence. The sensitivity to diffusion must be increased using 
magnetic field gradients (as explained in section 2.3.3). The amount of signal 
attenuation in a diffusion-weighted sequence depends on: (i) the diffusion 
properties of the tissue, which determine the motion of the spins; (ii) the 
sequence parameters that determine the magnetic field gradients; and (iii) the 
time during which  the diffusion process takes place. 
 
2.3.3 The pulsed field gradient sequence 
 
In 1965 Stejskal and Tanner proposed a practical scheme to introduce diffusion 
weighting in an MRI acquisition, i.e. to make MRI sensitive to diffusion along 
one or more directions (Stejskal and Tanner, 1965). This was obtained by 
adding a pair of pulsed magnetic field gradients in a SE sequence, positioning 
them around a 180° refocusing pulse. In particular, the first gradient pulse 
induces a phase shift for all spins, while the second reverses this phase shift. 
Therefore, the phase shift for static spins is cancelled, while the spins which 
71 
Chapter II: Introduction to MRI, DTI and MTI 
 
 
 
have changed location due to the diffusion of molecules during the time period 
between the two gradients (∆ in Figure 2.6) are not completely refocused by the 
second gradient pulse, and determine a signal attenuation (Pipe, 2009). In 
particular, the faster-moving water protons undergo a larger net dephasing. 
                            
∆
δ g
90º
180º
0 TE/2 TE
 
Figure 2.6. Diagram of the Stejskal-Tanner Pulse Field Gradient (PFG) sequence. The interval 
between the centres of the diffusion gradient lobes corresponds to the diffusion time (∆). The 
strength of the diffusion weighting (i.e. the b-value) depends on the magnitude (g) and duration 
(δ) of the diffusion gradients, as well as the diffusion time, according to equation 2.5.  
 
 
The resulting signal intensity of a voxel of tissue containing moving protons is 
equal to its signal intensity on a T2-weighted image decreased by an amount 
related to the rate of diffusion. If two acquisitions are performed, one without 
superimposed diffusion gradient (b value = 0), and one with diffusion gradient 
(i.e. b value ≠ 0), diffusion can be calculated using the equation of Stejskal and 
Tanner:  
 
S = S0 e -bD    (2.4) 
 
Where S is the MRI signal in the presence of diffusion gradients, S0 is the signal 
in the absence of diffusion gradients, D is the diffusion coefficient, and b is the 
diffusion weighting factor, introduced by Le Bihan et al. (Le Bihan et al., 1986): 
 
   b = (  g   )2 (  – 3

)     (2.5)  
 
where   is the proton gyromagnetic ratio (267x106 rads-1T-1), and g  is the 
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strength of the diffusion sensitizing pulses. Therefore, the b factor depends on 
the amplitude of the diffusion gradient and on the diffusion times (δ and  ). If 
the diffusion gradient is small (i.e. the b factor is small), there will be a small 
signal attenuation due to diffusion. If instead the diffusion gradient is very big 
(i.e. the b factor is big), there will be a much higher loss of signal.  
 
2.3.4 Diffusion-weighted images and Apparent Diffusion Coefficient maps 
 
The Pulse Field Gradient (PFG) method can be included in most MRI 
sequences to introduce diffusion weighting (DW) (i.e. sensitization of MRI 
images to diffusion) along multiple directions. This produces a reduced signal in 
the direction where there is the highest diffusion coefficient (Schaefer et al., 
2000). For example, in anisotropic areas of white matter, where the diffusion is 
preferential along one direction, which generally corresponds to the main axis of 
axons, the signal attenuation is most evident when the diffusion gradients are 
applied along that direction, Conversely, the signal attenuation in isotropic areas 
of the brain is independent from the directions of diffusion gradients application 
(Figure 2.7).  
  
     
Figure 2.7. DW MR images, with diffusion gradients applied along the x (left), y (middle), and z 
(right) axes, demonstrating anisotropy in the brain. For example the corpus callosum (arrow on 
the left image) is hypointense when the gradient is applied in the x direction (right to left), the 
posterior white matter (arrowhead on the middle image) is hypointense when the gradient is 
applied in the y (anterior to posterior) direction, and the corticospinal tracts (arrow on the right 
image) are hypointense when the gradient is applied in the z (superior to inferior) direction. The 
ventricles are typical isotropic areas, presenting the same signal characteristics, independent of 
the direction of application of the diffusion gradients. (Adapted from Schaefer et al., 2000) 
 
 
73 
Chapter II: Introduction to MRI, DTI and MTI 
 
 
 
However, DWI is a qualitative type of image, which is very sensitive to the 
acquisition parameters and patient positioning in the scanner. Moreover, in DW 
images the MRI signal intensity remains sensitive to the T2 value of the tissue. 
For example, pathological conditions causing an increase in the T2 value of the 
affected brain area could result in an increased signal intensity of the DW 
images, which in turn could be erroneously interpreted as a reduction in 
diffusivity. To distinguish between diffusion and relaxation effects on image 
contrast, it is possible to obtain quantitative images of the diffusion coefficient, 
or more exactly the Apparent Diffusion Coefficient (ADC), which depends on the 
diffusion time and weighting used. Measuring the ADC is possible with a 
minimum of two measurements, one acquired without diffusion weighting and 
the other with diffusion weighting. If S and  S0, together with the value of the b 
factor, are known for each voxel of the image, it is possible to calculate the 
diffusion coefficient voxel-by-voxel, using the equation 2.4. This procedure can 
generate a diffusion map where each voxel is the average diffusion coefficient 
of the tissue contained in that voxel, measured along the direction of application 
of the diffusion gradient.  
 
This diffusion map (ADC map) has an intensity scale which is inverted relative 
to the DWI used to calculate it (i.e. areas with high mobility of water molecules 
along the direction of application of the diffusion gradient, which appear dark on 
DW images, appear bright on the ADC maps).  
 
 
 
Figure 2.8. Inverted intensity scale of the ADC map (right) relative to the DWI (left) used to  
calculate it (normal brain of a 35 year old man).  
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2.3.5 Diffusion tensor and its indices 
 
As mentioned above, in anisotropic tissues, the diffusion properties of a 
substance are better described by the diffusion tensor (DT) rather than a single 
diffusion coefficient. The main advantage of using the DT rather than just the 
ADC of the tissue is that the D reflects the underlying diffusion properties 
independently of the orientation of the tissue with respect to the direction of 
measurement (i.e. how the subject has been orientated within the scanner). 
 
Calculation of the DT requires a non-diffusion-weighted image (i.e. a b=0 
image) plus at least six DW measurements along non-collinear directions 
(Basser et al., 1994). The diffusion weighting is obtained by simultaneously 
applying diffusion gradients along combination of the three physical axes (e.g.,. 
x, y, z, xy, xz, yz). Knowing the six different components of the DT, shown in 
equation 2.3, it is possible to transform the DT into a new tensor, DT1, (this 
process is called tensor diagonalisation) with all the off-diagonal elements equal 
to 0, and the diagonal elements reflecting the intrinsic properties of the tissue, 
independent of the coordinate system in which they were measured.  
 
                                              λ1         0          0  
                               DT1 =      0          λ2         0                                    (2.6) 
                                              0          0          λ3 
 
The D is characterized by three eigenvectors (ε1, ε2 and ε3), which are 
orthogonal vectors in the scanner reference frame, representing three unique 
directions along which the displacement of water molecules is not correlated.  
λ1, λ2  and λ3 are the corresponding ADC values, and they are defined as the D 
eigenvalues.  In other words, the D eigenvalues correspond to the diffusion 
coefficients along the principal directions of the diffusion tensor. By convention, 
the eigenvalues are ordered with decreasing value of their eigenvalues (λ1>λ2> 
λ3), so that ε1 represents the principal direction of diffusivity characterised by 
λ1>λ2 and λ2> λ3. Therefore, if the DT has been acquired and diagonalised, ε1 
will always be aligned with the axis of the fibres and λ1 will be the diffusion 
coefficient along ε1, corresponding to the maximum diffusion in each voxel, 
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regardless how the head is oriented in the scanner reference frame. Several 
rotationally-invariant indices (or parameters) can be extracted from the DT to 
describe the behavior of diffusion within each voxel.  
 
The mean diffusivity (MD) is the simplest way to summarise the diffusion 
properties of a voxel, and is given by the average of the eigenvalues of the DT 
within a voxel: 
 
MD = 3
321  
      (2.7) 
 
Another index derived from the DT is fractional anisotropy (FA), which is equal 
to the ratio between the square root of the variance of the eigenvalues and the 
square root of the sum of the squares of the eigenvalues (Basser and Pierpaoli, 
1996). Therefore FA estimates what proportion of diffusion is due to anisotropic 
diffusion:  
 
FA = 
     
222
222
321
321



 DDD
   (2.8) 
 
FA is of special interest in the study of brain tissues, as it is different between 
the grey and white matter, being low in the former and high in the latter 
(Pierpaoli and Basser, 1996). Indeed, FA=1 for a cylindrically symmetric 
anisotropic medium with λ1>>λ2=λ3 , and FA=0 for complete isotropy (a sphere) 
where λ1=λ2=λ3. An example of a brain MD and FA maps is provided in Figure 
2.9.  
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Figure 2.9. Diffusion tensor-derived maps. On the left a mean diffusivity (MD) map is displayed. 
On the right a fractional anisotropy (FA) map is displayed.  
 
 
The diffusion ellipsoid is another way of visualising the DT within each image 
voxel. This ellipsoid is a surface representing the distance that a molecule will 
diffuse to with equal probability from the origin. The principal axes of the 
ellipsoid are given by the eigenvectors of the DT, and the lengths are given by 
the diffusion distance in a given time t . The shape of the ellipsoid reflects the 
degree of anisotropy (it is a sphere for isotropic voxels), and its main axis, if 
eccentric, represents the principal direction of the greatest diffusivity, as 
displayed in Figure 2.10. 
                               
ε
ε
ε
Figure 2.10.  The diffusion ellipsoid in an anisotropic voxel is characterised by a cylindrically 
symmetric shape, with λ1>>λ2=λ3 , where λ1 represents the greatest diffusivity along the 
principal direction.  
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2.3.6 Artifacts in the acquisition of diffusion-weighted images 
 
DW imaging (DWI) is inherently sensitive to motion, and thus suffers from 
motion artifacts. Furthermore, DTI requires the collection of several images with 
gradients applied along non-collinear directions. For both motivations, DTI 
requires fast acquisition sequences, and typically EPI is used. EPI, however, is 
characterised  by a low bandwidth in the phase encoding direction and thus is 
sensitive to a number of artifacts. 
 
I. Eddy currents: Large, rapidly switched magnetic field gradients produced by 
gradient coils during a pulse sequence induce eddy currents in the 
electrically conductive structures of the MRI scanner which, in turn, produces 
additional unwanted magnetic fields (Jones, 2009). This can result in the 
generation of geometrical distortions. A number of different approaches have 
been developed for warping each DW image to a common template and 
remove distortions. One of the most commonly used method to correct for 
eddy-currents, which we have applied in the studies presented in Chapter III, 
IV, VI and VII, takes into account the bulk motion that is related to scanning 
live subjects. It consists of a full affine rigid-body approach to align whole 
diffusion-weighted volumes to the non-diffusion-weighted images, using the 
FLIRT package (Jenkinson and Smith, 2001). 
 
II. Magnetic susceptibility gradients: Large discontinuities in bulk magnetic 
susceptibility, such as those occurring at tissue/air interfaces, produce local 
magnetic fields that can degrade and distort DWI, particularly during echo-
planar imaging. Susceptibility effects are particularly acute in the brain 
regions adjacent to the sinuses (Jones, 2009). 
 
III. Cardiac pulsation: Another source of artifacts is the physiological motion that 
arises from cardiac pulsation. It has been known for a long time that the 
pulsation of  the brain, caused by the systolic part of the cardiac cycle, leads 
to additional phase dispersion in the brain parenchyma, which increases the 
apparent diffusivity (Jones, 2009). Several methods have been developed to 
remove these artifacts. One of the most commonly used is the method 
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consists of triggering the acquisition from the heart cycle of the participant 
with a peripheral gating device, to avoid the arrival of the pressure wave in 
the brain (Wheeler-Kingshott et al., 2002). This cardiac gating method has 
been employed in the studies presented in Chapter III, IV, VI and VII. 
 
2.4   Magnetisation transfer imaging (MTI) 
 
In this section, we will discuss the basic principles of magnetisation transfer 
imaging (MTI) (Tofts, 2003), which has been employed in the studies presented 
in the Chapters IV and VI of this thesis. MTI was first introduced by Wolff and 
Balaban in 1989 (Wolff and Balaban, 1989).  
 
2.4.1 Basic principles of MTI 
 
In brain tissue, protons exist in two states: a free state, in which they are very 
mobile, and a bound state, where they are associated with macromolecules 
such as proteins and lipids (for example in the context of cell membranes or 
myelin sheaths). MTI allows us to explore the properties of protons bound to 
macromolecules.  
 
The relaxation characteristics of protons change depending on which 
compartment or proton pool they are in. Free water protons have faster average 
rotational frequency and, as a consequence, less fixed protons that may cause 
local field inhomogeneities. Because of this uniformity, most free water protons 
have resonant frequencies lying in a narrow range around the Larmor frequency 
of 63 MHz (at 1.5 Tesla). The high rotational frequency also results in fewer 
interactions with the environment so that dephasing of the transverse 
magnetisation is slower and the T2 of the free pool is long.  
 
Conversely, bound protons are slowed down by extensive interactions with the 
protons in the local macromolecules and therefore magnetic field 
inhomogeneities are generated that lead to a wider resonance frequency 
spectrum (they absorb energy at frequencies not included in the narrow water 
resonance spectrum). The interactions with other protons result in faster 
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dephasing of the spins and therefore much shorter T2 values (<20 μs). This 
rapid loss of signal makes it impossible to image the bound proton pool directly. 
As discussed previously in this Chapter, in conventional MRI, the frequency of 
the RF pulse must match the resonant frequency of free water to obtain a signal 
from the free protons. With MTI, there is an additional pulse with a frequency 
off-set from water resonance, and this pulse saturates only the bound pool due 
to the much larger range of resonant frequencies of the bound pool (i.e. the 
magnetization of the bound proton pool is reduced) while having little effect on 
the free proton pool (Figure 2.11). 
 
on-resonance pulse
              
0 -10 +10 
offset frequency (kHz)
off-resonance pulse  
free water molecules 
bound water 
 
Figure 2.11. This diagram illustrates that the two different pools of protons (free and bound) 
resonate a different frequencies. As a consequence, the bound protons are selectively 
saturated by an off-resonance pulse that does not significantly affect the free water protons.  
 
 
We can then indirectly measure the saturation of the bound pool via the effect 
this has on the free pool. The two pools exchange magnetization with each 
other, therefore applying an off-resonance pulse to excite protons in the bound 
pool has a detectable effect on the signal received from the free water 
molecules. After irradiating the bound pool, there is a magnetisation transfer 
between the two pools, which results in a reduction of longitudinal 
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magnetisation in the free pool. This causes an increase in the T1 of the free 
water and reduced signal from the free proton pool in tissues in which the 
magnetisation transfer mechanism is present. In other words, the reduction in 
signal depends on the exchange rate between the free and bound protons. 
 
2.4.2 Magnetisation transfer ratio (MTR) 
 
If images of the same slice are produced  with and without an MT presaturation 
pulse, the MT ratio (MTR), which provides a measure of the saturation effect on 
a given tissue, can be calculated as follows: 
 
 
100
0
0 
M
MMMTR s     (2.9) 
 
where 0M  is the signal intensity without MT presaturation, and sM is the signal 
intensity with MT presaturation. MTR is therefore the percentage reduction in 
the signal when the saturation is applied, and is usually expressed in 
percentage units (pu).  
 
The greater the MTR, the greater the reduction in signal and, therefore, the 
greater the bound water pool size, although many other factors contribute to the 
MTR. It should also be noted that the MTR is only ‘semi-quantitative’, in that it 
depends heavily on sequence acquisition parameters and MT pulse details, 
therefore MTR values are not necessarily comparable between different 
centres.  
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Figure 2.12. Example of an MTR map, derived from one of our patients with primary-
progressive multiple sclerosis, involved in the study presented in Chapter VI.  
 
 
2.5   Imaging analysis 
 
In this section of the Chapter, the post-processing techniques which have been 
employed in the studies presented in this thesis will be described. The analysis 
methods applied to conventional images (i.e. GM volume analysis and lesion 
probability mapping) will be discussed first, and will be followed by a description 
of the post-processing techniques used to analyse DT and MT images.  
 
2.5.1 Post-processing of conventional images  
 
2.5.1.1 Voxel-based morphometry (VBM) 
VBM is a fully automated technique which allows to perform voxel-wise analysis 
of the local concentration of GM (Ashburner and Friston, 2000; Ashburner and 
Friston, 2005). A VBM-style post-processing approach has been employed in 
the studies presented in  Chapters III and VII of this thesis, to explore the role 
played by GM volume in the pathogenesis of early PPMS, and in the long-term 
prognosis of this disease. After an introduction of the basic VBM procedure, in 
this section we will review the optimisations and the improvements that we have 
included in the studies presented in this thesis. The basic VBM approach 
consists of the following steps: 
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I. Spatial normalisation: all subject’s structural images are aligned to a standard 
space template image (such as a study-specific template or the standard 
MNI152, which we have used in the studies presented in this thesis). This 
step usually involves a first linear registration, which is followed by a non-
linear transformation. This spatial normalization is not an attempt to match 
every cortical feature exactly, instead is aimed to correct for global brain 
shape differences.  
 
II. Segmentation: each subject’s structural image is segmented into different 
tissue types (GM, WM, and CSF), generating GM, WM, and CSF masks. 
Two sources of information are used to classify the image into the three 
tissue types: spatial prior probability maps (to which the original image is 
compared), and image intensities (each voxel in the original image has an 
intensity which corresponds to a specific probability of it being in one of the 
three tissue types).  
 
III. Smoothing: Segmentation output data (GM mask) are then smoothed with an 
isotropic Gaussian kernel. As a result of this procedure, each voxel in the 
smoothed image contains the average concentration of GM from around the 
voxel. This is done for several reasons: (i) the smoothing helps reduce the 
effects of misalignment of structures when the registration is not completely 
accurate; (ii) smoothing can increase sensitivity if the extent of smoothing 
matches the size of an effect of interest; (iii) finally, smoothing makes the 
data more normally distributed, improving the validity of parametric statistical 
tests. The size of the smoothing kernel sensitizes the analysis to differences 
of comparable size as the kernel (Rosenfeld and Kak, 1982). In the study 
presented in Chapter III, a 12-mm FWHM Gaussian kernel has been 
employed, while in the study presented in Chapter VII, GM images were 
smoothed using both 12-mm FWHM and 8-mm FWHM Gaussian kernels. 
 
IV.Voxelwise statistics: Statistical analysis using the General Linear Model 
(GLM) is then carried out voxel by voxel using one of the standard statistical 
parametric procedures. For example,  to identify regions of GM concentration 
that are significantly different between two groups (e.g. patients versus 
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controls) it is possible to carry out a t-test or a F-test whereas, to identify GM 
areas related to a particular effect under study (e.g. areas where the GM 
concentration is related to specific clinical variables, such as disease severity 
or various clinical scores) it is possible to perform a regression analysis. A 
design matrix and a contrast of interest have to be defined. For example, for 
an independent two-sample t-test, such as the one we have used in the study 
presented in Chapter III to test for differences in GM volume between 
patients (group 1) and controls (group 2), a t-contrast of [-1 1] will correspond 
to a right-tailed (group2 > group1) t-test, while a contrast of [1 -1] to a left-
tailed (group1 > group2) t-test. It is also possible to take into account the role 
of possible confounding factors (for example age and gender) in the 
relationship between the GM concentration and a specific variable of interest 
(for example clinical test scores), including in the model the relevant 
covariates (which will be set as “0” in the the contrast matrix). The resulting 
set of voxels from each contrast represents a statistical parametric map of 
the t-statistic (or F-statistic). 
 
V.Thresholding: The resulting statistical parametric image includes the result of 
many statistical tests, and it is necessary to correct for these multiple 
comparisons. In the studies presented in Chapters III and VII of this thesis, 
we have used a family-wise error (FWE) correction at p<0.05 for multiple 
comparisons at voxel level across the whole brain (i.e. it is assumed that less 
than 5% of the resulting statistical parametric maps contain false positive 
voxels).  
 
VBM is fully automated, simple to apply, and its main advantage is that it offers 
the opportunity to investigate the whole brain without the need to generate an a 
priori hypothesis. The main limitation of this approach relates to problems 
caused by possible alignment inaccuracies, that can lead to a misinterpretation 
of results in voxels that in fact are not localized in the same position in all 
subjects included in a study, and by the arbitrariness of the spatial smoothing, 
which can influence the results of the analysis.  
 
In the studies presented in this thesis, VBM has been carried out using the 
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Statistical Parametric Mapping (SPM) software package 
(www.fil.ion.ucl.ac.uk/spm/software/, Wellcome Department of Cognitive 
Neurology, London, UK). Over the years, SPM has proposed a number of 
improvements and optimizations of the original VBM protocol, which we have 
included in the studies presented in this thesis. The optimised VBM protocol 
(Good et al., 2001) introduced with SPM99 and SPM2, in which the GM 
segmentation is used to drive the registration (instead of the raw structural 
images), to improve the results of the spatial normalization, has been employed 
in the studies presented in Chapter III and VII. Moreover, in both these studies, 
the modulation option offered by SPM has been used, that allows to correct the 
segmentation output after non-linear registration (i.e. voxel intensities are 
multiplied by the local value in the deformation field from normalization), so that 
the total amount of GM in the modulated GM remains the same as it would be in 
the original image. This procedure allows us to make inferences about GM 
volume, instead of GM concentration. In April 2009, a major update to the SPM 
software, called SPM8, has been released. In this updated version of the SPM 
software, which has been employed in the study presented in Chapter VII, the 
VBM protocol consists of an iterative combination of segmentations and 
normalizations to produce a GM probability map (Ashburner and Friston, 2005). 
Finally, as the presence of lesions in the WM  has recently shown to 
significantly affect brain segmentation (Nakamura and Fisher, 2009) and 
registration (Sdika and Pelletier, 2009), which are key steps in VBM, in the 
study presented in Chapter VII we applied the recently developed lesion 
automated preprocessing (lesion automated preprocessing, LEAP) (Chard et 
al., 2010) technique to the T1-weighted images, before feeding them into the 
VBM procedure. Briefly, LEAP is an “in-painting” technique developed in our 
Unit, which replaces lesional voxels with values derived from the intensity 
distribution within the WM outside visible lesions in the presegmentation phase 
(Chard et al., 2010). This technique minimises lesion-associated segmentation 
biases that may significantly affect VBM results. 
 
2.5.1.2 Lesion Probability Mapping (LPM) 
LPM is a method that, applied to conventional T2-weighted and T1-weighted 
images, allows defining the probability of each image voxel to be lesional (Di 
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Perri et al., 2008). In the study presented in the Chapter V of this thesis, we 
generated LPMs on both T2-w and T1-w images, in order to explore the role of 
lesion location in predicting long-term clinical outcome in patients with PPMS.  
 
The LPM method which has been applied in Chapter V consists of the following 
steps: 
 
I. Lesion mask: PD hyperintense and T1 hypointense lesions were contoured, 
with reference to the co-registered T2 weighted images, using a 
semiautomated technique (Plummer, 1992). Binary lesion masks were then 
produced and individual lesion loads calculated. 
 
II. Template construction: Each patient's T1 scan was registered to the Montreal 
Neurological Institute (MNI152) template using a fully affinetransformation 
(12 parameters), as previously described in patient groups with a variety of 
neurological conditions (Karagulle Kendi et al., 2008; Ginestroni et al., 2009; 
Vellinga et al., 2009). All of the resulting transformed images were averaged 
to obtain our “internal” T1 template. 
 
III. Transformation of individual scans and lesion masks into T1 template: Each 
patient's PD weighted scan was registered to the corresponding T1 scan in 
native space using a rigid body transformation and trilinear interpolation. The 
transformation parameters were then applied to the T2 lesion masks, 
bringing them into alignment with the individual T1 scans. Each patient's T1 
scan was then registered to the T1 template, using non-linear registration, 
and the resulting transformation parameters were applied to the T1 and T2 
lesion masks, which had been previously registered onto the individual T1, 
using trilinear interpolation. In order to maintain the volume of the 
transformed lesion masks as close as possible to those in the native brain 
images, after the trilinear interpolation, the lesion masks were thresholded 
using a value of 0.5.  
 
IV. Generation of T2 and T1 LPMs: T2 and T1 LPMs were generated by 
averaging the T2 and T1 lesion masks, at each voxel, in standard space. For 
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each map, the resulting voxel intensity indicates how frequently the voxel in 
question is within a lesion across all patients, ie, the probability of that voxel 
being lesional. Regions containing the peaks of lesion probability were 
localised using the Johns Hopkins University DTI-based white matter 
tractography atlas (Mori, 2005). 
 
2.5.2 Post-processing of DTI  and MTI images 
 
2.5.2.1 Methodological considerations 
From a methodological point of view, the DTI- and MTI-derived parameters can 
be measured in the brain in clinical studies using different post-processing 
approaches, which can be summarised as follows: 
 
I.  Region-of-interest analysis: This methodology consists of drawing ROIs in 
specific areas of the brain, and then quantifying DTI or MTI parameters (FA 
and MTR, for example) within those areas. The main advantages of this 
approach are that the regions can be chosen on the basis of a priori 
hypotheses, and can be located in a specific part of the brain. On the other 
hand, this approach can miss significant abnormalities in regions that are not 
selected, and it is highly dependent on the observer and on the anatomical 
clues used in positioning the regions. The registration process and its related 
methodological issues must be carefully considered when images from 
different modalities are co-registered to allow the transfer of regions. It is also 
necessary to reposition the ROIs in exactly the same location in longitudinal 
studies. In the study presented in the Chapter IV of this thesis, tractography 
has been employed to identify ROIs (tracts of interest, in this specific case), 
from which the mean MTR was extracted. 
 
II.  Histogram analysis: An alternative approach to the ROI is the histogram 
analysis. This methodology has been used widely in patients with 
neurological disorders, such as MS and brain tumors, to investigate the 
differences between patients and controls and to explore correlations 
between MRI parameters and clinical disability. The histogram of DTI and 
MTI parameters is a frequency distribution showing the number of voxels with 
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a particular range of parameter values. From the histogram of each 
parameter, the following variables can be derived: the mean; the peak height 
(the proportion of voxels at modal value); the peak location (the location of 
the modal value). These variables are then used in statistical tests, for 
example comparing patients and controls. The histogram analysis allows the 
characterisation of the parameters in the whole brain in a fully automated 
way. Histograms of WM or GM only can also be obtained. In contrast to the 
ROI approach, it does not retain any information about location of 
abnormalities, and avoids any pre-judgment about which parts of the brain is 
investigated. However, this approach does not allow to localise regional 
abnormalities, as it provides a measure of the global tissue changes.  
 
III. Voxel-wise analysis:  More recently, a voxel-wise approach, similar to the 
one described in the VBM section of this Chapter, has been proposed to 
analyse both DTI- and MTI-derived metrics on a voxel-by-voxel basis. This 
approach allows us to localise changes in these metrics related to tissue 
abnormalities, and allows to combine the ability of ROIs to be spatially 
specific with the ability of histograms to be unbiased. In simple terms, it 
involves co-registration of the DTI-and MTI-derived metrics maps (FA or MTR 
maps, for example), into a standard space, and then making comparisons of 
diffusion parameter values between groups or testing for correlations with an 
external variable, such as disability or age. Advantages of this approach are 
that all locations across the brain are tested in an unbiased way, and that 
location of significant group differences or correlations is automatically 
shown. As previously discussed, the limitations of this approach relate to the 
possible inaccuracy of the registration algorithms and to the arbitrariness of 
the spatial smoothing. To overcome some of these limitations, in the studies 
presented in the Chapter III, VI and VII of this thesis tract-based spatial 
statistics (TBSS) (Smith et al., 2006) has been employed to analyse FA maps  
and MTR maps (see next section of this Chapter for a full description of the 
method). 
 
2.5.2.2 Tract-based spatial statistics (TBSS) 
Tract-based spatial statistics (TBSS) is a fully automated method that allows a 
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voxelwise analysis of multi-subject diffusion data which aims to solve some of 
the issues related to the VBM approach (Smith et al., 2006). This is achieved by 
generating a group mean FA skeleton (Figure 2.13), which represents the 
centre of all WM tracts that are common across all the subjects included in a 
study. Each subject’s FA map is then projected onto the mean FA skeleton in 
such a way that each skeleton voxel takes the FA value from the local centre of 
the nearest relevant tract, thus resolving issues of alignment and 
correspondence of voxels and, in turn,  ensuring reliable results.  
 
 
 
 
Figure 2.13. The image sh ows the mean FA skeleton of the cohort of patients with PPMS 
investigated in Chapter VII, which represents the core of all white matter tracts that are common 
across all patients, and is overlaid onto the mean patients’ FA image. 
 
 
The TBSS approach consists of the following steps: 
 
I. Non-linear alignment:  All subjects’ FA images are aligned to a common 
target using a linear registration first (FLIRT) (Jenkinson and Smith, 2001), 
and then a non-linear registration (FNIRT) (www.fmrib.ox.ac.uk/fsl/fnirt). The 
target image used in the registrations can either be a pre-defined target, or 
can be automatically chosen to be the most "typical" subject in the study, i.e. 
to be the target image which minimizes the amount of warping required for all 
the other subjects to align to it. In the studies presented in this thesis we 
followed the recommendation of FSL website (www.fmrib.ox.ac.uk/fsl/tbss), 
using as target image the FMRIB58_FA 1x1x1mm standard-space image. At 
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this stage, a perfect alignment is not expected nor required. 
 
II. Mean FA image and FA skeleton: The transformed images are then 
averaged to obtain a mean FA image. To achieve skeletonisation, the local 
surface perpendicular direction is estimated, and then a search is carried out 
in this direction to identify the voxel with the highest FA, which is considered 
to be the centre of the tract. This FA skeleton, which represents the different 
tract structures in the mean FA image, is then thresholded to exclude from 
further analysis those voxels where it is unsafe to assume good tract 
correspondence across subjects (Figure 2.13). Then, the mean FA is 
thresholded to exclude voxels which are in the GM or in the CSF in the 
majority of subjects and to ensure that the skeleton does not run to the 
outermost edges of the cortex, where the most variable tracts across 
subjects are not well aligned (in the studies presented in this thesis a 
threshold of 0.2 was used). 
 
III. Projection of each subject’s FA onto the mean FA skeleton:  Each subject’s 
aligned FA image is then projected onto the mean FA skeleton, to account for 
the residual misalignments after the initial non-linear registration. Then, at 
each point in the skeleton, each subject’s FA image is searched in the 
perpendicular tract direction to find the maximum FA value, and this value is 
assigned to the skeleton voxel. At this stage the skeleton has been filled, for 
each subject, with FA values from the centers of the nearest relevant tracts.  
 
IV Voxel-wise statistics: Finally, voxel-wise statistics across subjects is 
performed on the skeleton-space FA data. To perform the statistical analysis, 
a design matrix  to perform a specific test has to be generated (for example a 
t-test to search for differences in FA between patients and controls, as in the 
study presented in Chapter III), together with a contrast matrix which 
specifies the contrast of interest (in the example of the Chapter III study, the 
contrast of interest was control group FA> patient group FA). It is also 
possible to correct for possible confounding factors.  
 
2.5.2.3 White Matter tractography 
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As previously discussed, the diffusion tensor (DT) can be defined as a 
mathematical description of the magnitude and the directionality of the diffusion 
of water molecules in a three-dimensional space (Basser, 1995). White matter 
tractography (WMT) algorithms use this information extracted from the DT to 
estimate the connectivity patterns between different brain regions, by inferring 
the continuity of fibre paths from voxel to voxel (Ciccarelli et al., 2008; Lazar, 
2010). To date, a large number of WMT algorithms have been proposed, that 
can be classified into deterministic, probabilistic, and global optimization 
algorithms (Lazar, 2010).  
 
The deterministic algorithms generate a unique trajectory for each seed point. In 
this case, a trajectory is calculated from the seed point in both forward and 
reverse directions of the fiber orientation field in a stepwise fashion (i.e. at each 
step, the trajectory is advanced along the estimated tract direction) (Figure 
2.14). 
 
 
 
Figure 2.14. The deterministic algorithms define fiber trajectories following fiber direction 
estimates from voxel to voxel starting from a seed point, indicated with a dot in the picture.  
 
 
Several strategies can be employed to step along the trajectory, including a 
constant step size with the propagation direction estimated at the beginning of 
the step, or calculated along the step, or a variable step size. The propagation 
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of the fiber trajectory is stopped when a previously established stopping criteria 
is met (e.g. exiting the brain space, the intersection with voxels characterised by 
low anisotropy values such as the GM or the CSF, or large local curvature of 
the trajectory) (Bick et al., 2012). In this approach the point reached is not 
known a priori, but the tracking process, being deterministic, is fully repeatable. 
In contrast to deterministic algorithms, which estimate WM connectivity by 
assuming a unique fiber principal direction within a voxel, probabilistic 
algorithms generate a set of possible propagation directions for a given voxel. 
For each seed point, a set of possible trajectories is obtained, each one 
generated in a streamline fashion, with the propagation direction at each step 
being chosen at random from the distribution of directions available at the step’s 
corresponding voxel. A probability of connection between the seed voxel and 
other voxels or regions of the brain is defined as the density of the trajectories, 
where the density is calculated as the number of connecting trajectories 
normalized by the total number of trajectories. A higher density of trajectories 
between two regions of the brain indicates a higher probability of connection 
between those two regions. To map the extent of a tract, connectivity is then 
thresholded, such that voxels with low probability of connection are not included 
in the estimated tract volume.  
 
Finally, global optimisation algorithms reconstruct the most probable paths in 
the brain space, such as the path trajectories that are consistent with the 
underlying diffusion data and satisfy specific constraints. The first constraint is 
to consider path optimization between two regions, i.e. a seed point and a target 
point. Often, path smoothness is used as additional constraint to find  optimal 
trajectories.  
 
WMT has been used extensively with various applications (Lazar, 2010). In 
particular, WMT has proved useful in (i) demonstrating the in vivo mapping of 
the brain WM tracts; (ii) generating new information regarding brain organization 
and internal connection; (iii) identifying specific WM tracts and using them as 
regions of interest; (iv) segmenting GM regions on the basis of their connectivity 
patterns; (v) presurgical planning.  
In the study presented in Chapter IV, probabilistic tractography on healthy 
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controls data has been employed, to identify the route of the tracts of interest 
(see below) and to investigate these fibre bundles in patients with PPMS. In 
particular, the tractography algorithm from the Camino toolkit (www.camino.org) 
was used and the probabilistic index of connectivity (PICo) (Parker et al., 2003)) 
was computed using 5000 iterations and no interpolation. Importantly, no FA 
thresholds were included to constrain the outcome of the tractography. As 
discussed above, a curvature threshold was used such that each run of the 
tractography stops if there is curvature of more than 80° between adjacent 
voxels; connectivity maps were thresholded at a connectivity value of 0.02 
(Toosy et al., 2004). Seed regions and exclusion masks were defined, and used 
to constrain the tracts to anatomically plausible regions of the brain, to extract 
the following tracts: i) the left and right cortico-spinal tracts (CST), ii) the genu of 
the corpus callosum (GCC), and (iii) The left and right optic radiations (OR). 
 
2.5.2.4 Linking WM tracts to associated cortical GM: a tract-extension 
methodology 
A new method to extend WM tracts into the cortical GM has been developed in 
our Unit and has been employed in the study presented in Chapter IV to identify 
the “cortical targets” of the three WM tracts, extracted following the steps 
described in the previous section (i.e. CST, GCC and OR) (Tozer et al., 2012).  
 
This new method is based on geometrical, rather than diffusion information, and 
starts from a WM tract, as defined by a diffusion-based tractography algorithm, 
and extends it through to the outer edge of the cortical GM ribbon, to the 
boundary between brain and CSF, as defined from segmented T1-weighted 
volumes (or other segmented images) in the same space. The tractography 
algorithm and the seed voxel used for the tractography, as well as the 
segmentation method used to generate the GM ribbon will determine the 
starting point for the tract extension method. The tract extension method itself, 
though, is independent of the method used to determine the starting point.  
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Figure 2.15. A schematic representation of the tract extension method. In all parts the original 
tract is in green, the GM is in sandy yellow and the extended tract in shown in red. a) Shows the 
start points of the extension method, marked with a *, being the points on the edge of the tract 
within or adjacent to the GM. In b) end points have been identified, marked as ^, which are the 
closest points to each of the start points. c) Shows the voxels in a straight line between the start 
and end points and d) shows the final extension after the dilation/erosion step.  
 
 
The steps to define the GM extension of a WM tract are as follows (Figure 
2.15): 
 
I. Definition of a starting point (SP): 
A starting point is a voxel satisfying two criteria: (i) the voxel is on the boundary 
of the original tract; (ii)  the voxel is either within the GM, or on the GM/WM 
boundary, such that the voxel adjacent to the tract boundary voxel is within the 
GM); 
 
II. Definition of an end-point (EP):  
For each SP found by step I, the EP must be a voxel on the outer edge of the 
GM, i.e. on the boundary between tissue and CSF surrounding the brain. For 
each SP, the EP is chosen by satisfying two criteria: (i) the straight line 
connecting SP and EP must be the shortest possible; (ii) the line connecting SP 
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and EP must not pass through non-tract WM or non-brain tissue voxels. The 
process performed in the study presented in Chapter IV was performed in a 
multiplanar 2-dimensional (2D) manner, where three EPs, were defined for each 
SP, one in each of three orthogonal representations of data with the EP being 
chosen in plane only. 
 
III. WM tract extension to include GM voxel selection: 
The voxels that lie on the straight line between each SP and the corresponding 
EP are then classified as part of the GM most likely to be connected with the 
tract. The results of the extension in the three directions were then combined to 
produce the GM extension and then with the original tract to produce a mask of 
the entire tract (WM and GM). 
 
IV. Erosion–dilation steps: 
The combined WM tract and resulting GM region generated in step II was 
dilated and eroded by 2 voxels, in 3 dimensions, to fill in gaps and then masked 
with both a GM mask and the original WM tract, to remove any non-brain and 
non-tract WM voxels. This masking can also be used to divide the extended 
tract into the original WM portion and a GM portion, so the WM tract parameters 
can then be analysed alongside their associated cortical GM values. 
 
2.5.2.5 “Skeletonised MTR”: a novel approach to explore microstructural WM 
changes 
 
In the study presented in Chapter VI, a novel method is proposed to explore 
WM microstructural changes over one year in patients with PPMS, which 
consists of a combination of TBSS and MTR (see previous sections of this 
Chapter for further details on TBSS and MTR). In summary, a common skeleton 
of patients’ WM tracts was created using the standard TBSS approach, and 
then the MTR value,corresponding to each voxel of the skeleton, was extracted. 
To obtain a “skeletonised” MTR image for each patient, the following steps were 
followed: 
 
I. MT was first co-registered with DTI data, by matching the non-MT weighted 
95 
Chapter II: Introduction to MRI, DTI and MTI 
 
 
 
96 
volume with the b0 volume, after skull-stripping, with an affine transformation 
using FLIRT (FMRIB's Linear Image Registration Tool, part of FSL) (Smith et 
al., 2004). 
 
II. The transformation was then applied to the MTR map. 
 
III. Finally, the transformed MTR map underwent the same projection as the FA 
data onto the common FA tract skeleton (which had been previously created 
using TBSS), to obtain a “skeletonised” MTR image for each subject at each 
time point of the study (i.e. baseline and one year).  
 
2.6     Conclusions 
 
This Chapter reviewed the basic principles of conventional and non-
conventional imaging techniques, as well as the post-processing methods that 
have been employed in the clinical studies presented in this thesis. In the final 
part of the Chapter, two novel imaging analysis methods have been described: 
the “tract-extension” methodology and the “skeletonised MTR” approach. Both 
methods have been employed for the first time in the clinical studies shown in 
this thesis. 
 
After these two introductory Chapters, the next part of the thesis will discuss the 
results of the clinical studies that have been performed to answer the two main 
questions presented at the end of Chapter I. In particular, Chapter III will 
address the first question, i.e. the relationship between WM and GM damage in 
PPMS, through an investigation of cross-sectional links between the damage 
occurring in the two compartments, and will assess their clinical relevance. 
 
 
  
 
 
 
Exploring the relationship between white 
matter and grey matter damage in PPMS 
 
 
 
 
 
 
Chapter III 
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This Chapter addresses the first question presented in Chapter I, investigating 
whether there is a spatial relationship between the damage occurring in the 
normal appearing WM (NAWM) and in the GM of patients with PPMS at the 
earliest stage of their disease. The cross-sectional spatial link between the 
abnormalities affecting the two compartments will be explored using TBSS 
(Smith et al., 2006) and an optimized VBM approach (see Chapter II for 
technical details on methods).  
 
3.1 Introduction 
 
As reported in Chapter I, MRI studies have consistently reported structural 
abnormalities in the NAWM of patients with PPMS, even in the early stages of 
the disease; these abnormalities have been shown to be clinically relevant 
(Rocca et al., 2012a). One of the MRI measures most commonly employed to 
assess the integrity and orientation of WM tracts is FA, which is derived from 
the diffusion tensor (Basser et al., 1994). Reduced FA, which reflects underlying 
demyelination and axonal loss (Schmierer et al., 2007; Moll et al., 2011) has 
been described in the WM of PPMS using various approaches, including ROIs 
and histogram analyses (Ciccarelli et al., 2001; Vrenken et al., 2006). These 
results are consistent with the data coming from post-mortem studies in PPMS 
(see Chapter I), which have demonstrated widespread demyelination and 
axonal injury in the NAWM in the brain of patients with PPMS (Kutzelnigg et al., 
2005). In addition, it has been suggested that activated microglia and microglial 
nodules may explain reduced FA in the WM of patients with MS (Moll et al., 
2011). 
 
As discussed previously, GM damage and, in particular, GM atrophy, has been 
detected in PPMS (Sastre-Garriga et al., 2004; Sepulcre et al., 2006; 
Roosendaal et al., 2011), but the precise pathological substrate of GM atrophy, 
as measured in vivo with MRI, remains unknown. However, a post-mortem 
study has suggested a correlation between MRI-measured atrophy and 
neuronal and glial loss (Wegner et al., 2006). In addition, in histological studies, 
extensive GM demyelination has been described in progressive MS patients 
(Kutzelnigg et al., 2005; Bo et al., 2007).  
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Since GM tissue does not have strong directionality, FA is generally considered 
not to be useful as a measure of local GM abnormalities. On the other hand, 
VBM  (Ashburner and Friston, 2000) and histogram analysis of T1-weighted 
images have outlined regions of GM atrophy in patients with PPMS when 
compared with controls (De Stefano et al., 2003; Ramio-Torrenta et al., 2006; 
Khaleeli et al., 2007b), which progress relentlessly throughout the course of the 
disease (De Stefano et al., 2010) predicting clinical evolution over time .  
 
The important question addressed in the study presented in this Chapter is 
whether NAWM damage correlates with abnormalities in connected GM or the 
two compartments are affected independently in early PPMS. Previous 
histological studies addressing this question have been inconclusive. Kutzelnigg 
et al. (Kutzelnigg et al., 2005) reported a weak correlation between diffuse WM 
inflammation and GM demyelination, whereas Bo et al. (Bo et al., 2007) found 
no association between abnormalities in the grey and white matter 
compartments. MRI studies, on the other hand, have focused on the 
relationship between lesions in the WM and GM damage in patients with PPMS 
and other forms of MS (De Stefano et al., 2003; Pagani et al., 2005b; Ramio-
Torrenta et al., 2006; Sepulcre et al., 2006; Charil et al., 2007; Bendfeldt et al., 
2010; Roosendaal et al., 2011), and have suggested that at least a proportion of 
cortical pathology may be secondary to WM abnormalities. 
 
The investigation focused on the relationship between NAWM damage and GM 
atrophy in vivo in patients with early PPMS, who are probably in the most 
clinically active phase of the disease (Thompson, 2004), combining the results 
of TBSS (Smith et al., 2006), which localised areas of reduced FA in the NAWM 
of patients, with the results of an optimized VBM approach (Good et al., 2001), 
which detected areas of GM atrophy in patients (see Chapter II for more 
details). As previously discussed, both techniques test the whole brain without 
requiring any specific a priori hypothesis.  
 
A similar methodology of combining TBSS and VBM has been applied to 
healthy individuals of different age (Giorgio et al., 2010; Moy et al., 2011), as 
well as to patients with psychiatric and neurological diseases, such as 
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adolescent-onset schizophrenia (Douaud et al., 2007), bipolar disorder (Haller 
et al., 2011), Friedreich’s ataxia (Della Nave et al., 2008), cluster headache 
(Absinta et al., 2011), RRMS (Roosendaal et al., 2009) and clinically isolated 
syndromes suggestive of MS (CIS) (Raz et al., 2010a; Raz et al., 2010b). In the 
study presented here, this methodology was applied in order to investigate the 
quantitative relationship underlying the anatomical correspondence between 
GM and WM damage in patients with early PPMS. In particular, the aim of this 
study was to assess whether: (i) there was an anatomical correspondence 
between reduced FA in the NAWM and GM atrophy; (ii) FA values of abnormal 
tracts correlated with the GM volume of connected atrophic regions; and (iii) 
NAWM FA or GM volume independently correlated with disability. 
 
3.2 Methods 
 
3.2.1 Subjects 
 
Thirty-six patients with a diagnosis of PPMS according to Thompson’s criteria 
(Thompson et al., 2000) within 5 years of symptom onset (15 females, 21 
males, mean age 45.3 years, and SD 11.32) underwent an imaging and clinical 
assessment protocol approved by the Joint Medical Ethics Committee of the 
National Hospital for Neurology and Neurosurgery and the Institute of 
Neurology, London (see Appendix I). Written and informed consent was 
obtained from all participants. One patient was later excluded from the analysis 
(as discussed below), leaving a total of 35 patients. 
 
All patients were assessed on the day of scanning using the EDSS (Kurtzke, 
1983) and the Multiple Sclerosis Functional Composite (MSFC) subtests: Paced 
Auditory Serial Addition Test (PASAT), Nine-Hole Peg Test (NHPT), and Timed 
Walk Test (TWT) (Cutter et al., 1999). 
 
Two different groups of controls were used, as this was a retrospective analysis 
performed on previously acquired data, which were combined for the purpose of 
this study. The first group included 18 healthy subjects, who were age-matched 
to the patient group (8 females, 10 males, mean age 41.5 years, and SD 12.63) 
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and were used for the localization of WM abnormalities. The second group 
included 23 healthy subjects (12 females, 11 males, mean age 35.1 years, and 
SD 7.9), who were used for the localization of regions of GM atrophy. The 
difference in age between this second group of controls and the patient group 
were adjusted for, at each stage of the analysis. The patients’ and controls 
demographic, clinical and radiological characteristics are summarised in Table 
3.1. 
 
Number                                        36                          18                              23          
Age, years (SD)                            44.8 (11.13)           41.5 (12.63)              35.1 (7.9) 
Gender, female/male                     15/20                     8/10                           12/11 
EDSS, median (range)                   4.5 (1.5–7.0)            -                                - 
Disease duration, years (SD)          3.3 (0.9)                   -                                - 
T2 lesion load, ml (SD)                   31.56 (24.79)           -                                - 
PASAT score, mean (SD)               47.65 (11.24)           -                                -  
NHPT score, mean (SD)                 22.48 (3.69)             -                                - 
TWT score, mean (SD)                   8.63 (8.37)               -                                - 
Characteristics Patients Controls 1st group Controls 2nd group 
 
 
 
Table 3.1 Patients' and healthy controls' characteristics. 
 
 
3.2.2 Image acquisition and analysis 
 
All imaging was obtained using a 1.5-T GE Signa scanner (General Electric, 
Milwaukee, IL), with maximum gradient strength of 22 mT m−1. Images were 
displayed on a Sun workstation (Sun Microsystems, Mountain View, CA) for 
analysis.  
 
3.2.2.1 Dual-echo images, lesion load, and creation of a mean lesion mask 
All subjects had a fast spin echo scan that collects PD and T2-weighted images 
(repetition time [TR] 2000 ms; echo times [TEs] 17/92 ms; matrix size 256 × 
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ach subject's T2-weighted image was registered to the Montreal Neurological 
.2.2.2 Diffusion-tensor imaging and TBSS analysis 
ontrols underwent a whole-
fter correction for eddy-current-induced distortions, the diffusion tensor was 
256; field of view [FOV] 240 × 180 mm2; 28 contiguous axial slices of 5 mm 
thickness). Lesions were delineated by a single observer (who was blinded to 
the clinical details) on the PD images, with reference to the coregistered T2-w 
images, using a semiautomated contour thresholding technique (Plummer, 
1992), and used to calculate each subject's lesion load and lesion mask. Each 
individual binary lesion mask was obtained by setting the signal within lesion 
boundaries to one and the remainder of the brain to zero. 
 
E
Institute (MNI) template using an affine transformation (FLIRT, part of FSL 
www.fmrib.ox.ac.uk/fsl) (Jenkinson and Smith, 2001). The same transformation 
parameters were then applied to the lesion mask. The individual, normalized 
lesion masks were then averaged to obtain a mean lesion map indicating the 
proportion of the cohort having a lesion in each voxel. Finally, this map was 
binarised to retain only voxels with a value higher than 0.1 (indicating that at 
least 10% of the subjects had a lesion in a given voxel). 
 
3
All patients and the first group of 18 age-matched c
brain, cardiac-gated Spin Echo Diffusion Weighted Echo Planar Imaging (SE-
DW-EPI) sequence (Wheeler-Kingshott et al., 2002). Full brain coverage was 
obtained with three separate acquisitions, each collecting 14 axial slices of 3 
mm thickness, which were interleaved off-line. The data was acquired with the 
following parameters: FOV 240 × 240 mm2, matrix size 96 × 96 (reconstructed 
to 128 × 128), image resolution 2.5 × 2.5 × 3 mm (reconstructed to 1.9 × 1.9 × 3 
mm), TE 95 ms, TR 7RRs, and maximum b factor 1000 sm m−2. Diffusion 
gradients were applied along 25 optimized directions (Jones et al., 1999). Three 
images with no diffusion weighting (b0) were also acquired. 
 
A
calculated on a voxel-by-voxel basis (Basser et al., 1994), and FA maps were 
generated using DTIfit provided by the fMRIB Diffusion Toolbox [part of FSL; 
www.fmrib.ox.ac.uk/fsl; (Smith et al., 2004)]. TBSS (Smith et al., 2006) was 
used to create a mean FA skeleton, following the procedure described in 
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oxel-wise differences in projected FA between patients and controls were 
.2.2.3 T1-weighted volumetric images and SPM2-VBM analysis of GM 
nsional 
re-processing of T1-weighted images was performed according to the 
Chapter II. Since the focus of the study was the investigation of NAWM only, the 
final binary lesion mask was subtracted from the skeleton in order to produce a 
NAWM only significant skeleton.  
 
V
tested using a two sample t-test. Two contrasts, patients greater than controls' 
FA and controls greater than patients, were estimated. The resultant statistical 
maps were thresholded at p < 0.05 corrected at cluster level for multiple 
comparisons using a permutation-based approach (Nichols and Holmes, 2002). 
In particular, a cluster-forming threshold t > 2 was used (the threshold-free 
cluster enhancement was not available at the time of this study), and the null 
distribution of maximum values (across the image) of the test statistic was 
estimated. A similar cluster-forming threshold had been used in the only TBSS 
study of patients with MS published at the time of this study (Cader et al., 2007).  
 
3
All patients and the second group of 23 controls underwent a three-dime
inversion-prepared fast spoiled gradient recall (3D FSPGR) T1-weighted 
sequence of the brain [FOV 300 × 225 mm, matrix size 256 × 160 
(reconstructed to 256 × 256 for a final in plane resolution of 1.17 mm), TR 13.3 
ms, TE 4.2 ms, inversion time 450 ms, 124 contiguous axial slices, slice 
thickness of 1.5 mm]. 
 
P
previously described optimized VBM-style protocol (Good et al., 2001) (see 
Chapter II for details) using the segmentation and registration tools available in 
the statistical parametric mapping software (SPM2, as SPM5 had recently being 
released at the time of the analysis, and the same software used in previous 
studies on the same group of patients was employed in this case). The protocol 
was modified to account for the presence of WM lesions in patients, as 
described by Khaleeli et al. (Khaleeli et al., 2007b). The procedure will now be 
briefly summarised. The 3D FSPGRs of all subjects were segmented in native 
space. Lesions masks were applied to the GM partitions to remove lesions 
erroneously classified as GM. GM volume was estimated for every subject, and 
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o localize areas where GM volume was significantly lower in patients 
.2.2.4 Anatomical correspondence and quantitative relationship between 
l correspondence between tracts of lower FA and 
.2.2.5 Correlation between NAWM and GM abnormalities and disability 
ample 
relationship between NAWM 
the images normalized onto the SPM GM template. Lesion masks were used to 
weight the normalization. The normalization parameters were then applied to 
the T1-volumes, and the normalized images were segmented and masked 
again to produce GM segments. One patient was excluded from the study 
because of segmentation failure due to a high lesion load. All data were then 
smoothed using a 12-mm FWHM Gaussian kernel.  
 
T
compared with controls, an analysis of covariance adjusted for age and for total 
GM volume was performed. A family-wise error correction at p < 0.05 for 
multiple comparisons at voxel level across the whole brain was used. Regions 
comprising clusters of less than 100 voxels were excluded from the analysis. 
 
3
NAWM and GM abnormalities 
In patients, areas of anatomica
adjacent regions of GM atrophy were visually identified by overlaying the results 
of the two different analyses on the same anatomical image (Douaud et al., 
2007). To assess whether there was a quantitative correlation underlying this 
anatomical relationship, for each area of anatomical correspondence, the mean 
FA value of the cluster of significantly lower NAWM FA and the mean volume of 
the cluster of significantly lower GM volume were extracted. The relationship 
between mean FA and mean GM volume of these areas was quantified using 
the Spearman's correlation coefficient (using SPSS 11.5 for Windows). 
 
3
The Z-score (z) for each MSFC subtest was calculated using our own s
as reference (Cutter et al., 1999). Patients were also divided into three 
categories of roughly similar size on the basis of disability as follows: (i) EDSS ≤ 
3.5 = Group 1 (patients with minimal disability and fully ambulatory); (ii) EDSS 
between 4.0 and 5.5 = Group 2 (patients with moderate disability and restricted 
ambulation); and (iii) EDSS ≥ 6.0 = Group 3 (patients with severe disability who 
required unilateral or bilateral assistance to walk). 
In patients, for each region where a quantitative 
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o identify which MRI variable (i.e., GM volume and NAWM FA) was associated 
.3 Results 
.3.1 Reduced FA of NAWM tracts
FA and GM volume was found, the association between clinical scores and 
NAWM and GM changes was assessed using (i) multiple linear regression 
analysis for the zPASAT, zHPT, zTWT and (ii) multiple ordinal logistic 
regression analysis for the EDSS categories, as the EDSS is not a linear scale 
and was not normally distributed.  
 
T
with disability, independently from the other and from age and gender, each 
disability score (i.e., EDSS, zPASAT, zHPT, zTWT) was selected, in turn, as 
dependent variable, whilst NAWM FA, GM volume, age, and gender were 
selected as independent variables. We chose not to analyse the impact of MRI 
changes on the global MSFC, but rather on the individual MSFC subtests, 
which can be more informative than the global MSFC score, as this is obtained 
by calculating the mean of the three subtest z-scores. Results with p values < 
0.05 were reported. 
 
3
 
3  
atients showed reduced FA compared with controls in the NAWM along the 
A was also significantly reduced in patients than in controls in the following 
 
P
corticospinal tracts bilaterally (posterior limb of the internal capsule, corona 
radiata, and WM adjacent to primary motor cortex), in the WM adjacent to the 
premotor cortex bilaterally, and in the entire corpus callosum (i.e., rostrum, 
genu, body, and splenium).  
 
F
areas bilaterally: (i) thalamic radiation, (ii) optic radiation, (iii) fornix, (iv) 
fasciculus arcuatus, (v) inferior longitudinal fasciculus, and (vi) WM of the 
temporal and frontal lobe (Figure 3.1). 
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Figure 3.1  Results of the TBSS analysis: significant reduction in FA along the bilateral 
corticospinal tract, the bilateral optic radiation, the bilateral corona radiata, the corpus callosum, 
and the left arcuate fasciculus in patients when compared with controls, displayed on the mean 
FA map (from Bodini et al., 2009). 
 
 
3.3.2 GM atrophy 
 
The cortical regions which showed the most extensive and significant reduction 
in volume in patients compared with controls were the sensory motor cortex 
bilaterally, followed by the insula bilaterally, the GM around the left sylvian 
fissure, and the right superior temporal gyrus.  
 
Patients also showed significantly reduced GM volume in the deep GM regions, 
including the bilateral thalamus and the left cerebellar hemisphere. Other 
regions with lower GM volume in patients included the left precuneus and the 
right angular and cingulate gyrus (Figure 3.2, Table 3.2). 
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Figure 3.2  Results of SPM-VBM results: significant reduction in grey matter volume (yellow 
voxels) in the bilateral sensory-motor cortex, in the bilateral thalamus, in the right superior 
temporal gyrus, and in the left grey matter around sylvian fissure in patients when compared 
with controls, displayed on the Montreal Neurological Institute (MNI) template. (from Bodini et 
al., 2009). 
 
 
Sensory-motor cortex                        L                      −49     −18     56                2793                       6.84 
Sensory-motor cortex  R                        42     −21     53           4196              6.62 
Inferior frontal gyrus  L                       −61     −6       31             184              5.58 
Inferior frontal gyrus  R                        55     −15     20               52              5.38 
Middle frontal gyrus  R                        43     −2       58               73              5.52 
Superior temporal gyrus  R                        67     −22       2             697              5.95 
Middle temporal gyrus  L                       −62     −4      −8             185              5.08 
GM around sylvian fissure  L                       −42     −23     17             858              6.30 
Precuneus                            L                       −12     −69     44             101              5.47 
Cerebellar hemisphere  L                       −20     −80   −38             375              5.88 
Angular gyrus                            R                         34     −63     45               74              5.54 
Cingulate gyrus                           R                         15     −65     14               72              5.38 
Thalamus                            L                       −18     −29       5           1599              6.30 
Thalamus                            R                       −20    −28        5           1220              6.57 
Insula                            L                        −36       5         1             726              6.53 
Insula                            R                         33        9        0                    61              5.28 
Region Side MNI coordinates  of local maxima Number of voxels 
Local maximum  
t-value 
 
 
 
Table 3.2 List of regions showing a lower GM volume in patients when compared with controls.  
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3.3.3 Anatomical correspondence between NAWM and GM abnormalities 
 
Anatomical correspondence was observed between the reduced NAWM FA of 
the corticospinal tract and the GM atrophy in the sensory-motor cortex, 
bilaterally. Similarly, a topographic correspondence was found between reduced 
FA in the NAWM adjacent to (i) the left inferior frontal gyrus, (ii) the right 
superior temporal gyrus, (iii) the left middle temporal gyrus, (iv) the left GM 
around sylvian fissure, (v) the left precuneus, (vi) the right angular gyrus, (vii) 
both thalami, and (viii) the left insula, and the atrophy of the same GM regions 
(Figure 3.3 A,B). 
 
 
Figure 3.3  Examples of regions where anatomical (A and B) or anatomical and quantitative 
correlations (C) between NAWM damaged tracts (voxels in red) and GM atrophy (areas in blue) 
have been found in patients. This figure shows: In (A), the left corticospinal tract projecting onto 
the left sensory-motor cortex (see yellow arrow); in (B), the NAWM immediately adjacent to the 
GM of the right superior temporal lobe (see yellow arrow); and in (C), the right corticospinal tract 
and the connected sensory-motor cortex (see yellow arrow) (from Bodini et al., 2009). 
 
 
3.3.4 Quantitative relationship between anatomically related NAWM and GM 
abnormalities 
 
Out of the eleven regions showing anatomical correspondence between 
abnormal NAWM FA and GM volume, four areas showed also a quantitative 
relationship (Table 3.3):  
(1) Reduced FA in the corticospinal tract correlated with greater GM atrophy in 
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the adjacent right sensory-motor cortex (Figure 3.3 C); 
(2) Reduced FA of the thalamic radiations correlated with greater GM atrophy of 
both thalami (Figure 3.3 B); 
(3) Reduced FA of the tracts immediately adjacent to the left insula correlated 
with greater GM atrophy of the insula (Table 3.3, Figure 3.3 B). 
 
Right sensory-motor  0.48 (0.04)  4.52 (0.30)  0.53  0.001 
Left thalamus                               0.43 (0.04)  5.79 (0.59)  0.70  0.0001 
Right thalamus                               0.54 (0.03)  5.60 (0.53)  0.64  0.0001 
Left insula                               0.42 (0.04)  7.6 (0.21)  0.51  0.002 
Region
 
                    
          
 
 
FA,  
mean (SD) 
Volume (ml),  
mean (SD) r p value 
 
 
Table 3.3  Regions where grey matter atrophy was significantly correlated with FA reduction in 
the adjacent NAWM in patients.  
 
 
3.3.5 Correlation between NAWM and GM abnormalities and disability 
 
Either the NAWM FA or the GM volume of the four regions showing a 
quantitative relationship between NAWM and GM damage correlated with 
disability independently from the other, and from age and gender.  
 
In particular, patients with greater GM atrophy in the right sensory-motor cortex 
had greater upper limb disability, as measured by zNHPT (p = 0.01, coeff. = 
1.27, 95% confidence interval (CI) 0.26, 2.28), independently from the NAWM 
FA of the right corticospinal tract. The NAWM FA of the left and right thalamic 
radiations was lower in patients with greater cognitive impairment, as measured 
by zPASAT (p = 0.0001, coeff. = 0.001, 95% CI 0.001, 0.002 and p = 0.0001, 
coeff. = 0.002, 95% CI 0.001, 0.002, respectively), independently from the GM 
thalamic volume. We also found that the NAWM FA of the tracts adjacent to the 
left insula was associated with zPASAT (p = 0.0001, coeff. = 0.001, 95% CI 
0.001, 0.002), independently from the insular GM volume. 
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No correlation was found between either NAWM or GM damage and the 
categorized EDSS. 
 
3.4 Discussion 
 
3.4.1 NAWM and GM abnormalities 
 
In this study, tracts of reduced FA in the NAWM of patients with early PPMS 
were localised using TBSS (Smith et al., 2006). This was the first time that this 
technique was used to map FA changes in the NAWM of patients with PPMS 
when compared with controls and to investigate whether they related to the GM 
atrophy of connected regions, measured using a VBM approach. This study 
was particularly focused on the investigation of the NAWM, as a correlation 
between T2 lesion load and GM pathology had already been demonstrated in 
this form of disease (De Stefano et al., 2003; Ramio-Torrenta et al., 2006; 
Sepulcre et al., 2006; Roosendaal et al., 2011). Moreover, the diffuse NAWM 
abnormalities in PPMS are known to be only partially explained by axonal 
destruction in the plaques, followed by secondary Wallerian degeneration 
(Pelletier et al., 2003; Kutzelnigg et al., 2005).  
 
In this study, patients with early PPMS showed reduced FA than controls in 
several NAWM tracts, in line with data obtained in patients with well established 
PPMS, with other forms of MS and in CIS (Cader et al., 2007; Roosendaal et 
al., 2009). Using VBM (Ashburner and Friston, 2000), extensive and focal areas 
of GM atrophy were detected early in the disease course of PPMS, confirming 
results obtained in RRMS (Morgen et al., 2006; Prinster et al., 2006) and in our 
larger cohort of PPMS patients (Khaleeli et al., 2007b).  
 
3.4.2 Anatomical and quantitative relationship between NAWM damage and 
GM atrophy 
 
When the topographic distribution of reduced NAWM FA and GM atrophy in 
patients was investigated, eleven regions of clear anatomical correspondence 
between the two compartments were identified. For example, there was a 
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reduced FA in the bilateral corticospinal tract and a reduced GM volume in both 
connecting sensory-motor cortices. Conversely, other abnormal WM tracts did 
not show any anatomical correspondence with areas of GM atrophy. Similarly, a 
number of regions of GM atrophy were not adjacent to any regions of reduced 
NAWM FA. 
 
Interestingly, out of these eleven regions with visible anatomical 
correspondence, only four areas showed a significant quantitative correlation 
between GM atrophy and reduced NAWM FA in the connected tracts. These 
areas were the right sensory-motor cortex and the connected corticospinal tract, 
both thalami and the adjacent thalamic radiations, and the left insula and the 
adjacent WM. This suggests that in these regions there may be a link between 
the pathological processes occurring in the two compartments. For example, it 
is possible that the GM atrophy is secondary to degeneration of WM tracts 
resulting from transection of axons in inflammatory WM lesions (Trapp et al., 
1998). Alternatively, the GM may be the primary target of the disease process, 
resulting in secondary axonal degeneration and demyelination in WM (the 
“inside out” model of MS) (Tsunoda and Fujinami, 2002; Geurts et al., 2009). 
Finally, a combination of the above mechanisms could also occur. In the next 
Chapter of this thesis, these hypotheses will be explored in further detail. The 
remaining seven regions, where a quantitative correlation was not found, 
suggest that the pathological processes occurring in the NAWM and in the GM 
could to some extent develop independently from each other (Geurts and 
Barkhof, 2008; Geurts et al., 2009; Geurts et al., 2012), at least in some areas 
of the brain and in the early stages of the disease. 
 
It should be noted here, for clarity, that the term “anatomical correspondence” 
was used in this study to indicate areas which appear contiguous on visual 
inspection, while more sophisticated approaches, such as DT tractography, 
would be needed to confirm the connection between the identified NAWM and 
GM areas..Indeed, this technique was employed in the study presented in 
Chapter IV of this thesis, and confirmed the connection between the WM tracts 
of interest and their cortical targets.  
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From a methodological point of view, the quantitative approach applied in this 
study has proven valuable in providing additional information not available from 
a purely qualitative and anatomical analysis. For example, the finding that only 
a minority of anatomically associated areas showed a quantitative correlation 
between the MRI measures, may help explain the minimal or absent 
correlations between the damage affecting the two compartments reported in 
histological studies (Kutzelnigg et al., 2005; Bo et al., 2007). 
 
This study, however, has a major limitation, as the analysis of the differences in 
NAWM FA and GM volume between patients and controls was performed using 
two different groups of controls, with differing mean age. Further investigations 
based on data from the same control group are warranted to confirm the 
reported findings. However, the age of the two control groups was not 
significantly different from each other (p = 0.07, using the two-sample t-test), 
and the difference in age between patients and the group of 23 controls was 
corrected for, at each stage of the analysis. Furthermore, the mapping of 
regions of reduced FA and increased atrophy is consistent with what has been 
reported in previous studies, as discussed above. Another methodological 
limitation of this study lies in the coregistration of DTI and FSPGR images, 
which have different slice thicknesses, within the same anatomical image, 
during post-processing procedures. These aspects, together with the smoothing 
of the images, which is needed in the VBM analysis to render the data normal 
for statistical purposes, may have influenced the reported results by 
compromising accurate localization of abnormal regions and subsequent 
identification of areas of anatomical correspondence. 
 
3.4.3 Contribution of NAWM and GM abnormalities to disability 
 
Interestingly, all four areas of visually identified and quantitatively confirmed 
correlation between NAWM damage and GM atrophy were clinically eloquent, 
and in each area an independent contribution from one of the two 
compartments to disability was observed. In particular, the GM atrophy in the 
right sensory-motor cortex correlated with the upper limb function, as measured 
by the NHPT, independently from the NAWM damage in the right corticospinal 
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tract. These findings indicate that, in this area, GM damage has a role in 
determining motor disability, which is greater than, and independent from, the 
injury of the connected corticospinal tract. This finding confirms the relationship 
between atrophy in the motor cortical areas and disability that was already 
documented in a previous study on this same cohort of early patients with 
PPMS  (Khaleeli et al., 2007b). 
 
In this study it was also found that reduced FA in the thalamic radiations and in 
the tracts adjacent to the left insula was independently associated with poor 
performance on the PASAT test in patients; this association was independent of 
the GM atrophy of the thalamus and insula, respectively. These data suggest an 
important contribution from these tracts to cognitive function, as the PASAT test 
is a complex working memory task involving several distinct brain areas that 
interact simultaneously. This is in line with other reports of a correlation 
between WM tract injury and PASAT score in patients with MS  (Ozturk et al., 
2010; Van Hecke et al., 2010; Yu et al., 2012).  
 
The lack of correlation with EDSS, on the other hand, could be explained by the 
limitations of this scale (Hobart et al., 2000). However, it is important to take into 
account that NAWM and GM damage in the brain are not the only contributors 
to clinical disability in PPMS. WM lesions, GM lesions, and spinal cord atrophy 
(which were not included in this investigation) are also known to significantly 
contribute to clinical disability in this form of disease (Rocca et al., 2012a), and 
the interpretation of the presented results shall not disregard these important 
aspects of MS pathology. 
 
3.5 Conclusions 
 
In conclusion, this study has demonstrated that NAWM damage and GM 
atrophy in early PPMS are strictly interdependent in specific, clinically relevant 
brain regions. This suggests that that there may be a link between the 
mechanisms of damage occurring in the two compartments in these areas in 
the early phase of progression, and it is noteworthy that damage in these 
regions was associated with disability. However, another possible interpretation 
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of our results is that the pathological processes affecting the two compartments 
develop independently of each other (as suggested by the evidence in the 
presented data of NAWM regions where a significant difference between 
patients and controls was found, which was not paralleled by significant 
changes affecting the connected GM areas, and viceversa) reaching a similar 
(correlated) degree of damage in few, specific areas of the brain.  
 
In the next Chapter, the spatial and temporal characteristics of the changes 
occurring in the NAWM tracts and in the connected GM areas will be explored, 
in order to establish whether there is a directionality in the pathological changes 
affecting these two compartments over time in the same cohort of patients with 
early PPMS.  
 
  
 
 
 
Exploring the temporal relationship between 
white and grey matter pathology in early PPMS 
 
 
 
 
 
 
Chapter IV 
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Moving from the data presented in Chapter III on the cross-sectional spatial 
relationship between WM and GM damage in early PPMS, in this Chapter I aim 
to complete the answer to the first question of this thesis, describing the 
temporal relationship between the pathological changes occurring in the WM 
tracts and those occurring in the connected cortical areas. My aim was to 
establish the temporal sequence and the directionality of the pathological 
processes affecting the two compartments, in our cohort of patients with early 
PPMS followed-up for two years. In particular, the two following hypotheses on 
the pathogenesis of the early phase of PPMS were tested: (i) the damage in the 
WM tracts, as reflected by MTR, precedes that occurring in the connected GM 
areas (“primary WM damage model”); (ii) pathological changes, as reflected by 
MTR, originate in the cortex, and subsequently spread to the connected WM 
tract (“primary GM damage model”).  
 
4.1 Introduction:  
 
As discussed in the first Chapter of this thesis, the pathological changes 
affecting both the white (WM) and the grey matter (GM) are known to contribute 
to the complex pathogenesis of primary-progressive multiple sclerosis (PPMS), 
from the early stage of the disease (Antel et al., 2012; Rocca et al., 2012a). 
Post-mortem studies, and in-vivo investigations using different quantitative 
magnetic resonance imaging (MRI) techniques, have contributed to the 
characterization of the damage occurring within focal lesions in both WM and 
GM, and to the description of the pathological changes affecting normal-
appearing brain tissues (Filippi et al., 2012).  
 
The study presented in Chapter III has shown that, at least in some clinically 
relevant brain areas, the pathological processes affecting the WM tracts and 
their anatomically adjacent GM regions were interdependent, suggesting a 
relationship between the mechanisms of damage occurring in the two 
compartments in the early phase of clinical progression (Bodini et al., 2009). 
However, the temporal relationship (i.e. the directionality) linking the damage 
occurring in the WM tracts to that affecting the connected cortical areas, 
remains unknown. There are two alternative hypotheses that can describe the 
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pathogenic processes leading to WM and GM changes in progressive MS 
(Geurts et al., 2009): the first hypothesis (which I will refer to as “primary WM 
damage model” herein after) is that the cortical changes are secondary to 
continuing damage in the connected WM tracts (both focal and in the NAWM), 
where the pathology would originate, through anterograde (Wallerian) or 
retrograde degeneration (Bjartmar and Trapp, 2001), or as a result of both. In 
contrast, the second hypothesis (the “primary GM damage model”), postulates 
that the GM damage could represent an important and initial target of the 
disease, which would subsequently spread to the connected WM tract, resulting 
in a “whole brain” pathology (Geurts et al., 2009). Obviously, both models may 
coexist, but this would represent a third hypothesis that was not tested in this 
study.    
 
In order to assess the validity of these two models in describing the 
pathogenesis of PPMS in its early phase, it is necessary to follow-up structural 
changes as detected by MRI over time, from completely intact WM and GM 
areas to damaged regions (Filippi et al., 2012). This has been explored in this 
study, using tissue-specific MTR as a measure of microstructural tissue damage 
(Schmierer et al., 2004; Moll et al., 2011), along with tissue-specific volumetric 
measures, in our cohort of patients with early PPMS, which was compared with 
a group of healthy controls followed-up for two years. In keeping with the aim to 
test both the “primary WM damage” and the “primary GM damage” models in-
vivo, we sampled three “tract-cortex pairs” of anatomically connected WM-GM 
regions, each one consisting of a WM tract and its associated GM cortical 
target, at baseline and after two years. The WM (or tract) component of each 
tract-cortex pair is composed of both NAWM tissue and tract-specific WM 
lesions, which have been investigated separately from each other.  
 
4.2  Methods:   
 
4.2.1 Subjects 
 
Forty-seven patients with a diagnosis of PPMS according to Thompson’s criteria 
(Thompson et al., 2000) within five years of symptom onset  underwent a 
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clinical and imaging protocol at study entry, and after 24 months, which was 
approved by the Joint Medical Ethics Committee of the National Hospital for 
Neurology and Neurosurgery and the Institute of Neurology, London (see 
Appendix I). At each time point, patients were assessed and scored with the 
Expanded Disability Status Scale (Kurtzke, 1983) (see Table 4.1 for the 
patients’ clinical, demographic and radiological characteristics at study entry), 
and then performed the MRI protocol described below. 
 
Since this was a retrospective analysis performed on previously acquired data, 
MTR and DTI images were not available in the same group of healthy controls. 
Therefore, MTR data were available for 18 healthy subjects (Group A), and DTI 
data were found to be available for 23 healthy controls (Group B) (see Table 4.1 
for their demographic characteristics).  
 
    
 
Table 4.1 Demographic and radiological characteristics of patients and healthy controls (HC) at 
study entry. 
 
 
4.2.2 Image Acquisition  
 
The imaging protocol was performed using a 1.5-T GE Signa scanner (General 
Electric, Milwaukee, IL), with maximum gradient strength of 22 mT m -1. Images 
were displayed on a Sun workstation (Sun Microsystem, Mountain View, CA) for 
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analysis. 
 
4.2.2.1 Brain imaging 
At baseline and after two years, all subjects had a three-dimensional inversion-
prepared fast spoiled gradient recall (3D FSPGR) T1-weighted (T1-w) sequence 
of the brain [field of view (FOV) 300 x 225mm2, matrix size 256 x 160 
(reconstructed to 256 x 256 for a final in plane resolution of 1.17 mm), repetition 
time (TR) 13.3 ms, echo time (TE) 4.2 ms, inversion time 450 ms, 124 
contiguous axial slices, slice thickness of 1.5 mm].  
 
At both time-points, all patients and the Group A of healthy controls underwent: 
(i) a fast spin echo scan that collects proton-density-weighted and T2-weighted 
(T2-w) images  (TR 2000 ms ; TE 17/92 ms ; matrix size 256 x 256; FOV 240 x 
180 mm2 ; 28 contiguous axial slices of 5 mm thickness); 
(ii) magnetisation transfer (MT) dual echo interleaved spin-echo sequence (28 
contiguous axial slices, TR 1720 ms, TE 30/80 ms, number of excitations 0.75, 
acquired matrix 256×128, reconstructed matrix 256×256, FOV 240×240 mm), 
including PD and T2-weighted images, acquired with and without a MT 
presaturation pulse to calculate the MT ratio (MTR) images from the short echo 
data. A Hamming-apodised three-lobe sinc MT pulse (duration 16 ms, peak 
amplitude 23.2 μT, bandwidth 250 Hz, 1 kHz off-water resonance) was 
employed.  
 
At baseline, the healthy controls of Group B underwent a whole-brain, cardiac-
gated, spin echo diffusion-weighted (DW) echo planar imaging sequence [FOV 
240x240mm², matrix size 96x96 (reconstructed to 128x128), image resolution 
2.5x2.5x3mm (reconstructed to 1.9x1.9x3mm), TE 95ms, TR 7RRs, maximum 
b-factor 1000 smm-2; three series, each collecting 14 axial slices of 3mm 
thickness, which were interleaved off-line; diffusion gradients were applied 
along 25 optimised directions, and three images with no diffusion weighting 
were also acquired, which was used to generate a DTI template in standard 
space. 
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4.2.2.2 Spinal cord imaging 
In patients, volumetric images of the spinal cord were also acquired, using a 
standard phased array spinal coil. In particular, a volume acquired inversion 
prepared fast spoiled gradient echo was performed (60 1 mm “partitions”, TI 
450 ms, TE 4.2 ms, TR 15.6 ms, flip angle 20°, FOV 24x24 cm, matrix 
246x256). Five contiguous 3 mm axial slices from the caudal landmark of the 
C2/3 intervertebral disc were reformatted from the volume data set and a coil 
radiofrequency uniformity correction was applied. 
 
4.2.3 Image analysis 
 
4.2.3.1 White matter lesions 
In patients, white matter lesions (WML) were delineated with a semi-automated 
contour thresholding technique (Plummer, 1992) by a single rater on the PD 
images. The co-registered T2-w images were always used as a reference to 
increase confidence in lesion identification. Lesion masks were obtained by 
setting the signal intensity equal to 1 for all voxels within a lesion and zero 
outside lesions. The same procedure was performed on the baseline and the 
follow-up scans. 
 
4.2.3.2 Generation of the DTI template, reconstruction of tracts and tract 
extension in standard space 
After correction for eddy current distortions using a software tool (eddy_correct) 
provided by FSL   (www.fmrib.ox.ac.uk/fsl/), the DW images from the healthy 
controls of Group B were used to generate a high-resolution diffusion tensor 
(DT) dataset (voxel size=1×1×1 mm3), constructed by averaging the DT data 
into the EPI equivalent of the MNI standard space (Mazziotta et al., 2001). 
  
To briefly summarise the procedure, each subject’s fractional anisotropy (FA) 
map was nonlinearly registered to the FA map in standard space provided by 
the FSL library, using the flirt/fnirt functions (Woolrich et al., 2009). The 
transformations were applied to the individual tensor components using the 
preservation of principal direction algorithm (Alexander et al., 2001), which were 
then averaged (using the mean) and diagonalised to give the mean DT in 
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standard space.  
 
The probabilistic tractography algorithm, called PICo (probabilistic index of 
connectivity) provided by the Camino toolkit (www.camino.org) (Parker et al., 
2003) was used to reconstruct five tracts, as described below, on the high-
resolution DTI dataset.  5000 iterations of the FACT algorithm were used. No 
interpolation and no FA thresholds were included to constrain the outcome of 
the tractography, while a curvature threshold was used, such that each run of 
the tractography stops if there is a curvature of more than 80° between adjacent 
voxels; connectivity maps were thresholded to a connectivity value of 0.02 
(Toosy et al., 2004). Seed regions and exclusion masks, used to constrain the 
tracts to anatomically plausible regions of the brain, were defined to reconstruct 
the following tracts: 
 
(i) The left and right cortico-spinal tracts (CST) were obtained by placing seed 
regions (size= 60 voxels) in the posterior limb of the internal capsule. The 
exclusion mask sheets divided the images in the sagittal plane through the 
interhemispheric fissure, and axially at the level of the interior margin of the 
genu of the corpus callosum (Figure 4.1, voxels in light blue-blue). 
ii) The genu of the corpus callosum (GCC) was generated using a seed mask 
(size= 64 voxels) in the genu of the corpus callosum. The exclusion mask 
sheets divided the brain in the coronal plane immediately posterior to the genu 
of the CC, in the axial plane immediately inferior to the genu of the CC, and in 
the sagittal plane starting anteriorly to the genu of the CC (Figure 4.1, voxels in 
green). 
iii) The optic radiations (OR) were generated using a seed mask (size= 52 
voxels) in the region posterior and lateral to the lateral geniculate nucleus 
(LGN). The exclusion mask contained four planar sheets, a complete mid 
sagittal sheet dividing the two hemispheres, a complete coronal sheet anterior 
the LGN, an axial sheet touching the inferior margin of the occipital lobes and 
extending anteriorly to the level of the splenium of the CC, and another axial 
sheet starting in the splenium of the CC and extending posteriorly (Figure 4.1, 
voxels in pink).  
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Figure 4.1 Reconstructed tracts and corresponding cortical targets in standard space, 
overlayed onto the MNI T1-w template: CST (voxels in light blue-blue) and 
precentral/postcentral cortex (voxels in red); GCC (voxels in light green-green) and frontal 
cortex (voxels in green); OR (voxels in light pink-pink) and occipital cortex (voxels in pink). 
 
 
To define each tract’s anatomically connected cortical region (the “cortical 
target”), each point on the tract boundary, which is either within or abutting the 
GM, was extended geometrically to the corresponding outer boundary of the 
cortex following a straight line, employing the novel « tract-extension» approach 
described in Chapter II (Tozer et al., 2012), (see Chapter section 2.5.2.4 and 
Figure 2.15). Each tract (CST, GC, OR) went through the tract-extension 
procedure in standard space using tissue templates derived from the 
segmentation of the MNI template using SPM8 (www.fil.ion.ucl.ac.uk/spm) and 
the maximum likelihood algorithm to assign each voxel to a tissue type.  
 
After these steps, we obtained three “tract-cortex (T-C) pairs” of anatomically 
connected WM-GM regions, each one consisting of a WM tract and its 
associated GM cortical target: (i) right and left motor pair (CST and connected 
GM in the pre- and post-central cortex); (ii) callosal pair (genu of the CC and its 
connected GM region in the frontal lobe); and (iii) right and left optic pair  (OR 
and its connected GM area in the occipital cortex).  
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4.2.3.3 MTR map calculation and transformation of extended tracts into native 
space 
In all patients and in the Group A of healthy controls, at each time point, the 
MTR map was calculated in the subject-specific space (native space) on a 
voxel-by-voxel basis from the short echo data from the MTR sequence 
according to the standard equation (Grossman et al., 1994). 
 
At each time point, each extended tract reconstructed in standard space was 
transformed into native space, using algorithms from the FSL software package 
(http://www.fmrib.ox.ac.uk/fsl/), as follows:  
i) The individual (and native) short echo non-MT weighted data was registered 
to the native T1-w image using a linear transformation algorithm (FLIRT) from 
the FSL library; 
ii) The native T1-w images were registered to the T1-weighted MNI template 
provided by the FSL software library, using a non-linear registration algorithm 
(FNIRT); 
iii) The two registration steps (i and ii) were combined and then the  
transformation from standard space to native space (MNI2map) was calculated; 
iv) The MNI2map transformation parameters were applied to the extended 
tracts in order to transform them into native space.  
 
4.2.3.4 Segmentation of extended tracts in native space and extraction of WM 
and GM MTR values  
In order to segment the WM tracts from the corresponding cortical targets in 
native space, we followed the steps below:  
(i) The native T1-w scans were registered to native MTR map space (which will 
be referred to as “MTR map space” herein after) by applying the inverse 
transformation of the FLIRT registration described in the previous section. We 
maintained a high resolution (e.g., 1×1×1 mm3) for the T1-w registered images 
in order to reach a better segmentation, rather than matching the MTR map 
resolution (e.g. 0.97×0.97×5 mm3) at this step. 
ii) The T1-w scans in MTR map space, obtained in (i), were then segmented 
into WM, GM and CSF probability maps using SPM8 
(www.fil.ion.ucl.ac.uk/spm/). 
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iii) The WM and GM probability maps, obtained in (ii), were then down-sampled 
to match the resolution of the MTR map space, which was 0.97×0.97×5 mm3. 
iv) Tissue segments were then produced from the down-sampled probability 
maps by applying the maximum likelihood algorithm. 
v) The WM and GM maps obtained in step (iv) were then used to mask the 
extended tracts in native MTR map space, resulting in WM and GM segments 
of each tract-cortex pair for each subject and at each time point (Figure 4.2). 
 
 
Y=109 Z=23 
 
 
Figure 4.2 Left and right CST (voxels in red), and associated voxels in the 
precentral/postcentral cortex (voxels in blue) in a single patient, overlayed onto the patient’s T1-
w image in native space. 
 
 
In patients, and for each tract, the WM lesion masks were used to mask the WM 
tracts, to obtain a mask for normal-appearing white matter (NAWM) and a tract-
specific lesional tissue mask. The tract-specific lesion load was calculated in all 
tracts at each time-point. 
 
At each time-point, the WM and GM segments of each T-C pair were then used 
as region-of-interests (ROIs) and applied to the MTR map to calculate: 
(i) in patients, the mean MTR values of the tract NAWM, of the tract-specific 
lesional tissue, and of the connected cortex;  
(ii) in controls, the mean MTR values of both the WM and GM. The mean MTR 
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values of the whole WM and of the whole GM were also calculated.  
The maps of WM tracts and of connected GM areas were then used to calculate 
the corresponding tissue volume, by multiplying the number of non-zero voxels 
by the voxel volume.  
 
4.2.3.5 Cord cross-sectional area 
In patients, cord cross-sectional area at the C2-3 level was calculated using a 
semi-automated technique previously described by Losseff and colleagues 
(Losseff et al., 1996). This level was selected as it offers several anatomical 
advantages for measuring cord cross-sectional area, with high cord-to-
cerebrospinal fluid contrast, limited inter-subject variability in cord cross-
sectional area at this level and a low probability of disc protrusions.  
 
4.2.4 Statistics 
 
Statistical analysis was carried out using Stata 12.1 statistical software (Stata 
Corporation, College Station, Texas, USA). Results with p value < 0.05 were 
considered statistically significant. 
 
4.2.4.1 Comparison of WM and GM MTR between patients and controls 
Cross sectional differences in mean MTR between patients and controls at the 
two time points were obtained using a multivariate regression, which is based 
on four simultaneous regressions for each pair (i.e. NAWM MTR regressed 
against GM MTR and viceversa, for the two time-points), using subject group, 
age and gender as common covariates.  This was performed using the 
Structural Equation Modelling (SEM) command in Stata, using the Maximum 
Likelihood for Missing Values (MLMV) estimation method.  An advantage of this 
method is that correlations between the variables are taken into account to 
smooth out the effect of different missing values at different time points in 
different variables; this yields estimates which are less prone to bias than the 
separate regressions under the assumption a) that regression residuals are 
multivariate normal; and b) that the missing values are either Missing 
Completely At Random (MCAR) or Missing at Random (MAR) (Schott and 
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Bartlett, 2012): briefly this assumption is that values are missing either 
completely randomly or in a way that is dependent only on observed values. 
 
4.2.4.2 Evolution of NAWM, WML and GM values over time in patients 
To assess the evolution of NAWM, WML and GM values over the follow-up 
period in patients, changes in mean MTR of tract NAWM, of WM lesions and of 
connected GM cortex from baseline to 24 months were estimated using a single 
multivariate regression for each tract-cortex pair (this is equivalent to 
simultaneously performing the three paired t-tests, for NAWM MTR, WM lesions 
MTR and GM MTR, for each tract-cortex pair).  
 
4.2.4.3 Cross-sectional relationship between NAWM and GM values at each 
time-point 
In patients, at each time point a multivariate regression was performed over the 
five tract-cortex pairs (corresponding to five simultaneous regressions at a time 
point); each regression was between that tract-cortex pair’s NAWM mean MTR 
and the corresponding GM target’s mean MTR, giving standardised regression 
coefficients and p-values to assess each association.  To investigate whether 
any tract-cortex pair specific baseline GM vs WM MTR associations were 
explained by age, gender, disease duration, whole WM or GM mean MTR, 
NAWM or GM volumes, lesion MTR or volume, or spinal cord area, these 
variables were entered in turn as covariates into the regressions.  
 
4.2.4.4 Temporal relationship between tract-specific NAWM and GM values: the 
“primary WM damage” and the “primary GM damage” model 
 (i) Primary WM damage model: In order to investigate whether, in each pair, 
the baseline NAWM MTR predicted the GM MTR at 24 months, independently 
of baseline GM MTR (as the GM MTR at 24 months is expected to significantly 
correlate with the GM MTR at baseline), a multivariate regression was 
performed over the five tract-cortex pairs using for each pair the NAWM MTR at 
baseline as independent variable and GM MTR at 24 months as dependent 
variable; the multivariate regression was then repeated adjusting for GM MTR 
at baseline. 
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(ii) Primary GM damage model: Similarly, in order to investigate whether, in 
each pair, the baseline GM MTR predicted the NAWM MTR at 24 months, 
independently of baseline NAWM MTR (as the NAWM MTR at 24 months is 
expected to significantly correlate with the NAWM MTR at baseline), a 
multivariate regression was performed over the five tract-cortex pairs using for 
each tract-cortex pair the GM MTR at baseline as independent variable and 
NAWM MTR at 24 months as dependent variable; the multivariate regression 
was then repeated adjusting for NAWM MTR at baseline. 
 
To examine whether other potential confounders (age, gender, disease 
duration, whole WM or GM mean MTR, NAWM or GM volumes, tract-specific 
lesion MTR or volume, or spinal cord area) explained the two models, these 
variables were added singly as covariates in the models. 
 
4.2.4.5 The role of lesions: post-hoc analysis on the correlation between 
baseline lesion MTR and later NAWM and GM MTR 
To assess in further detail the role of early lesions in contributing to later NAWM 
and GM damage, in addition to examining whether baseline tract-specific lesion 
MTR explained the “primary WM damage” or the “primary GM damage” model, 
as described above, multivariate regressions were performed over the tract-
cortex pairs, using WML MTR at baseline as independent variable and the tract-
specific NAWM and corresponding GM area’s MTR at 24 months as dependent 
variables.   
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4.3 Results:   
 
The mean MTR in NAWM, GM, and lesions in patients, and the mean MTR in 
WM and GM in healthy controls (Group A) are reported for each tract-cortex 
pair at the two time points in Table 4.2. 
 
Left motor pair 
mean MTR 
Right motor pair 
mean MTR 
Callosal pair 
mean MTR 
Left optic pair 
mean MTR 
Right optic pair 
mean MTR 
month patients controls patients           controls patients controls patients controls patients controls 
GM NAWM GM WM GM                NAWM GM WM GM NAWM GM WM GM NAWM GM WM GM NAWM GM WM 
M  0 3513 3622 3568 3719 3392 3612 3534 3698 3242 3807 3364 3953 3122 3407 3263 3550 3221 3438 3364 3612 
M 24 3443 3633 3509 3708 3347 3625 3512 3717 3234 3849 3361 3937 3120 3424 3259 3509 3236 3456 3359 3619 
 
 
Table 4.2 Each tract-cortex pair’s mean MTR in NAWM and GM in patients, and in WM and GM 
in healthy controls, at baseline and year 2.  
 
 
4.3.1 Comparison of WM and GM MTR between patients and controls 
At baseline, there was a significantly reduced mean MTR in patients compared 
with controls in the NAWM of the CST, bilaterally (p=0.001 in the left CST, 
p=0.002 in the right CST), while there was no significant difference between 
patients and controls in the GM of the corresponding motor areas. At baseline, 
in the callosal pair and in the optic pair, bilaterally, there was a significant 
reduction in both NAWM and corresponding GM mean MTR in patients 
compared with controls (except in the NAWM of the left OR, where the 
difference between patients and controls was only borderline significant) (Table 
4.3). At year 2, there was a significant reduction in MTR in patients compared 
with controls in the NAWM and in the GM of all the tract-cortex pairs except in 
the motor area on the left side, and in the NAWM of the OR on the left side 
(Table 4.3).  
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Table 4.3 Comparison of mean MTR between patients and healthy controls (mean difference 
and p-value) adjusted for age and gender, at baseline and year 2. 
 
 
4.3.2 Evolution of NAWM, WML and GM damage over time in patients 
 
In both CSTs, there was no suggestion of progressive change in NAWM MTR 
over the follow-up period (Table 4.4), while in the corresponding motor areas, a 
progressive reduction of GM mean MTR was found, though this was not 
statistically significant. In the callosal pair, there was no suggestion of 
progressive damage in the NAWM of the GCC nor in the corresponding frontal 
GM mean MTR over two years (Table 4.4). In the optic pair, there was no 
evidence for a significant progressive change in the mean MTR of NAWM in the 
bilateral OR over two years.  
 
On the other hand, while the right occipital cortex showed no suggestion of 
progressive change in mean MTR over two years, we found a progressive and 
significant reduction in mean MTR in the left occipital cortex over two years 
(p=0.017, Table 4.4). 
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 Left motor pair Right motor pair Callosal pair Left optic pair Right optic pair
 GM WM lesions GM WM lesions GM WM lesions GM WM lesions GM WM lesions
M0 to 
M24 -63.6 -4.2 -45.9 -45.4 -4.3
-77.2 
P=0.084 -19.3 -16.3 15.7 
-42.8 
P=0.017-20.7 -15.6 -31.5 -4.6 -38.1 
 
 
Table 4.4 Mean MTR change in the NAWM and GM of all the tract-cortex pairs over the follow-
up (p value indicated where mean MTR change was significantly different between baseline and 
month 24). 
 
4.3.3 Cross-sectional relationship between NAWM and GM damage at each 
time-point 
 
At baseline, there was a significant correlation between the mean MTR of each 
tract’s NAWM and the mean MTR of the corresponding GM target, in the left 
motor pair (p=0.023), in the callosal pair (p=0.002), and in the optic pair, both on 
the left (p=0.001) and on the right (p=0.001), where the resulting association 
was the strongest. On the other hand, at baseline the mean NAWM MTR of the 
right CST was not significantly associated with the mean MTR of the 
corresponding motor cortex (p=0.288). In the callosal and in the optic pairs, 
when included in the model, neither age, gender, disease duration, baseline 
lesion MTR and volume, baseline spinal cord area, global WM and GM MTR, 
NAWM or GM volumes, affected the reported baseline associations. However, 
when including the global WM in the model in the left motor pair, the association 
between the mean NAWM MTR of the left CST and the mean MTR of the left 
motor cortex lost significance (p=0.358) while, when including baseline spinal 
cord area in the model in the right motor pair, the association between the mean 
NAWM MTR of the right CST and the mean MTR of the right motor cortex, 
showed a trend towards a statistical significance (p=0.086).  
 
At year 2, there was a significant association between the mean MTR of each 
tract and the mean MTR of the corresponding GM region in all tract-cortex 
pairs, except for the left motor pair, where the correlation between the mean 
MTR in the CST NAWM and the mean MTR in the motor cortex did not reach 
statistical significance independently of baseline whole WM MTR.  
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4.3.4  Temporal relationship between tract-specific NAWM and GM damage 
 
4.3.4.1 “Primary WM damage” model 
In the motor pair and in the optic pair bilaterally, the baseline mean MTR of 
each tract’s NAWM was a significant predictor of the corresponding GM area’s 
mean MTR at year 2 (Table 4.5). The association between NAWM mean MTR 
at baseline and GM mean MTR at year 2, was not significant in the callosal pair 
(p=0.274). When repeating the significant regressions including the baseline 
GM region’s mean MTR in the model, all the abovementioned regressions 
remained significant apart from the left optic pair where the association lost 
significance.  
 
0.231, P=0.022 0.112, P=0.290 0.612, P=0.274 0.444, P=0.004 0.320, P=0.034 NAWM0 
Right optic pair Left optic pair Callosal pair Right motor pair Left motor pair 
 
 
Table 4.5 Standardised regression coefficients and p-values for each tract-cortex pair’s “primary 
WM model” regression, adjusted for baseline GM area’s MTR (i.e. baseline NAWM mean MTR 
as independent variable, and corresponding GM area’s mean MTR as dependent variable, 
adjusted for baseline GM area’s MTR). 
 
 
When age, gender, disease duration, baseline NAWM and GM volumes, 
baseline lesion MTR and volume, and baseline spinal cord area, were included 
in the model, in all tract-cortex pairs the “primary WM damage model” 
regressions remained significant. When correcting for baseline whole WM and 
GM mean MTR, in all tract-cortex pairs the “primary WM damage model” 
regressions remained significant, except in the optic pair, bilaterally, where the 
“primary WM damage model” regression lost significance (p=0.322 on the right, 
p=0.19 on the left). 
 
4.3.4.2 “Primary GM damage” model 
In the motor pair bilaterally, the baseline mean MTR of the motor cortex was not  
a significant predictor of the CST’s NAWM mean MTR at year 2. On the other 
hand, in the callosal pair and frontal cortex, the mean MTR at baseline 
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significantly predicted the GCC’s NAWM mean MTR at year 2.  In the right optic 
pair, bilaterally, the baseline mean MTR of the occipital cortex significantly 
predicted the mean MTR of the OR’s NAWM at year 2 (Table 4.6). When 
repeating the significant regressions including the baseline NAWM tract’s mean 
MTR in the model, the regression in the callosal pair and in the left optic pair 
lost significance (p=0.107 and p=0.119, respectively), while that in right optic 
pair became borderline significant (p=0.045). When adjusting for spinal cord, all 
the regressions lost statistical significance.  
 
0.425, P=0.001 
0.206, P=0.045 
0.216, P=0.099 
0.114, P=0.127 
0.563, P<0.001 
0.178, P=0.158 
 
0.062, P=0.260 
 
0.001, P=0.992 GM0 
Right optic pair Left optic pair Callosal pair Right motor pair Left motor pair 
 
 
Table 4.6 Standardised correlation coefficient and p-values for each tract-cortex pair’s “primary 
GM model” regression, adjusted for NAWM MTR at baseline (i.e. baseline GM region mean 
MTR as independent variable, and corresponding NAWM tract’s mean MTR as dependent 
variable, adjusted for baseline tract’s NAWM MTR). 
 
 
4.3.4.3 Comparison between the “primary WM damage” and the “primary GM 
damage” model 
The direct comparison of coefficients between the “primary WM model” and the 
“primary GM damage model” reached the statistical significance in the motor 
pair on both sides (p=0.03 on the left, p=0.007 on the right). The direct 
comparison of coefficients between the “primary WM” and the “primary GM 
damage model” in the callosal pair and in the right optic pair (in which both 
models resulted significant), did not provide significant evidence of a difference 
(p=0.201 in the callosal pair, and p=0.422 in the right optic pair). However, in 
terms of the size of the standardised regression coefficients, and the p-values, 
the “primary GM damage model” regression appeared to be weaker than the 
corresponding “primary WM damage model” regression.  
 
4.3.4.4The role of lesions: correlation between baseline lesion MTR and later 
WM and GM MTR 
In the left motor cortex, a higher baseline WML volume showed a trend towards 
a significant correlation with a lower MTR in the NAWM at 24 months (r=- 0.316, 
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p=0.081). In the right motor cortex, both baseline lesion MTR and volume were 
significantly associated with NAWM MTR of the CST at 24 months (r=0.522, 
p=0.046 and r=-0.808, p<0.001, respectively). In the callosal pair, only baseline 
WML MTR was significantly associated with NAWM MTR of the GCC at 24 
months (r=0.97, p<0.001). In the optic pair bilaterally, there was no significant 
association between lesion MTR or volume at baseline, and NAWM MTR at 24 
months. Finally, in all tract-cortex pairs, no significant association was found 
between tract-specific lesion metrics at baseline, and the corresponding cortical 
area’s GM MTR at 24 months.  
 
4.4  Discussion 
 
In this study on the pathological mechanisms underlying the early phase of 
PPMS, the early microstructural damage in the NAWM of the bilateral pyramidal 
tract (where pathological changes were already present at baseline, in contrast 
to the motor cortices, which resulted relatively spared at study entry), was found 
to precede and significantly predict the pathological changes later affecting the 
connected motor cortex bilaterally. This was independent of focal lesion load 
and spinal cord area. In addition, data from the other two tract-cortex pairs of 
WM tracts and their anatomically connected GM areas, were also compatible 
with the same temporal relationship. Overall, these preliminary data suggest 
that cortical pathology in the early phase of clinical progression, rather than 
reflecting a primary target of the disease, may originate from ongoing damage 
in the connected WM tracts, as described by the “primary WM model” 
hypothesis.  
 
At study entry, there was a significant decrease in MTR in patients compared 
with healthy controls, reflecting microstructural damage consisting of 
demyelination and axonal loss (Schmierer et al., 2004) in the NAWM of all tracts 
and in the correspondent GM targets (with the exception of the motor cortex 
bilaterally). This finding is in agreement with previous studies on this same 
cohort, which showed structural damage affecting both WM and GM from the 
early stage of the disease (Sepulcre et al., 2006; Ramio-Torrenta et al., 2006; 
Khaleeli et al., 2007b; Bodini et al., 2009). On the other hand, the patients’ 
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motor cortex on both sides, which was showed to be atrophic in previous 
studies on this same cohort (Khaleeli et al., 2007b; Bodini et al., 2009) did not 
present any significant MTR reduction in our analysis, when compared with 
healthy controls. A possible explanation for this may lie in the novel approach 
we used in this study to identify the specific cortical target of the motor tracts 
(consisting in the geometrical extension of each point of the tract boundary into 
the GM) (Tozer et al., 2012), which defined specific regions within the motor 
areas, not entirely overlapping with those analysed and discussed in previous 
reports from this same cohort. In addition, previous studies only focused on a 
subgroup of the same cohort, whilst here we included all 37 patients who 
participated in the study. 
 
Looking at the tissue-specific evolution of NAWM and GM damage over time, 
there was no evidence for a significant progressive MTR reduction in the 
NAWM of all tracts, whilst a significant reduction in MTR over time was 
demonstrated in all cortical targets (with the exception of the right occipital 
cortex). Our data could reflect the temporal sequence of the pathological 
damage described by the “primary WM model” hypothesis, with the disease 
initially affecting the WM tracts, and then spreading progressively over time to 
the connected GM regions (Geurts et al., 2009). Interestingly, the notion that 
GM atrophy proceeds relentlessly over the course of the disease, has already 
been reported in all subtypes of MS, including PPMS (De Stefano et al., 2010). 
 
When the cross-sectional relationship between NAWM and GM damage at each 
time-point was investigated, a significant correlation between the damage 
occurring in the two compartments, which was independent of all the 
confounding variables (including baseline lesion load and spinal cord area), was 
found in all tract-cortex pairs. These data are in agreement with what was 
previously reported in this same cohort in Chapter III (Bodini et al., 2009), and 
support the notion that the pathological processes affecting the two 
compartments are strictly interconnected, at least in some clinically relevant 
brain areas and at specific stages of the disease. Interestingly, the findings here 
reported suggest that there is a continuing damage between the NAWM and the 
GM, which evolves, at least to some extent, independently of the changes 
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secondary to WM lesions and spinal cord damage.  A possible interpretation of 
this result could be that pathological processes primarily affecting the NAWM 
tracts (i.e. not resulting from focal lesion/ spinal cord damage), have the 
potential to spread along the axons back to the neuronal soma, resulting in 
secondary effects within the cortex (Filippi et al., 2012). On the other hand, in 
the motor pair, at both time-points, the association between the damage 
affecting the NAWM in the CST and that occurring in the corresponding motor 
cortex was weaker  (i.e. either it was non significant, or was significantly 
influenced by other covariates). These data suggest that in the motor pair, at 
the time of the study, the disease had not yet spread to the two compartments, 
and had not reached in both the same degree of extent and severity; as a 
result, the analysis of the damage affecting this specific tract-cortex pair, gave 
us the unique opportunity to follow-up directly the temporal sequence of the 
pathological processes affecting the two compartments, as they were first 
appearing, and then developing over time.  
 
When we explored the temporal relationship between the damage in the tract-
specific NAWM and the abnormalities in the connected GM areas, we found 
that overall, the “primary WM damage model” described more accurately than 
the “primary GM model” the temporal evolution of the pathological processes in 
our cohort of patients with early PPMS. Indeed, in all tract-cortex pairs (except 
the callosal pair and the left optic pair), the tract-specific microstructural damage 
in the NAWM at baseline, as measured by the mean MTR, significantly 
correlated with the damage affecting the connected GM area after two years, 
independently of the baseline GM area’s mean MTR, and of all the other 
confounding variables included in the model, including T2-w lesion load and 
MTR, and spinal cord area. According to the “primary WM model” hypothesis, 
the pathological processes initially affecting the WM tracts, over time start 
spreading to their connected cortical areas, resulting in subsequent GM 
pathology. Different pathogenic mechanisms potentially underlying the temporal 
sequence described by the “primary WM damage model” have been proposed, 
and are currently under investigation (Geurts and Barkhof, 2008). Indeed, 
several different pathogenic processes affecting the WM tracts (including 
glutaminergic excitotoxicity, disrupted intra-axonal transport, and mythocondrial 
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dysfunction), may cause an axonal pathology associated with a dying-back 
axonopathy along the tract. This axonopathy could result in a secondary 
damage to the cortical regions connected with the tracts (Geurts and Barkhof, 
2008; Filippi et al., 2012). The “primary WM damage model” regressions 
remained significant when T2-w lesion load and MTR, as well as spinal cord 
area, were included in the model. Our results could be interpreted in the light of 
an intriguing pathogenic hypothesis which has been recently proposed to 
explain the pathogenesis of MS. This suggests that a degenerative mechanism 
within the NAWM (affecting the axons, or the oligodendrocytes, or both) might 
be the earliest event, which then triggers an immunitary response (whose 
severity varies in different MS subtypes, being less pronounced in PPMS) that 
is responsible, in turn, of the inflammatory reaction that is found in the WM (Stys 
et al., 2012).  
 
Interestingly, the “primary WM damage model” hypothesis did not explain the 
temporal evolution of the disease processes in the case of the callosal pair. This 
could be because, in this particular brain region, the damage had already 
reached an advanced stage at baseline, with the sequence of pathological 
events (i.e. early damage accrual in the WM tract followed by the secondary 
occurrence of abnormalities in the connected GM area) being already 
completed at study entry.  
 
On the other hand, when the “primary GM damage model” was tested, this was 
not significant in the motor pair, bilaterally, and in the left optic pair. In the 
callosal pair and in the right optic pair, it resulted to be significant (p<0.001 and 
p=0.001), when no covariates were included in the model. However, when the 
“primary GM damage model” regression was repeated adjusting for baseline 
occipital cortex mean MTR, it became borderline significant in the right optic 
pair (p=0.045), while it lost significance in the left optic pair (p=0.119). This 
suggests that the abovementioned correlations were not completely genuine, as 
they seemed to be induced by the strong association existing between the MTR 
values at the two time-points in the occipital cortex.  
 
The statistical comparison between the two proposed models showed that the 
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“primary WM damage model” was significantly stronger than the “primary GM 
damage model” in the motor pair, bilaterally. In the callosal pair and in the optic 
pair, bilaterally, although the direct comparison between the two models did not 
reach  statistical significance, there was a suggestion that the “primary WM 
damage model” was stronger than the “primary GM damage model” one, in 
terms of both the standardised regression coefficients, and the p-values. This 
suggests that, in the early phase of PPMS, the main sequence of pathological 
events seems to consist of primary damage of the WM tracts which precedes, 
and possibly causes, the pathological changes occurring in the connected GM 
areas. However, data from the callosal and the optic pair, suggest that this 
sequence of events may coexist, in specific brain regions, with a concurrent 
pathogenic mechanisms, consisting of a primary neurodegenerative damage 
affecting the GM (possibly due to meningeal inflammation (Magliozzi et al., 
2007; Choi et al., 2012), gradually leading to a subsequent axonal retraction 
and, in turn, to a degeneration of the resulting empty myelin sheaths along the 
WM tracts (Geurts et al., 2009). 
 
When we looked at the impact of tract-specific WM lesions on the spatial and 
temporal relationship between the damage of WM tracts and that of the cortical 
regions connected to them, we obtained rather interesting results. We found 
that, although the damage of tract-specific WM lesions  (in terms of both mean 
MTR and volume), clearly correlated with the concurrent and subsequent 
changes affecting the NAWM of the tracts, the cross-sectional and longitudinal 
association between the changes affecting the two compartments were 
independent of lesional damage. Our data are in line with the hypothesis that 
the pathological changes occurring in the NAWM, may partly depend on 
retrograde degeneration of axons that are transected in WM lesions (Trapp et 
al., 1998) but, to some extent, they may be also attributable to independent 
processes primarily originating within the NAWM itself (Geurts et al., 2010). 
 
4.5  Conclusions 
 
In conclusion, we described, for the first time in-vivo, the temporal sequence of 
pathological events affecting the WM and the GM in the early phase of PPMS. 
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The results presented in this study may suggest that, at least in the early phase 
of clinical progression in this subtype of disease, the tract NAWM could 
represent the initial target of the disease, as described by the “primary WM 
damage model”. I showed that microstructural damage affecting the NAWM, as 
reflected by MTR, precedes and predicts that occurring in the connected cortical 
areas. However, it is noteworthy to underline the limitations of the hypothesis-
driven approach employed in this study to test the “primary WM damage” and 
the “primary GM damage” models. In particular, the presented results could 
simply reflect the temporal sequence of the pathological events affecting the 
two compartments, and they do not imply any causal relationship between 
them. Secondly, our study does not exclude the possibility that MS is a “whole 
brain disease”, where WM and GM are affected independently of each other, or 
where both the two models (“primary WM damage” and “primary GM damage” 
models) are valid and can accurately describe the temporal sequence of events, 
each one possibly prevailing on the other at different stages of disease and/or in 
different brain areas. Future work applying the methodology described in this 
study, will explore the temporal sequence of pathological events, as well as the 
role of T2-w lesions in contributing to WM and GM pathology over time, in the 
relapsing-onset forms of disease.  
 
With the studies presented in Chapter III and Chapter IV, I tried to answer the 
first question of this thesis. In the following Chapters, the second question 
presented in Chapter I will be addressed, exploring the relative contribution of 
the two compartments to short-term and long-term clinical progression.  
 
  
 
 
 
The role of focal WM damage in predicting 
clinical progression over 10 years in PPMS 
 
 
 
 
 
 
Chapter V 
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The study presented in this Chapter will address the second question proposed 
in the Chapter I of this thesis, investigating the role of WM lesions (and in 
particular their spatial location) in predicting long-term clinical deterioration in 
PPMS. DThe data presented in this Chapter are is the result of a 10-year follow-
up of a large cohort of patients with PPMS recruited in five European centres 
(Amsterdam, Barcelona, Bordeaux, London and Milan), all members of the 
MAGNIMS (MRI in MS) consortium.  
 
5.1 Introduction 
 
As discussed in the Chapter I of this thesis, predicting long term clinical 
outcome in patients with PPMS has important clinical implications, since this 
can affect the recruitment criteria for treatment trials (that would benefit from an 
appropriate stratification of risk for patients at study entry) and, in future, provide 
prognostic advice to individual patients.  
 
Whole brain T2 and T1 lesion loads, which are objective measures of visible 
tissue damage, have been studied as potential predictors of long-term clinical 
outcome in a previous MAGNIMS study, where a large cohort of PPMS patients 
was followed-up for 10 years (Khaleeli et al., 2008b). The results of this study 
showed that neither T2 nor T1 lesion load at study entry predicted clinical 
deterioration over 10 years. This is surprising, since T2 lesion volume has been 
shown to predict disability after 20 years in patients who presented with 
clinically isolated syndrome (Fisniku et al., 2008), and suggests differences in 
the mechanisms of tissue damage between RRMS and PPMS. 
 
In searching for other features of T2 and T1 brain lesions, which could predict 
long term outcome in PPMS, Khaleeli et al. also examined the short-term 
increase in T2 and T1 lesion loads over 2  years, finding that this also failed to 
predict progression over 10  years (Khaleeli et al., 2008b). On the other hand 
two other studies, one from the MAGNIMS PPMS cohort and one from the 
London early PPMS cohort, indicated a more promising role for the short-term 
change in T2 and T1 lesion loads in predicting clinical progression over 5  years 
(Ingle et al., 2003; Sastre-Garriga et al., 2005b). This suggests that 
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accumulation of visible lesions over a short time showed no advantage over 
total lesion load at study entry when it came to predicting progression at 10  
years. Thus, predictors which are promising in short-term follow-up studies, may 
not be as compelling in long-term studies. 
 
Another, mostly unexplored, feature of lesions, which may be relevant to 
predicting long-term clinical progression, is their topographic distribution. 
Therefore, the study presented in this Chapter aimed to investigate whether the 
location of T2 and T1 lesions at baseline predicts progression over 10  years, 
performing a retrospective study in the same MAGNIMS cohort of patients with 
well-established PPMS previously studied by Khaleeli et al. (Khaleeli et al., 
2008b). To explore lesion location, in the study presented here I employed the 
Lesion Probability Mapping (LPM) approach was employed, whichthat provides 
a voxel-wise, quantitative description of the topographic distribution of brain 
lesions (Di Perri et al., 2008). 
 
Among the other possible limitations of previous studies, which explored 
predictors of progression, there could be the use of step-changes of EDSS as 
the outcome measure in this form of disease (Kragt et al., 2008). In the attempt 
to address this issue, the time (in years) taken to require bilateral support in 
order to walk was defined in this study as a measure of the individual 
progression rate. Then, a time to event (TTE) analysis was performed and 
combined with LPM.  
 
Although cervical cord cross sectional area at study entry did not predict clinical 
outcome at 10 years in this cohort of PPMS patients (Khaleeli et al., 2008b), 
spinal cord damage is thought to play an important role in determining disability 
in PPMS (Nijeholt et al., 1998; Rovaris et al., 2001; Bieniek et al., 2006); 
therefore, the LPM analysis presented here was corrected for baseline cord 
cross-sectional area. Moreover, it was tested whether regional T2 and T1 lesion 
loads located in specific, clinically strategic areas, were significant predictors of 
TTE. 
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5.2 Methods 
 
5.2.1 Patients 
 
Out of 101 patients with PPMS who were followed-up for 10 years in five 
European centres (Amsterdam, Barcelona, Bordeaux, London and Milan) 
(Khaleeli et al., 2008b), 80 participants, whose baseline imaging data were 
available, were included in this study (see Appendix I). All of these patients 
were clinically assessed using the EDSS (Kurtzke, 1983) at baseline (see Table 
5.1 for baseline demographic, clinical and radiological characteristics), 76 after 
1  year, 59 after 2 years, 75 after 5 years and 79 after 10 years. Of the 79 
patients assessed after 10 years, 36 were scored using the EDSS telephone 
interview (Lechner-Scott et al., 2003). Four patients scored 10 on the EDSS, as 
their death was due to MS; one death occurred between years 2 and 5, and 
three between years 5 and 10. All subjects gave informed, written consent 
before the study, which was approved by the local Ethics Committees in each 
one of the participating centres. 
 
Patients, number                          20                        22                       4                    22                   12   
Age, years 
(mean (SD))                      53.5 (76–34)        45.7 (31–64)    48.7 (43–59)   52.7 (29–74)    45.1 (32–50) 
Gender, female/male                   10/10                   9/13                     3/1               1 1/11                2/10 
EDSS, median (range)              6.0 (2–8)              5.5 (2–7.5)          5.0 (4–6)        6.0 (2.5–8.5)   4.0 (2–8.5) 
Disease duration, years            11.7 (2–32)            8.8 (3–24)           9.0 (2–11)    10.3 (1–24)       6.8 (2–17) 
(mean (SD)) 
T2 lesion load, ml (SD)                8.4 (11.0)         15.8 (16.0)           12.6 (17.7)     15.3 (17.5)        7.7 (5.7) 
T1 lesion load, ml (SD)                3.4 (4.9)             5.6 (7.2)               6.0 (7.7)         4.7 (7.7)          3.8 (6.6) 
Spinal cord area (mm2)  
(mean (SD))                       72.3 (10.1)          77.9 (8.2)                   –               70.3 (9.4)         77.4 (8.1) 
Characteristics Amsterdam Barcelona Bordeaux London Milan 
 
 
Table 5.1 Demographic, clinical and radiological characteristics of the patients studied in each 
centre, at study entry. 
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5.2.2  MRI acquisition 
 
Patients underwent the same imaging protocol in each centre at study entry. In 
London, data were acquired using a 1.5 T GE Signa scanner, whereas at the 
other four sites a 1.5 T Siemens scanner was used. The protocol included T1-w 
and dual echo (T2- and proton density (PD)-w spin echo) imaging of the brain 
(see Table 5.2 for the acquisition parameters in each centre). Volumetric 
images of the spinal cord were also acquired, as described in Chapter IV 
(Stevenson et al., 1999). 
 
 
Repetition time, ms                    2500             3000        3000          3000        2500
  
Echo time, ms                       45/90               14          19           15/90          30 
Continuous axial slices, n            44                 46          45             44             44  
Slice thickness, mm                      3                   3            3              3               3 
Acquisition parameters  
T2/PD 
Amsterdam Barcelona Bordeaux London Milan 
Acquisition parameters  
T1 
Repetition time, ms                    620                690         600           600         550
  
Echo time, ms                         15                  15          14             20           10 
Continuous axial slices, n           44                  46          45             44           44  
Slice thickness, mm                      3                    3            3               3             3 
 
 
Table 5.2. Acquisitions parameters for T2-w/PD and T1-w sequences performed in each centre 
at study entry. 
 
 
5.2.3  MRI processing 
 
5.2.3.1 Lesion probability map (LPM) 
A detailed description of the LPM approach is given in Chapter II. Here, the 
main steps relevant to this specific study are summarised. The imaging tools 
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available in the Functional MRI of the Brain's Software Library (FSL, 
http://www.fmrib.ox.ac.uk/fsl) were used. 
 
1. Lesion masks 
A single observer, who was blinded to the clinical details, contoured the PD 
hyperintense and T1-w hypointense lesions, with reference to the co-registered 
T2-w, using a semiautomated technique (Plummer, 1992). Binary lesion masks 
were then produced and individual lesion loads calculated. 
 
2. Template construction 
Each patient's T1-w scan was registered to the Montreal Neurological Institute 
(MNI152) template using a fully affine transformation (12 parameters) (FLIRT - 
FMRIB's Linear Image Registration Tool), as per previous work in patient 
groups with a variety of neurological conditions (Karagulle Kendi et al., 2008; 
Ginestroni et al., 2009; Vellinga et al., 2009). All of the resulting transformed 
images were averaged to obtain an internal T1-w template. 
 
3. Transformation of individual scans and lesion masks into T1-w template 
Each patient's PD weighted scan was registered to the corresponding T1-w 
scan in native space using a rigid body transformation and trilinear interpolation 
(with FLIRT). The transformation parameters were then applied to the T2-w 
lesion masks, bringing them into alignment with the individual T1-w scans. Each 
patient's T1 scan was then registered to the T1 template, using non-linear 
registration (FNIRT-FMRIB's Non Linear Image Registration Tool), and the 
resulting transformation parameters were applied to the T1 and T2 lesion 
masks, which had been previously registered onto the individual T1, using 
trilinear interpolation. In order to maintain the volume of the transformed lesion 
masks as close as possible to those in the native brain images, after the trilinear 
interpolation, lesion masks were thresholded using a value of 0.5. Two 
observers independently checked all the co-registered lesions masks. 
 
4. T2 and T1 LPMs 
T2 and T1 LPMs were generated by averaging the T2-w and T1-w lesion 
masks, at each voxel, in standard space. For each map, the resulting voxel 
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intensity indicates how frequently the voxel in question is within a lesion across 
all patients, ie, the probability of that voxel being lesional. Regions containing 
the peaks of lesion probability were localised using the Johns Hopkins 
University DTI-based white matter atlas, provided by FSL  (Mori, 2005).  
 
Since male gender has been associated, in this patient cohort, with a worse 
long term outcome (Khaleeli et al., 2008b), the differences in the probability of 
each voxel being lesional between male and female patients were assessed 
using an unpaired t-test and corrected for multiple comparisons at cluster level 
(t 2, p<0.05) using permutation based inference (Nichols and Holmes, 2002). 
 
5.2.3.2 Cord cross-sectional area 
Cord cross-sectional area at the C2–3 level was measured using a 
semiautomated technique previously described by Losseff and colleagues 
(Losseff et al., 1996). 
 
5.2.4  Statistical analysis 
 
5.2.4.1 Correlation between lesion location and time to event 
For each patient, the time (in years) taken from disease onset to reach the level 
of disability that requires a constant bilateral support to walk (i.e., EDSS=6.5) 
was defined as the TTE and was used as a measure of progression rate. An 
EDSS of 6.5 was chosen as it is easy to recognise and represents a clinically 
meaningful stage in the progression of disability. It was also appropriate for the 
selected cohort, whose median EDSS at study entry was 5.7 (range 2–8.5). In 
cases where the EDSS was scored as equal or greater than 6.5 at a follow-up 
visit for the first time, it was assumed that the patient reached this score midway 
between the date of the visit and the preceeding assessment. 
 
Patients were divided into three groups of similar size on the basis of their TTE, 
as follows: (1) patients who reached EDSS 6.5 before entering the study (n=23); 
(2) patients who reached EDSS 6.5 between the baseline assessment and year 
5 (n=23); and (3) patients who reached EDSS 6.5 between year 5 and year 10 
(n=13) and those who had not reached the event at the end of the study (n=21). 
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To identify regions where the probability of each voxel being lesional in T2-LPM 
and T1-LPM correlated with TTE, an ordinal multiple regression was used, with 
an indicator of the three TTE categories as regressor, and age, gender, disease 
duration at baseline, centre and cord cross-sectional area as additional 
covariates. Corrections for multiple comparisons at cluster level (t 2, p<0.05) 
were performed using permutation-based inference (Nichols and Holmes, 
2002). 
 
5.2.4.2 Predictors of progression rate 
A Cox regression analysis was performed, entering TTE as the dependent 
variable, and the number of lesional voxels (or regional lesion loads) extracted 
from tracts that encompassed regions showing significant associations in the 
previous analysis, as independent variables. T2 and T1 total lesion loads, cord 
cross-sectional area, gender, age, disease duration and centre were entered as 
additional, independent variables. In particular, each independent variable was 
entered individually into the model. Subsequently, significant and borderline 
predictors were modelled together to determine the best, independent predictor. 
This analysis was performed using Stata 9.2 (http://www.stata.com) (Stata-
Corp, College Station, Texas, USA), and results with p<0.05 were considered 
significant. 
 
5.3 Results 
 
5.3.1  T2 and T1 lesion probability maps 
 
The brain locations that showed the highest probability of detecting T2 
hyperintense and T1 hypointense lesions were the superior and posterior 
regions of the corona radiata (Figure 5.1). The maximum local probability was 
higher in T2-LPM compared with T1-LPM (42% vs 26%).  
 
No significant differences in the probability of a voxel being lesional in T2-LPM 
and T1-LPM between men and women were found. 
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Figure 5.1. T2-Lesion probability map (LPM) (top row) and T1-LPM (bottom row); the colour 
code indicates the probability of a voxel being lesional. The maximum probability was found in 
the superior and posterior regions of the corona radiata, and was higher in T2-LPM compared 
with T1-LPM (42% vs 26%). 
 
 
5.3.2  Correlation between lesion location and time to event 
 
Of the 80 patients included in the study, 59 (73.7%) reached the event 
(EDSS=6.5) either before entering the study (23 patients, 28.7%) or during the 
course of the study (36 patients, 45%), while 21 (26.3%) had not reached the 
event when the study terminated. The median of the TTE calculated on those 
who reached EDSS 6.5, was 11.5 years (range 3–29 years). 
 
There was a significant correlation between a higher probability of a voxel being 
lesional on T2-LPM and a shorter TTE (p<0.05) in the following three regions: 
the bilateral corticospinal tract (CST) (from the cortex to the corona radiata), the 
bilateral superior longitudinal fasciculus (SLF) and the right inferior fronto-
occipital fasciculus (IFOF) (Figure 5.2). Conversely, there was no correlation 
between lesion probability on T1-LPMs and TTE, although a statistical trend 
towards a significant association was found in a region in the right posterior 
corona radiata, which included the CST and the SLF (p<0.08). 
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5.3.3  Predictors of progression rate 
 
The number of lesional voxels and corresponding regional lesion loads 
extracted from tracts containing regions that showed an association between 
lesion location and TTE are summarised in Table 5.3.  
 
Number of lesional voxels 
mean, SD                                                          37.6 (58.8)     38.4 (76.1)      30.1 (47.4) 
Lesion load (ml) 
mean, SD                                                            0.3 (0.5)       0.3 (0.6)        0.2 (0.4) 
Measures of regional lesional damage Bilateral CST Bilateral SLF Right IFOF 
 
 
Table 5.3. Number of lesional voxels and corresponding regional lesion loads extracted from 
the three tracts containing regions that showed an association between lesion location and time 
to event (CST, corticospinal tract; IFOF, inferior fronto-occipital fasciculus; SLF, superior 
longitudinal fasciculus).  
 
 
 
 
Figure 5.2.  Red–orange voxels show the regions on the regression maps where a higher 
probability of a voxel being lesional on T2 images was significantly associated with a shorter 
time to event. These regions are: the bilateral corticospinal tract (CST) (from the cortex to the 
corona radiata), the bilateral superior longitudinal fasciculus (SLF) and the right inferior fronto-
occipital fasciculus (IFOF). In blue, yellow and green are displayed the courses of the three 
white matter tracts (bilateral CST, bilateral SLF and right IFOF, respectively). 
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When predictors were entered individually into the Cox regression model, it was 
found that a greater number of T2 lesional voxels extracted from the right IFOF 
was associated with a shorter TTE (p=0.01, hazard ratio (HR) 1.00689, 95% CI 
1.00158 to 1.01225); in other words, for every extra ml of lesions within the right 
IFOF, the time taken to reach EDSS 6.5 was halved.  
 
The number of T2 lesional voxels extracted from the bilateral CST showed a 
trend towards a correlation with TTE (p=0.07, HR 1.002, 95% CI 0.99981 to 
1.00442); in this case, for every extra ml of lesions localised within the CSTs, 
the time taken to reach the event was reduced by 30%. The number of lesional 
voxels in the bilateral SLF did not predict TTE. 
Among the other variables tested individually in the Cox regression, it was 
found that: (i) the whole brain T1-w hypointense lesion load was significantly 
associated with TTE (p=0.04, HR 1.00004, 95% CI 1.000001 to 1.00007); in 
other words, for every extra ml in total T1-w lesion load, the time taken to reach 
the event was reduced by 0.5%; and (ii) there was a borderline significant 
association between gender and TTE (p=0.062, HR 1.62, 95% CI 0.96 to 2.73), 
so that the time taken for men to reach the event was reduced by 60%. 
 
When all significant and borderline predictors were entered together into the 
Cox regression model, the number of T2-w lesional voxels in the right IFOF was 
the best independent predictor of TTE (p=0.016, HR 1.00652, 95% CI 1.00121 
to 1.01186). The number of T2-w lesional voxels in the bilateral CST (p=0.07, 
HR 1.0022, 95% CI 0.99979 to 1.00461) and the whole brain T1-w hypointense 
lesion load (p=0.07, HR 1.00003, 95% CI 0.99999 to 1.00006) became 
borderline independent predictors, while gender became non-significant. 
 
5.4 Discussion 
 
The study presented in this Chapter showed that the location of T2-w lesions at 
baseline is associated with the rate of progression in PPMS over a 10 year 
period. In particular, a relationship between a higher probability of a voxel being 
lesional and a faster progression rate was found in the motor tract (ie, the 
bilateral CST) and two associative tracts (ie, the bilateral SLF and the right 
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IFOF). These results extend the findings of previous cross-sectional studies that 
have found correlations between mobility and regional MRI abnormalities 
localised within the motor tract in MS (Wilson et al., 2003; Reich et al., 2008; 
Gorgoraptis et al., 2010).  
 
Furthermore, the SLF and the IFOF are two associative tracts, which are part of 
the longitudinal association fibre system that connects each frontal lobe with 
other regions in the same hemisphere. In particular, the SLF connects the 
parietal and the frontal lobe, whereas the IFOF mediates the connection 
between the frontal and the occipital lobe (Catani et al., 2002; Martino et al., 
2010). Both SLF and IFOF are known to be involved in the regulation of high 
order aspects of motor function, including conveyance of somatosensory and 
kinesthetic information and initiation and guidance of motor activity 
(Schmahmann and Pandya, 2007; Jang and Hong, 2012). Therefore, a possible 
interpretation of these findings is that disruption of long associative tracts, due 
to the presence of lesions, causes a disconnection syndrome that may 
contribute to a more rapid deterioration of mobility, as previously proposed (He 
et al., 2009; Vellinga et al., 2009). In fact, it is known that disrupted white matter 
pathways, which play a crucial role in the coordination of information flow 
between different grey matter regions, are likely to lead to an altered functional 
connectivity between regions and, ultimately, to clinical impairment (Rocca et 
al., 2005). Furthermore, damage in these tracts may reduce the cortical 
reorganisation that originates from activation of regions connected through 
these pathways, thus resulting in a reduced ability of the brain to limit the 
clinical impact of structural damage. Recent data from the Milan cohort of 
patients with PPMS, obtained combining functional MRI (fMRI) and structural 
imaging data, support this interpretation of data, showing a correspondence 
between the extent of damage to specific tracts and fMRI changes  in 
corresponding networks (Ceccarelli et al., 2010).  
 
In the study presented in this Chapter, the relationship between lesion location 
in the IFOF and TTE was found to be statistically significant on the right side 
only. This is in agreement with the reports of asymmetry in MS brain pathology 
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(Reich et al., 2007). In future, the contribution of handedness to these results 
needs to be further explored. 
 
The association between a higher probability of a voxel being lesional and a 
faster progression rate, was independent of spinal cord atrophy (the mean value 
of cord cross-sectional area in patients is similar to that previously reported in 
PPMS) (Rovaris et al., 2001). Interestingly, when the correlation between lesion 
location and TTE was investigated using both EDSS equal to 6 and EDSS 
equal to 7 as events, the same motor and associative tracts showed 
significance (results not shown), suggesting that the location of T2 brain lesions 
in these tracts is an important factor in contributing to disability progression in 
PPMS. 
 
When the best predictors of TTE were investigated, the regional T2 lesion 
volume measured in the right IFOF was found to be the best, independent 
predictor of progression. Conversely, the T2-w lesion load in the bilateral CST 
became a borderline predictor, and that in the SLF became non-significant, 
suggesting a preferential role of the right IFOF, perhaps through the infero- and 
dorso-lateral frontal, and occipital cortices that it connects (Catani et al., 2002; 
Martino et al., 2010). Indeed, the IFOF constitutes the inferior part of the fronto-
occipital fasciculus, that is thought to be involved in the use of visual information 
for the purpose of guiding movements and controlling motor actions 
(Schmahmann and Pandya, 2007).The clinical relevance of IFOF in MS is 
further supported by the results of a recent study conducted on a cohort of 
patients who were followed up 20 years after presenting with a CIS, where 
(using the same LPM procedure described here) it was found that patients who 
converted to clinically defined MS had a greater probability of having lesions in 
the right IFOF when compared with those who did not (Dalton et al., 2011).  
 
As previously demonstrated, the whole brain T2-w lesion load did not correlate 
significantly with the progression rate, supporting the concept that in MS a 
proportion of the total lesion load is clinically silent (Miki et al., 1999; Li et al., 
2006; Rudick et al., 2006) and is not as relevant in determining progression as 
other lesions localised in strategic areas. 
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In contrast with the reported data about T2-w lesions, no significant association 
was found between the T1-w hypointense lesion probability and progression 
rate. A possible interpretation for this finding is that the T1-w lesion load is 
considerably smaller than the T2-w lesion load and, therefore, tracts are less 
likely to contain T1-w compared with T2-w lesions. This, in turn, means that the 
range of lesion loads within a given region is smaller for T1-w compared with 
T2-w lesions, reducing the possibility of a correlation with clinical outcomes. 
Interestingly, it was found that whole brain T1-w lesion load was a borderline 
independent predictor of progression rate. This is not surprising, since T1-w 
hypointense lesions are known to be histopathologically associated with severe 
tissue destruction (van Walderveen et al., 1998) and T1-w total lesion load 
correlates with clinical disability in MS more strongly than T2-w lesion load 
(Truyen et al., 1996; O'Riordan et al., 1998). 
 
Moreover, the areas most likely to contain lesions were similar in the T2-LPMs 
and T1-LPMs, and included the superior and posterior regions of the corona 
radiata. This is interesting, since a large number of axonal projections that 
contribute to the generation of the CST converge in this region (Wakana et al., 
2004), and PPMS is typically characterised by a progressive decline in motor 
function. A previous study reported that patients with PPMS had a greater 
probability of a lesion occurring in these regions, compared with RR patients (Di 
Perri et al., 2008).  
 
Interestingly, a TTE analysis which had been limited to clinical trials (Panitch et 
al., 2004; Montalban et al., 2009a), was included in this study. In fact, TTE 
analysis can be easily adapted to different events as long as the event in 
question is temporally defined and clinically meaningful (Allen et al., 1999). 
When the event cannot be specifically dated, it is acceptable to use the 
midpoint between the visit at which the event is noted and the previous one, as 
the time of the event (Law and Brookmeyer, 1992).  
 
However, due to our study design, the interval between visits varied between 1 
and 5 years, and 13 patients (16%) reached the event during the 5 years which 
elapsed between the last two time points. When the analysis was repeated 
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without these patients, the results were found to be very similar to those 
presented here (results not shown); therefore, it is possible to conclude that the 
variability in follow-up intervals has not significantly distorted the results. 
Furthermore, the progression rate observed in the population presented in this 
study, was similar to the one previously reported in epidemiological studies in 
PPMS patients (Cottrell et al., 1999), suggesting that despite the retrospective 
design of the study and the suboptimal frequency of assessments, the definition 
of the clinical outcome was appropriate. Another limitation of this study lies in 
the fact that 28.3 % of the patient cohort had already reached the event (EDSS 
6.5) before entering the study. This implies that the design of the study, (which 
can be considered as being prospective for the 71% of the cohort which 
reached the event after entering the study), has necessarily to be defined as 
retrospective for this sub-group of patients. Future analysis should take into 
account this substantial difference, and the presented results should be 
confirmed in larger cohorts by repeating the analysis separately for the 
“prospective” and the “retrospective” sub-groups. 
 
In this study, a large number of PPMS patients recruited in five European 
centres, was studied over a very long follow-up period. A potential limitation of 
this study is that, with the available data, we were not able to look for grey 
matter lesions that may be very relevant in contributing to long term clinical 
disability, as discussed in the Chapter I of this thesis (Calabrese et al., 2012). 
Another possible limitation of this study is the potential for registration errors 
and consequent lesion location inaccuracies related to the LPM technique. Two 
observers, rather than one (Di Perri et al., 2008; Vellinga et al., 2009b), 
inspected registered lesion masks and were in agreement in all cases. While it 
is to be expected that there will be some residual misalignments, in the context 
of a lesion probability analysis, their effects will be negligible. 
 
5.5  Conclusions 
 
The study presented in this Chapter has demonstrated that the focal damage 
localised in motor and associative tracts, might have the potential to significantly 
contribute to clinical progression, independently of spinal cord atrophy, in 
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patients with PPMS. Furthermore, the time to bilateral support has been 
demonstrated to be a useful approach to identify patients who progress more 
rapidly. 
 
Having described the role of focal WM damage in predicting long-term clinical 
outcome in this form of disease, the next Chapter of this thesis will continue to 
address the question of which regions of WM and GM abnormalities 
significantly contribute to clinical progression, exploring the role of short-term 
accrual of WM damage (within and outside focal lesions) in determining clinical 
disability in patients with early PPMS.  
 
 
  
 
 
 
Short-term microstructural changes 
in white matter tracts in early PPMS 
 
 
 
 
 
 
Chapter VI 
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The study presented in this Chapter will further address the second question 
proposed in Chapter I of this thesis, exploring the tract-specific, short-term 
accrual of microstructural damage in PPMS, and its impact on clinical 
progression, by using a novel methodology, called “skeletonised MTR”, which 
combines TBSS and MTR. 
 
6.1 Introduction 
 
As discussed in Chapter I, MTI has proved valuable in identifying and 
quantifying in-vivo tissue changes including demyelination and remyelination, 
that occur within and outside visible lesions on T2-w scans (Ropele and 
Fazekas, 2009). In particular, decreased MTR values, which post-mortem 
studies have shown to be sensitive to a reduced myelin content, in addition to 
axonal loss (Schmierer et al., 2004), have been demonstrated in patients with 
RRMS and progressive forms of MS when compared with controls, since the 
early stages of the disease (Filippi and Agosta, 2010).  
 
Previous MTR studies in patients with MS have employed histograms in a priori 
selected areas, such as segmentation-based masks or hand-drawn regions 
(Filippi and Agosta, 2010). In the study presented in Chapter IV, tract-specific 
MTR changes have been measured using tractography-based strategies that 
determine the WM tract of interest, and a similar approach has been previously 
employed both in healthy controls and in patients with psychiatric and 
neurological disorders (Reich et al., 2006; Reich et al., 2007; Dalby et al., 2010; 
de Zeeuw et al., 2011). However, tractography-based ROI approaches do not 
allow the investigation of the whole brain, and require the a priori selection of 
the tract(s) of interest.  
 
On the other hand, as discussed in Chapter II and Chapter III, TBSS is a fully 
automated, voxel-wise method that is able to carry out voxel-wise cross-subject 
statistics on diffusion derived metrics without requiring an a priori hypothesis 
(Smith et al., 2006). By addressing the challenges of inter-subject data 
alignment, TBSS has been widely employed to localise WM changes related to 
normal brain development (Giorgio et al., 2008) and ageing (Giorgio et al., 
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2010), as well as neurological diseases, including Alzheimer’s disease 
(Damoiseaux et al., 2009; Stricker et al., 2009; Serra et al., 2010)(Damoiseaux 
et al., 2009; Stricker et al., 2009; Serra et al., 2010), epilepsy (Focke et al., 
2008; Nguyen et al., 2011), multiple sclerosis and clinically isolated syndrome 
(Roosendaal et al., 2009; Raz et al., 2010a; Raz et al., 2010b; Kern et al., 
2011). In particular, as described in detail in Chapter II, TBSS uses each 
subject’s FA to produce an alignment-invariant tract structure, representing the 
core of whole-brain WM tracts, known as the “skeleton”. This step is followed by 
the projection of FA values from the main WM tracts of every subject onto the 
skeleton, achieved by searching perpendicular to the local skeleton structure for 
the maximum FA value. This value is assumed to represent the nearest relevant 
tract centre. This step ensures the alignment of WM tracts rather than that of 
macroscopic features (e.g., the boundary between tissues or the sulci shape, as 
in standard voxel-based approaches).  
 
In this study, TBSS was employed to create an FA-based “skeleton”, and then 
the same “projection” procedure was applied to co-registered MTR data to 
create a “skeletonised” MTR map for every subject. This novel approach was 
employed to explore the microstructural abnormalities reflected by one year 
changes in diffusion-derived parameters and MTR values along the core of WM 
tracts, within and outside T2-w lesions, in patients with the early PPMS. The 
other aim of this study was to assess whether these WM changes were 
clinically relevant, by performing correlations with changes in clinical scores 
over the same follow-up.  
 
6.2 Methods 
 
6.2.1  Patients 
 
Twenty-one patients diagnosed with PPMS according to Thompson’s criteria 
(Thompson et al., 2000) (11 women, 10 men, mean age 46.6 yrs, SD 9.6), 
within 5 years of symptom onset, underwent a neurological assessment and a 
whole brain imaging protocol, including diffusion weighted imaging and MT 
imaging, at both study entry and after 12 months (see Appendix I). These 
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patients were part of a larger cohort of 50 subjects.  A subset had diffusion and 
MT data at both, baseline and year 1, and was included in the current study. 
One patient was being treated with oral corticosteroids every four months. 
Clinical assessment included measuring the EDSS (Kurtzke, 1983), and the 
MSFC subtests (Cutter et al., 1999): PASAT, NHPT, and TWT.  
 
The study was approved by the Joint Medical Ethics Committee of the National 
Hospital for Neurology and Neurosurgery and the UCL Institute of Neurology, 
London. Written and informed consent was obtained from all participants.  
 
6.2.2  Image acquisition 
 
Patients were imaged using a 1.5T GE Signa scanner (General Electrics, 
Milwaukee, IL). MRI acquisition and protocol were as follows:  
 
(a) Three-dimensional inversion-recovery fast spoiled gradient recall (3D 
FSPGR) T1-weighted sequence of the brain (FOV 300x225 mm, matrix size 
256x160 (reconstructed to 256x256 for a final in plane resolution of 1.17 mm), 
repetition time 13.3 ms, echo time 4.2 ms, inversion time 450 ms, 124 axial 
slices, 1.5 mm thickness).  
 
(b) Whole-brain, cardiac-gated, Spin Echo Diffusion-Weighted (DW) Echo 
Planar Imaging sequence [FOV 240x240mm², matrix size 96x96 (reconstructed 
to 128x128), image resolution 2.5x2.5x3mm (reconstructed to 1.9x1.9x3mm), 
TE 95ms, TR 7RRs, maximum b-factor 1000 smm-2; three series, each 
collecting 14 axial slices of 3mm thickness, which were interleaved off-line; 
diffusion gradients were applied along 25 optimised directions (Jones et al., 
1999), and three images with no diffusion weighting were also acquired. 
 
 (c) Magnetisation transfer (MT) dual echo interleaved spin-echo sequence 
(Barker et al., 1996) (28 contiguous axial slices, slice thickness 5 mm, repetition 
time [TR] 1720 ms, echo time [TEs] 30/80 ms, number of excitations [NEX] 
0.75, acquired matrix 256×128, reconstructed matrix 256×256, field of view 
[FOV] 240×240 mm). A Hamming-apodised three-lobe sinc MT pulse (duration 
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16 ms, peak amplitude 23.2 µT, bandwidth 250 Hz, 1 kHz off-water resonance) 
was used. The sequence collects inherently co-registered proton density (PD) 
(30 ms echo) and T2-weighted images (80 ms echo) before and after the 
saturation pulse. 
 
6.2.3  Image post-processing 
 
6.2.3.1 Lesions 
Lesions were delineated with a semi-automated contour thresholding technique 
(Plummer, 1992) by a single rater on the unsaturated PD images of the MT 
protocol. The T2-weighted images, which were inherently co-registered with the 
PD-weighted images (both acquired with the same dual-echo sequence), were 
always used as a visual reference to increase confidence in lesion identification. 
Lesion masks were obtained by setting the signal intensity equal to 1 for all 
voxels within a lesion and zero outside lesions. The same procedure was 
performed on the baseline and the follow-up scans. 
 
6.2.3.2 From “skeletonised” FA, AD, RD, to “skeletonized MTR” 
After correction for eddy-current induced distortions, the diffusion tensor was 
calculated on a voxel-by-voxel basis, and FA maps were generated using DTIfit, 
that is part of the FMRIB Software Library 4.1 (FSL, FMRIB Image Analysis 
Group, Oxford, UK) (Smith et al., 2004). FA maps were fed into TBSS (Smith et 
al., 2006)  to generate a common FA tract skeleton onto which every subject’s 
FA was then projected (see Chapter II for details). As some animal work 
suggests that axial diffusivity (AD) (coincident with the largest eigenvalue of the 
diffusion tensor, i.e., diffusion coefficient along the direction of maximum 
diffusion) and radial diffusivity (RD) (the average diffusion coefficient in the 
orthogonal directions) are more specific than FA to microstructural changes 
involving axons and myelin (Song et al., 2005), a TBSS analysis of these 
indices was also performed, as follows: AD and RD maps for all patients at 
baseline and follow-up were generated by fitting a tensor model to the raw 
diffusion data. By applying the original non-linear registration of each patient’s 
FA map to standard space, the axial and radial diffusivity maps were projected 
onto the mean FA skeleton generated with TBSS, to obtain a “skeletonised AD” 
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and a “skeletonised RD” for each patient at each time point. 
 
MTR maps were calculated from the inherently co-registered PD images of the 
MT sequence in native space, by subtracting the saturated from the unsaturated 
signal, using the formula MTR=[(Mo- Ms)/Mo]×100 percent units (pu) on a pixel-
by-pixel basis. These short-echo images were chosen because the resulting 
MTR map has higher signal-to-noise ratio than that from the 80-ms echo. To 
obtain a “skeletonised” MTR image for each subject, MT data were first co-
registered with DTI by matching the native non-MT weighted volume (inherently 
co-registered with the MTR maps) with the native b0 volume, after skull-
stripping, with an affine transformation using FLIRT (FMRIB's Linear Image 
Registration Tool, part of FSL), using normalised mutual information as the cost 
function. The transformation was then applied to the native MTR map. Finally, 
the transformed MTR map underwent the same projection as the FA data onto 
the common FA tract skeleton, to obtain a “skeletonised” MTR image in MNI 
space, for each subject at each time point.  
 
6.2.4  Statistical analysis 
 
6.2.4.1 Assessment of clinical progression over one year 
To assess whether there was a significant deterioration in EDSS score over the 
follow-up period, the EDSS scores at baseline and at year one were compared 
using the Wilcoxon matched-pairs signed rank test. Changes in EDSS scores 
were then converted into steps by considering 1 step change equal to 1 point 
increase for values of EDSS of 5.5 or lower, and to 0.5 increase for values of 
EDSS higher than 5.5 (Wingerchuk et al., 1997). To measure if changes in 
MSFC subtests were significant over the follow-up, all the scores were first 
transformed into z-scores (z-NHPT, z-TWT and z-PASAT), using our baseline 
sample as reference. A paired t-test between the z-scores at the two time points 
was then performed for each MSFC subtest.  
 
6.2.4.2 Changes in skeletonised FA, AD, RD and MTR over one year 
To assess the presence of any regional change in FA, AD, RD and MTR over 
the follow-up period, the skeletonised FA, AD, RD maps and MTR maps, at 
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baseline were compared with those at follow-up, using permutation tests (2000 
iterations). Age, gender and disease duration at baseline were added as 
covariates of no interest. Correction for multiple comparisons was performed 
using threshold free cluster enhancement (TFCE) (Smith and Nichols, 2009). 
Differences were considered significant if p<0.05.  
 
Tract specific FA, AD, RD, and MTR values were obtained and reported from 
every subject’s skeletonised maps. The John Hopkins University white matter 
tractography atlas provided with FSL was used to identify the forceps major, the 
forceps minor, and 9 bilateral tracts: anterior thalamic radiation, cortico-spinal 
tract, cingulum bundle (split into cingulate and hippocampal parts), inferior 
fronto-occipital fasciculus, inferior longitudinal fasciculus, superior longitudinal 
fasciculus (split into fronto-parietal and temporal parts), and uncinate fasciculus. 
 
6.2.4.3 Correlation between changes in FA, AD, RD and MTR, and clinical 
changes over one year 
In order to assess the association between the changes in FA, AD, RD and in 
MTR and the clinical variables, a map of the difference between baseline and 
follow-up skeletonised images was computed for every patient. Patients were 
divided into three groups of similar size on the basis of their step-change in 
EDSS over one year: (1) patients who had no change in EDSS; (2) patients 
whose EDSS step-change was equal to 0.5; (3) patients whose EDSS step-
change was greater than 0.5. To identify regions of significant correlation 
between FA and principal diffusivities changes and changes in the EDSS, the 
voxel-wise DTI parameters and MTR differences between baseline and follow-
up were regressed against the three groups of EDSS step-change. In addition, 
to assess the correlation between the areas of FA (and principal diffusivities) 
and MTR changes and the changes in MSFC subtests over one year, three 
linear multiple regression analyses were performed (one for each of the MSFC 
subtests), using the changes in z-NHPT, z-TWT and z-PASAT as regressors. In 
all the regressions, age, gender, and disease duration at baseline were included 
as additional covariates. Correction at p < 0.05 for multiple comparisons was 
performed using TFCE. 
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6.2.4.4 Post-hoc analysis 
(i) The role of lesions 
To create a mask of “new and enlarged lesions” which developed during one-
year follow-up, the lesion mask obtained from the T2-weighted images at 
baseline was subtracted from the lesion mask computed from the T2-weighted 
image at one year. This map includes both the new lesions, developed by 
patients during the follow-up period, and the portions of older lesions which 
have enlarged during follow-up. A lesion probability map was then created, in 
which a colour scale indicated the percentage of patients who had developed a 
new/enlarged lesion in a given voxel. To establish whether the areas of 
significant change in FA and MTR over one year were part of the “new/enlarged 
T2-weighted lesions” or were localised within the normal-appearing white matter 
(NAWM), the areas of significant decrease in FA and MTR, and the 
“new/enlarged T2-weighted lesion probability mask” were overlaid on the same 
anatomical image and then visually inspected. 
 
Finally, to assess the contribution of the change in T2-weighted lesion load over 
the follow-up period to the significant changes found in the skeletonised 
FA/MTR, the lesion load increase over one year was first computed for each 
patient. Then, the correlation between the average skeletonised FA/MTR 
changes (i.e., the mean FA/MTR differences between baseline and one year in 
the areas that showed a significant change over one year) and the T2 lesion 
load difference was calculated, using Pearson’s correlation coefficient.  
 
(ii) The role of total GM MTR  
To assess the correlation between total GM MTR changes over one year and 
clinical changes during the same period, the mean GM MTR value was 
computed for each patient at each time point using the following procedure. 
First SPM8 (Ashburner and Friston, 2005) was used to segment the T1-
weighted volumes into WM, GM and CSF in native space. The GM probability 
maps were thresholded (to retain only voxels with probability of more than 75% 
of belonging to the GM (Khaleeli et al., 2007b). These GM masks were applied 
to the whole brain MTR maps to obtain GM MTR maps. The mean GM MTR 
values were calculated for every patient at both baseline and follow-up. The 
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difference between these two values (mean GM MTR at baseline – mean GM 
MTR at follow-up) was calculated. Finally, the correlations between GM MTR 
changes and clinical changes (i.e., changes in EDSS, NHPT, TWT, and 
PASAT) were assessed using Pearson’s correlation coefficient.  
 
(iii) Correlation between FA changes and MTR changes in regions that showed 
correlation between MTR changes and clinical function 
To assess whether there was a correlation between FA changes and MTR 
decrease in the regions that showed a significant association between MTR 
decrease and clinical changes, we extracted the mean skeletonised FA and 
MTR values from these areas at baseline and at follow-up, calculated the 
difference between these two values and tested for significant correlations 
between FA and MTR changes in these regions using the Pearson’s correlation 
coefficient (results with p values < 0.05 were considered significant).  
 
6.3 Results 
 
6.3.1  Clinical progression over one year 
 
Patients showed weak evidence towards a significant progression of disability 
between baseline and year 1, as measured by EDSS (p = 0.08); there was a 
change in the MSFC subtest scores during the follow-up period, but it was not 
statistically significant. The clinical tests results at baseline and at one year are 
summarised in Table 6.1.  
 
EDSS (median, range)                     4.5, 3.5-7.0         5.25, 2-7.5                    0.08 
       
PASAT score (mean, SD)  43.3, 13.3         44.9, 14.2                    0.3 
 
NHPT score (mean, SD)                   33.2, 16         33.3, 18                    0.9 
 
TWT score (mean, SD)                     14.2, 20         15.8, 26.8                    0.4 
  
Clinical tests                                         Baseline assessment 
Year one 
assessment 
p-value  
(baseline vs 1 year)  
 
Table 6.1. Clinical test scores at baseline and year one. 
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6.3.2  Changes in skeletonised FA, AD, RD, and MTR over one year  
 
There was no significant change in skeletonised FA and AD between baseline 
and one year.  
 
A significant increase in RD over time was found. The main changes were 
located within the cortico-spinal tract (CST) at the level of the cerebral 
peduncles (bilaterally) and the corona radiata (left hemisphere), the inferior 
longitudinal fasciculus and the inferior fronto-occipital fasciculus (right 
hemisphere), the left cingulum bundle and the anterior thalamic radiation 
(bilaterally) (Figure 6.1).  
 
 
 
Figure 6.1: WM tracts showing a significant increase in RD over the follow-up (voxels in blue), 
overlaid onto the FSL fractional anisotropy template in MNI coordinates. 
 
 
Patients showed a significant reduction in skeletonised MTR over the same 
follow-up period in the WM along the bilateral CST (posterior limb of the internal 
capsule and cerebral peduncle), and in the genu and the body of the corpus 
callosum (CC) (p < 0.01) (Figure 6.2).   
 
A significant decrease in MTR over time was also detected bilaterally in the 
thalamic radiation, and in the superior and inferior longitudinal fasciculi (p<0.01) 
(Figure 6.2). 
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Figure 6.2: Red voxels show the regions of significant reduction in skeletonised MTR over one 
year, overlaid onto the FSL fractional anisotropy template in MNI coordinates. 
 
 
Within the areas of significant change, the average difference in MTR between 
baseline and one year, computed across the skeleton, was 2% (mean value 
[SD] at baseline = 35.4 [3.1] pu, mean value [SD] at one year = 34.7 [3.3] pu). 
Tract specific FA and MTR values obtained from skeletonised maps at baseline 
and one year are shown in Table 6.2. 
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baseline Year 1 
Tract mean FA 
(SD) 
mean MTR 
[pu] (SD) 
mean FA 
(SD) 
mean MTR 
[pu] (SD) 
Left ATR 0.407 (0.028) 34.14 (2.81) 0.402 (0.033) 33.58 (3.28) 
Right ATR 0.420 (0.032) 34.47 (2.68) 0.416 (0.042) 33.87 (3.62) 
Left CST 0.521 (0.029) 35.94 (1.48) 0570 (0.032) 35.59 (1.76) 
Right CST 0.582 (0.027) 35.87 (1.44) 0.577 (0.031) 35.44 (1.59) 
Left Cingulum 0.517 (0.051) 37.32 (1.45) 0.508 (0.057) 36.87 (1.60) 
L Cingulum (HP) 0.456 (0.038) 33.10 (2.36) 0.456 (0.046) 31.53 (3.28) 
R Cingulum (HP) 0.450 (0.043) 33.96 (1.60) 0.445 (0.054) 33.42 (1.79) 
Forceps Major 0.598 (0.057) 34.48 (2.05) 0.590 (0.071) 34.58 (2.20) 
Forceps Minor 0.480 (0.038) 37.46 (1.50) 0.473 (0.044) 36,96 (1.68) 
Left IFOF 0.455 (0.042) 35.93 (2.09) 0.450 (0.050) 35.59 (2.17) 
Right IFOF 0.455 (0.041) 35.61 (2.29) 0.449 (0.047) 35.35 (2.50) 
Left ILF 0.430 (0.040) 35.65 (2.21) 0.427 (0.045) 35.49 (2.44) 
Right ILF 0.447 (0.037) 35.80 (1.97) 0.440 (0.044) 35.78 (2.13) 
Left SLF 0.434 (0.041) 36.84 (2.00) 0.429 (0.048) 36.51 (2.35) 
Right SLF 0.445 (0.032) 36.70 (2.10) 0.441 (0.038) 36.58 (2.08) 
Left UNC 0.431 (0.039) 35.67 (1.86) 0.428 (0.047) 35.44 (1.95) 
Right UNC 0.448 (0.051) 35.25 (1.74) 0.446 (0.066) 35.28 (2.30) 
L SLF (temporal) 0.471 (0.059) 37.11 (1.56) 0.468 (0.068) 36.83 (1.84) 
R SLF (temporal) 0.505 (0.043) 36.91 (1.90) 0.496 (0.053) 36.76 (2.04) 
 
Table 6.2. Tract-specific FA and MTR values obtained from skeletonised images in patients at 
baseline and one-year follow-up. List of Abbreviations: ATR = anterior thalamic radiation; CST = 
cortico-spinal tract; HP = hyppocampal part; IFOF = inferior fronto-occipital fasciculus; ILF = 
inferior longitudinal fasciculus; SLF = superior longitudinal fasciculus; UNC = uncinate 
fasciculus; R=right; L=left. 
 
 
6.3.3  Correlation between changes in FA, AD, RD, and MTR, and clinical 
changes over one year 
 
Changes in FA over the follow-up period did not significantly correlate with any 
change in the clinical variables.  
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AD decreases in the left CST (next to the primary motor cortex) and CC (genu, 
body and splenium) over one year correlated with changes in upper limb 
function, as measured by the z-NHPT scores (Figure 6.3). On the other hand, 
changes in AD did not correlate with the changes in TWT z-score nor with the 
changes in PASAT z-score. 
 
 
 
Figure 6.3: In blue are displayed areas of significant associations between a reduction in axial 
diffusivity and reduction in NHPT z-score over 1 year overlaid onto the FSL fractional anisotropy 
template in MNI coordinates. 
 
 
Widespread significant inverse correlations were found between changes in the 
z-NHPT scores and changes in RD. These correlations were located in the right 
CST (at the level of the internal capsule), in the CC (genu, body and splenium), 
in the inferior longitudinal fasciculus (bilaterally), in the uncinate (bilaterally), in 
the anterior thalamic radiations, and in the cerebellar peduncles (Figure 6.4). 
 
 
 
Figure 6.4: Voxels in red show the areas of significant associations between an increase in 
radial diffusivity and a reduction in NHPT z-scores, overlaid onto the FSL fractional anisotropy 
template in MNI coordinates. 
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There was a significant inverse correlation between changes in z-PASAT and 
changes in RD in the left cingulum, in the left anterior thalamic radiation, in the 
body of the CC, in the inferior fronto-occipital fasciculus bilaterally, and in the 
left CST (Figure 6.5).  
 
 
 
Figure 6.5: Voxels in red show areas of significant association between an increase in radial 
diffusivity and a reduction in PASAT z-scores, overlaid onto the FSL fractional anisotropy 
template in MNI coordinates. 
 
 
In patients, a decrease in skeletonised MTR in the genu and the body of the 
CC, and in the superior part of the right CST (corona radiata) was significantly 
correlated with reduced upper limb function, as measured by the z-NHPT 
scores, over the follow-up period (p<0.05) (Figure 6.6). The decrease in MTR 
over one year was not significantly associated with changes in EDSS, in z-TWT 
or in z-PASAT. 
168 
Chapter VI: Short-term microstructural changes in WM tracts 
 
 
  
Z=30 X=11 
 
Figure 6.6:. Blue voxels indicate the areas of significant correlation between the decrease in 
skeletonised MTR over the follow-up period and the changes in upper limb function scores (z-
NHPT). The map is overlaid onto the FSL fractional anisotropy template in MNI coordinates. 
 
 
6.3.4  Post-hoc analysis 
 
6.3.4.1 The role of lesions 
The areas of significant change in MTR were localised in part within the 
“new/enlarged T2 lesions” which developed over the follow-up period, but also 
outside them, in the NAWM (Figure 6.7).  
 
 
 
Figure 6.7: Significant MTR changes over one year (blue) and probabilistic distribution of 
new/enlarged lesions over the same follow-up period in the patient group (red-yellow). The red-
yellow colour scale indicates the percentage of patients who developed a new/enlarged lesion 
in a given voxel. This figure shows that MTR changes were not confined to areas of 
new/enlarged lesions, but were also detectable in the NAWM, possibly through mechanisms of 
Wallerian degeneration. The maps are overlaid onto the FSL T1 template in MNI coordinates. 
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There was a significant correlation between the average MTR decrease over 
one year in the genu and the body of the CC, and in the superior part of the 
right CST, and the total T2 lesion load increase over the same follow-up period 
(r=0.49, p<0.033). This corresponds to an r2=0.24, i.e. the increase in T2 lesion 
load can explain 24% of the variance in MTR decrease in these brain areas.  
 
6.3.4.2 The role of total GM MTR 
No significant correlation was found between the changes in total GM MTR over 
one year and the changes in clinical scores during the same period. 
 
6.3.4.3 Correlation between FA changes and MTR decrease in regions that 
showed correlation between MTR changes and clinical function 
No significant correlation was found between the mean FA change and the 
mean MTR decrease extracted from the regions of significant association 
between changes in MTR and changes in z-NHPT scores (i.e., the genu and 
the body of the CC, and from the superior part of the right CST).  
 
6.4 Discussion 
 
In this study, a combination of MT imaging and TBSS has been employed for 
the first time to ”skeletonise” the MTR maps and explore tract-specific 
microstructural changes in the London cohort of patients with early PPMS, 
recruited within five years of symptom onset. Indeed, it is known that PPMS 
patients are particularly prone to show dynamic changes in their conditions in 
the early phase of the disease. This study shows a significant decrease in MTR 
along WM tracts, such as the CST, the CC, the SLF and the ILF over one year 
follow-up. RD (which is the average of the second and third eigenvalues of the 
DT) also significantly increased over time in similar regions, whilst AD (which is 
the principal eigenvalue of the DT) and FA did not change. These very early 
changes were localised within the NAWM and the new or enlarged lesions 
visible on T2-w scans, which developed over the same follow-up period. 
Moreover, this study showed that the significant decreases in MTR in the body 
and genu of the CC and the MTR decreases in the superior part of the CST 
correlated with a deterioration in the upper limb function occurring over one 
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year. Similarly, RD increases in several tracts, including the CC and the right 
CST (internal capsule) correlated with deterioration in the upper limb function.  
 
As reported in Chapter II, the MT effect is generated by the interaction between 
protons localised in a relatively free environment and those whose motion is 
restricted (Tofts, 2003), and MT-based imaging has been proposed as a 
sensitive and reliable surrogate marker of myelin content (Filippi et al., 1998; 
Filippi, 1999; Zivadinov, 2007). Brain areas with low MTR values (reflecting 
reduced efficiency in the exchange of magnetisation occurring between 
macromolecules and the surrounding water molecules) have been shown to 
correlate strongly with pathological changes in MS (Deloire-Grassin et al., 2000; 
Chen et al., 2007; Chen et al., 2008). In particular, post-mortem analysis of MS 
has demonstrated that MTR is remarkably sensitive to myelin content, in 
addition to axonal loss (Schmierer et al., 2004; Moll et al., 2011). 
 
Given its sensitivity to the degree of tissue damage, MTR has been acquired in 
all subtypes of MS to investigate pathological changes in vivo (Filippi and 
Agosta, 2010). To date, most of the assessments have been based on the 
histogram-based analysis of the whole brain (Filippi et al., 2000; Dehmeshki et 
al., 2001) or on the investigation of a priori selected regions of interest (ROIs), 
such as the normal-appearing WM (NAWM), NAGM,, tractography-selected 
WM tracts or user-defined anatomical masks (Filippi et al., 1998; Santos et al., 
2002; De Stefano et al., 2006; Reich et al., 2007; Lin et al., 2008; Tur et al., 
2011a). In several cross-sectional studies, these approaches demonstrated 
significant and clinically relevant abnormalities in the NAWM of patients with 
PPMS (Leary et al., 1999b; Tortorella et al., 2000b; Dehmeshki et al., 2003). A 
histogram-based approach has also been employed in longitudinal studies, 
which showed that normal-appearing brain tissues MTR at baseline predicted 
the deterioration of disability over time  (Khaleeli et al., 2007a; Khaleeli et al., 
2008a). However, there have been several attempts to develop an effective 
approach for performing a voxel-wise analysis of MTR images, assessing the 
GM compartment only or the whole brain (Audoin et al., 2007; Dwyer et al., 
2009). The attractiveness of voxel-based approaches lies in the fact that they 
provide information about the sites of abnormality as a result of the analysis. 
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The steps involved in image normalization and smoothing, however, might 
compromise the accurate localization of changes.  
 
In order to overcome some of these limitations, in this study a novel 
methodology has been proposed, that combines the sensitivity provided by 
MTR in detecting disease- related pathological changes with the accurate 
spatial information offered by TBSS. This technique allowed identification of  
early accrual of tract-specific microstructural abnormalities in PPMS, specifically 
affecting WM tracts involved in motor function control, such as the bilateral 
CST, the SLF and the ILF. Indeed, the CST is the main WM pathway controlling 
voluntary movements, whereas the SLF and the ILF are associative tracts that 
have been shown to play a key role in integrating multiple functions within the 
complex network system that controls the precise execution of fine movements. 
In particular, the SLF mediates the interaction between the parietal lobe and the 
motor and premotor areas, which are crucial in planning movement precision in 
space (Koch et al., 2010), whereas the ILF, connecting the occipital cortex with 
the temporal cortex, is thought to be involved in the use of visual information for 
the purpose of guiding movements and controlling motor actions (Schmahmann 
and Pandya, 2007). Moreover, a significant reduction in skeletonised MTR over 
the follow-up period was found in the genu and the body of the CC, where the 
WM fibres interconnecting motor and cognitive networks between the two 
hemispheres are localised. Indeed, the early disruption of the inter-hemispheric 
callosal pathways may result in a disconnection syndrome that contributes to 
long-term physical and cognitive disability. Also, in the cross-sectional study in 
this same patient cohort presented in Chapter III, patients showed a diffusively 
reduced FA compared with controls in the NAWM;  the areas of significant FA 
decrease in patients at baseline included the bilateral CST, the CC, the thalamic 
radiations and the inferior longitudinal fasciculus, which are the same regions 
showing a further accrual of damage during the first year of follow-up. In the 
future it would be of interest to investigate whether there is a difference in the 
location and in the extent of the skeletonised MTR short-term changes between 
PPMS and relapse-onset MS, whose WM changes may be more related to the 
presence of lesions than PPMS.  
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Contrary to the MTR results, no significant FA changes were found over the 12 
month follow-up. This suggests that MTR and FA offer complementary 
information when studying the evolution of brain diseases, since FA is sensitive 
to the detection of differences between patients and controls (as demonstrated 
in the study presented in Chapter III), whereas changes in MTR correlate with 
changes in clinical function over one year. The findings reported in this cohort of 
PPMS suggest that MTR is a more sensitive marker of disease progression in 
early PPMS than FA. Interestingly, when looking at changes in RD and AD over 
the same follow-up period, a significant increase in RD over one year was found 
in regions which overlapped with those found using MTR, although the MTR 
changes were more widespread, whilst no significant changes in AD were 
found. This suggests that the analysis of the directional diffusivities may reflect 
underlying pathological changes more accurately than FA, which is obtained by 
combining the three eigenvalues. The results of an interesting study which 
investigated the pathological correlates of quantitative MRI measures in MS 
brains study showed that, while both MTR and DTI changes significantly 
correlated with myelin integrity within T2-w visible lesions, in non-lesional WM 
they were correlated with activated microglia, but not with axonal or myelin 
integrity (Moll et al., 2011). Therefore, although it is tempting to suggest that the 
observed RD and MTR changes over one year reflect increased demyelination, 
at least inside WM lesions (Moll et al., 2011) and especially in view of the 
animals studies using directional diffusivities (Song et al., 2005) and post-
mortem analysis (Schmierer et al., 2004), it is likely that other processes, 
including axonal loss and activated microglia, are reflected by in vivo RD and 
MTR changes (van Waesberghe et al., 1999; Cader et al., 2007; Zhang et al., 
2009). As mentioned above, changes in MTR and RD were almost overlapping, 
which suggests that MTR probably does not allow the detection of specific 
pathological processes in the WM which are invisible to other currently available 
imaging measures. However, with this study it has been demonstrated the 
technical feasibility of combining TBSS with other imaging measures, which 
itself shows a great potential. Indeed, in future it will be possible to combine the 
accuracy in spatial location offered by TBSS with the pathological specificity 
offered by novel imaging techniques (such as [C-11] PIB, which has been 
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recently demonstrated to be highly accurate in detecting demyelination in MS) 
(Stankoff et al., 2011). 
 
With respect to correlations between imaging and clinical changes, we found 
that changes in skeletonised MTR, RD, and AD in the CST and in the CC 
significantly correlated with the deterioration in upper limb function, as 
measured by the z-NHPT (Cutter et al., 1999). These results extend to the 
PPMS population the findings of correlation between altered diffusion metrics 
within the pyramidal tract and motor dysfunction previously demonstrated in CIS 
and RRMS (Wilson et al., 2003; Pagani et al., 2005a; Lin et al., 2007). 
Moreover, these findings support the key role played by the disruption of 
callosal fibres in mediating the functional impairment of fine motor control 
(Larson et al., 2002; Johansen-Berg et al., 2007; Bonzano et al., 2008; Kern et 
al., 2011), probably through a mechanism of reduced inhibitory input (Kern et 
al., 2011). In addition, RD increases in the inferior longitudinal fasciculus, 
uncinate fasciculus, thalamic radiations and cerebellar peduncle, correlated with 
a deterioration of the upper limb function. These data suggest that motor 
dysfunction may result from the damage to a complex network of systems in 
MS, including the visual-motor coordination system, in which is implicated the 
inferior longitudinal fasciculus (Catani et al., 2003), and the control system of 
fine-tuning of movements during motor execution, mediated by the cerebellar 
structures (Voogd, 2003). In future, studies employing the TBSS-MTR 
methodology in combination with scores aimed at assessing individual 
neurological functions, such as the pyramidal and sensory scores, may test 
system-specific hypotheses in MS. 
 
In addition, a significant inverse correlation between changes in the z-PASAT 
score and changes in RD in the left cingulum, left anterior thalamic radiation, 
body of the CC, inferior fronto-occipital fasciculus bilaterally, and in the left CST, 
was demonstrated. The PASAT test is a complex working memory task 
involving several distinct brain areas that interact simultaneously, and is known 
to be heavily influenced by the disruption of connecting WM fibres in MS 
(Audoin et al., 2005). 
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On the other hand, no significant correlation between changes in total GM MTR 
and clinical changes over one year was demonstrated. This finding is in line 
with he results of previous studies on this same cohort of patients, which 
reported that while total GM MTR was shown to be a useful predictor of clinical 
progression over a long-term follow-up period (Tur et al., 2011a), WM MTR 
seemed to correlate better than GM MTR with short-term clinical changes 
(Khaleeli et al., 2007a).  
 
Looking more closely at the results of this study, it is worth mentioning that  
significant changes in skeletonised MTR not only included areas of newly 
developed or enlarged WM lesions, but also regions of NAWM. In particular, T2-
w lesion load increase over one year explained 24% of the variance in MTR 
decrease, suggesting that new/enlarging T2-w lesions are relevant for the 
observed MTR drop, although they are not the only factor. These results 
confirm data emerged in several studies conducted on all subtypes of MS that 
demonstrated the occurrence and the clinical relevance of the WM damage 
localised outside visible T2-w lesions when using other quantitative MRI 
techniques (Filippi and Agosta, 2010). In addition, these data showed the 
development of new T2-w lesions and the enlargement of pre-existing ones 
within the areas of significant and clinically eloquent changes in skeletonised 
MTR, suggesting that T2-w lesion load increase may contribute to the MTR 
decrease. This finding further underlines the already reported contribution of T2-
w lesions to the occurrence of the clinically relevant WM abnormalities that are 
detected by changes in MTR (Vrenken et al., 2007). 
 
A limitation of this study is that only 21 out of 50 patients included in the original 
cohort of 50 patients with early PPMS performed both DWI and MTR data at 
both baseline and one year and the lack of age- and gender-matched controls 
who performed the same protocol at the same time points. This limitation 
derives from analysis of data which were not originally acquired for the 
development of this specific methodology. Moreover, the differing slice 
thickness used for DTI and MT images should be considered as a limitation of 
this study, as it could potentially affect the co-registration between these 
images, thus compromising the accurate anatomical localisation based on 
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TBSS. However, in order to minimise these issues, the intra-subject co-
registration was optimised by the use of a cost function known to work well for 
images of different contrasts, namely normalised mutual information. Finally, 
our results need to be confirmed by future studies employing more recent, and 
potentially more sensitive, diffusion data acquisition protocols. 
 
6.5  Conclusions 
 
In conclusion, using the ‘skeletonised MTR’ approach presented in this Chapter, 
it has been demonstrated the short-term accrual of microstructural damage in 
specific WM tracts that may contribute to clinical impairment in early PPMS. 
This study gave me also the opportunity to face the technical challenges of 
combining TBSS with a different imaging technique. Using a similar technical 
approach, the combination of the accurate spatial information provided by TBSS 
with the sensitivity of different imaging techniques (such as PET imaging) in 
detecting disease-related pathological changes, could offer the opportunity of 
new insights into the pathogenesis of progression in MS. This novel method 
could be applied in future to explore regional microstructural WM changes in 
cross-sectional and longitudinal studies in patients with other forms of MS, and 
with other neurological diseases. Moreover, the combination of ‘skeletonised 
MTR’ and voxel-wise measures of GM damage could be employed to explore 
the spatial and temporal relationship between the WM and the GM damage in 
MS as well as in other brain diseases. 
 
Moving from the analysis of short-term pathological changes in PPMS, in the 
next Chapter I will address the second question of this thesis by investigating 
the contribution of early damage in WM and in GM to long-term clinical 
deterioration and cognitive dysfunction in this type of disease.  
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To complete the investigation on the impact of WM and GM damage on long-
term clinical outcome in PPMS, trying to address the second question 
presented in Chapter I, this Chapter moves to exploring the relative contribution 
of the regional damage occurring in the two compartments in predicting long-
term disability progression and cognitive dysfunction in patients with early 
PPMS. In the study presented here, the same techniques described in the study 
presented in Chapter III were applied, following-up the London population of 
early PPMS patients for five years.  
 
7.1  Introduction 
 
As discussed in Chapter I, quantitative MRI has the potential to provide 
prognostic indicators of clinical disability and cognitive dysfunction for patients 
with PPMS, whose disease course can vary widely (Cottrell et al., 1999; 
Tremlett et al., 2005; Koch et al., 2009). Over recent years, DTI and volumetric 
MRI techniques have been employed to establish the clinical relevance of in-
vivo brain WM and GM abnormalities in MS (Bakshi et al., 2008). In particular, 
as previously discussed, FA has been extensively used to quantify the integrity 
of WM tracts in MS; a reduction of this measure implies demyelination, axonal 
loss and migroglia activation (Schmierer et al., 2004; Moll et al., 2011). Despite 
being a measure which is pathologically non-specific, FA has been shown to 
correlate significantly with cognitive scores in MS (Roosendaal et al., 2009) and 
predict motor impairment in RRMS (Kern et al., 2010). With regard to GM, the 
most commonly used measure is GM volume, which, if reduced, reflects 
irreversible tissue loss (or atrophy) (Wegner et al., 2006), and has been 
demonstrated to proceed relentlessly throughout the course of the disease (De 
Stefano et al., 2010) and to correlate with disability progression and cognitive 
performance in MS (Fisher et al., 2008; Riccitelli et al., 2011).  
 
As discussed in Chapter II and Chapter III, several methods for detecting 
patient-control differences based on MRI parameters are available. TBSS 
(Smith et al., 2006) and VBM (Ashburner and Friston, 2000) are able to identify, 
respectively, WM regions of reduced FA and areas of GM atrophy in patients 
when compared with healthy controls. 
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The advantage of these two techniques is that they localise specific brain 
regions of WM damage and GM volume loss in patients compared with healthy 
controls without the need to generate an a priori hypothesis. In the cross-
sectional study of patients with early PPMS (i.e. patients who were studied 
within 5 years of symptom onset) presented in the Chapter III of this thesis, 
these two techniques have been combined, and allowed to find a reduced FA in 
extensive WM regions including the whole corpus callosum and the cortico-
spinal tracts in patients when compared with healthy controls, and a diffuse 
reduction of GM volume in patients, in areas such as the sensory-motor cortex 
bilaterally and the right superior temporal gyrus. In a subsequent longitudinal 
study in the same patient population, MTI histogram and volumetric analyses of 
WM and GM were employed, and allowed to demonstrate that WM lesion load 
is the most important predictor of subsequent cognitive dysfunction, but whole 
GM MTR also contributed (Penny et al., 2010). Despite evidence of damage in 
both tissue compartments, and of their role in the accumulation of disability, it is 
unknown whether the factors responsible for clinical progression in PPMS are 
the whole (diffuse) GM tissue pathology or abnormalities in specific GM and 
WM regions, above and beyond the contribution provided by WM lesion load. 
As discussed in Chapter I, this is an important question to address in order to 
understand the mechanisms underlying clinical deterioration, which is known to 
be quite variable in this type of MS.  
 
In the study presented in this Chapter, the specific location of grey and WM 
areas was hypothesised to play a relevant role in predicting long-term physical 
and cognitive disability in patients with early PPMS. Therefore the same 
longitudinal dataset obtained in the London cohort of early PPMS patients was 
re-analysed, and TBSS and VBM techniques were employed, for the first time, 
to identify specific areas of WM and GM which predict progression of physical 
disability over five years and cognitive dysfunction after five years. 
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7.2  Methods 
 
7.2.1  Study design  
 
Thirty-two patients with PPMS (Thompson et al., 2000) within five years of 
symptom onset (13 women, mean age 44.5 yrs, SD 10.3) (see Table 7.1 for 
clinical, radiological and demographic characteristics) underwent a whole brain 
imaging protocol, including diffusion sequences, and were clinically assessed 
on the EDSS (Kurtzke, 1983) at study entry (see Appendix I).  
 
After five years, they were again assessed on the EDSS and invited to undergo 
an extensive neuropsychological assessment, which was also performed on a 
group of healthy controls. 
 
 
 
Table 7.1 Patients’ clinical, radiological and demographic characteristics at baseline. 
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7.2.2  Neuropsychological assessment  
 
Out of 32 patients recruited at baseline, 25 (11 women, mean age 51.3 years, 
(range 31-68), mean years of education 13.0 (range 10-19)) underwent an 
extensive neuropsychological assessment five years after entry into the study. 
Out of the seven patients who were not cognitively assessed, four male patients 
were too physically impaired (they were very dysarthric and ataxic) to provide 
valid results for a significant proportion of the tests, and therefore were 
excluded; one female and one male patient declined to take part in the 
neuropsychological tests. The remaining female patient was not contactable. 
 
Thirty-one age- and gender-matched healthy controls (14 women, mean age 
48.9 years, (range 30-65), mean years of education 13.4 (range 10-19)) also 
underwent the same neuropsychological tests. The exclusion criterion applied 
to all subjects was a history of other neurological or systemic illness, of impaired 
cognition, of psychiatric illness, of head injury resulting in loss of consciousness, 
or of alcohol or drug abuse.  
 
The cognitive assessment included the following tests: (i) the National Adult 
Reading Test (NART) (Nelson HE, 1982) to estimate each patient’s premorbid 
intellectual functioning; (ii) the immediate and delayed conditions of the Story   
(SRT) and Figure Recall (FRT) subtests of the Adult Memory and Information 
Processing Battery (Coughlan AK and Hollows AK, 1985), to assess verbal and 
visual recall memory function; (iii) the Paced  Auditory Serial Addition Test (3-
second version) (PASAT-3) (Cutter et al., 1999) and the Symbol Digit Modalities 
Test (SDMT) (Smith A, 1982), to evaluate attention and speed of information 
processing; (iv) the Hayling Sentence Completion Task (HSCT) (Burgess PW 
and Shallice T, 1997) a test of verbal response generation and inhibition, and 
the Brixton Spatial Anticipation Test (Burgess PW and Shallice T, 1997), a 
spatial reasoning, rule detection and rule change task, to test executive 
functions. The whole neuropsychological assessment of both patients and 
controls was performed by an experienced neuropsychologist (S.P.). 
 
181 
Chapter VII: Contribution of WM and GM damage to long-term disability 
 
 
  
Patients had not previously received any of these tests with the exception of the 
PASAT, which had been administered up to seven times in earlier follow-ups. 
This study was approved by the Joint Medical Ethics Committee of the National 
Hospital for Neurology and Neurosurgery, London. Written and informed 
consent was obtained from all participants. 
 
7.2.3  Processing of clinical and cognitive data 
 
Analysis was performed using Stata version 9.2 (Stata Corporation, College 
Station, Texas) and results with a p<0.05 were considered significant.  
 
Significant changes in EDSS between baseline and five years were assessed 
using the Wilcoxon Signed Ranks Test. Since the EDSS is an ordinal (non-
continuous scale), parametrical statistical methods cannot be used to analyze 
changes in the EDSS score, and, for this reason, the mean raw change in the 
EDSS score is considered to be an inappropriate statistical endpoint 
(Wingerchuk et al., 1997). In addition, it is important to underline that the 
meaning of the changes in EDSS is not equivalent throughout the scale. For 
example, the difference between EDSS 0.5 and 1.0 is 0.5, as well as the 
difference between EDSS 6.0 and 6.5 is 0.5; however, this 0.5 difference does 
not reflect the same extent of clinical deterioration. Finally, there is a variable 
mean duration at different EDSS levels, as the frequency of progression is 
usually lower at higher levels of disability on the EDSS than at lower levels 
(Weinshenker et al., 1991). Therefore, to assess disability progression over the 
follow-up period, the recommendation to calculate the EDSS step-change in 
each patient was followed: one step deterioration on the scale was defined as 
an increase of 1 if the baseline EDSS was less than or equal to 5, or an 
increase of 0.5 if it was greater than 5. This approach is more sensitive in 
detecting significant clinical deterioration in the upper part of the scale (i.e., in 
more disabled patients), and has also been recommended for clinical trials 
(Wingerchuk et al., 1997).   
 
As far as the neuropsychological scores are concerned, the raw scores of all 
the measures, except premorbid IQ, were converted to z-scores referenced to 
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the control group, and these multiplied by -1 when appropriate, so that a lower 
score always indicated a poorer performance. A z-score ≤ -2 in a test was 
considered to be abnormal. Age, years of education and premorbid IQ were 
compared between patients and healthy controls using t-tests; gender was 
compared between groups using a chi-square test.  
 
To investigate the difference in cognitive performance between patients and 
healthy controls, a multiple linear regression model was used, entering each 
cognitive measure, in turn, as dependent variable, and a binary group indicator, 
together with age, gender, years of education and premorbid IQ, as covariates. 
Since the primary goal of this study was to identify predictors of cognitive 
dysfunction, only the neuropsychological test scores that showed a significant 
difference between patients and healthy controls, or a trend towards a 
difference (p<0.08), were entered in the subsequent steps of the analysis.  
 
Differences between male and female patients in EDSS scores at five years 
and in all neuropsychological tests scores were also tested for, using Mann-
Whitney test and independent samples t tests, respectively. 
 
7.2.4 Image acquisition and post-processing 
 
Patients were imaged at study entry using a 1.5T GE Signa scanner (General 
Electrics, Milwaukee, IL). The MRI protocol, which included fast spin echo 
scans, Diffusion-Weighted Echo Planar Imaging and T1 volumetric sequences 
(SPGR), and imaging analysis to obtain a TBSS skeleton were described in 
Chapter III.  
 
In this study, the SPGR volumes were segmented and normalized to obtain 
GM, WM and cerebro-spinal fluid volumes using SPM8 software (Wellcome 
Department of Cognitive Neurology, London, UK), according to the VBM 
protocol (Ashburner and Friston, 2005). As the presence of WM lesions is 
known to significantly affect brain segmentation (Nakamura and Fisher, 2009) 
and registration (Sdika and Pelletier, 2009), which are key steps in VBM, the 
recently developed lesion automated preprocessing (lesion automated 
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preprocessing, LEAP) (Chard et al., 2010) technique was applied to the T1w 
images, before feeding them into the VBM procedure. As described in detail in 
Chapter II, LEAP is an “in-painting” technique, which replaces lesional voxels 
with values derived from the intensity distribution within the WM outside visible 
lesions in the presegmentation phase (Chard et al., 2010). This technique 
minimises lesion-associated segmentation biases that may significantly affect 
VBM results. As the smoothing kernel sensitises the analysis to differences of 
comparable size as the kernel (Rosenfeld and Kak, 1982) GM images were 
modulated and smoothed using both 12-mm FWHM and 8-mm FWHM 
Gaussian kernels. 
 
7.2.5  Investigation of predictors of physical deterioration and cognitive 
dysfunction 
 
7.2.5.1 White matter FA analysis 
To investigate whether FA was associated with EDSS step-change and 
neuropsychological tests scores, a voxel-wise linear regression analysis was 
performed, adjusting for age, gender, years of education and NART (the last 
two variables were used only when predicting neuropsychological scores). As 
mentioned above, only tests that identified abnormality in patients compared 
with healthy controls were used. The analysis was based on permutation-based 
inference, and corrected for multiple comparisons using Threshold-Free Cluster 
Enhancement (TFCE) (p<0.05) (Smith and Nichols, 2009).  
 
To investigate the effect of gender on significant findings, the voxel-wise linear 
regression analysis was repeated by modelling the interaction between gender 
(male or female) and each clinical and neuropsychological score, using 
permutation-based inference, and correcting for multiple comparisons using 
TFCE (p<0.05). 
 
In order to understand the contribution of WM lesions to the results, where 
significant associations were found between baseline FA and clinical 
/neuropsychological variable, the regression analysis was repeated by 
including, in turn, the total LL and the tract-specific LL, as additional covariate. 
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This tract-specific LL was calculated by using the Johns Hopkins University 
(JHU) DTI-based white matter atlas, provided by FSL (Mori, 2005), which 
provides a probabilistic reconstruction of the main WM tracts. Each subject’s 
T2-w scan was co-registered with the atlas, and the same transformation was 
applied to the lesion mask. Lesions belonging to a specific tract were identified 
to obtain the tract-specific LL. 
 
7.2.5.2 Grey matter volumetric analysis 
A voxel-wise multiple regression analysis was used to investigate the 
association between regional GM volume and EDSS step-change and 
neuropsychological tests, adjusting for the same variables as those used for 
TBSS, and correcting for multiple comparisons with family-wise error rate. P-
values<0.05 were considered to be significant. 
 
7.3  Results 
 
7.3.1  Patients’ clinical and neuropsychological assessment 
 
Patients showed progression of disability on the EDSS during the follow-up 
period (median EDSS at baseline= 4.5 (range 1.5-4.5), at five years= 6.4 (range 
1.5-9), p=0.001).  
 
There were no significant differences between patients and healthy controls in 
age, gender, years of education or premorbid IQ. The neuropsychological test 
results, the number of patients who failed on each test, and the comparison 
between patient and control groups in all tests are summarised in Table 7.2, 
and have been previously reported in detail (Penny et al., 2010).  
 
Eighteen patients had abnormal scores on at least one test (six patients failed 
on one test only, six on two tests, and six on three or more tests). The 
neuropsychological tests on which patients performed significantly worse than 
healthy controls, and which were therefore retained for the subsequent part of 
the analysis, were the immediate and delayed Story Recall tests (SRT) and 
Figure Recall tests, the SDMT, and the HSCT.  
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There was no significant difference between male and female patients in EDSS 
scores at five years, and in all neuropsychological tests scores. 
 
  
Clinical and 
neuropsych. 
score at 
follow-up  
No. of voxels 
per significant 
white matter 
cluster 
MNI Atlas 
coordinates 
x, y, z 
Significant 
regions p value  
6025 106, 82, 80 Splenium of CC Immediate 
Story Recall 
Test  1084 74, 171, 59 Anterior part of genu of CC 
P=0.003  
4471 105, 84, 80 Splenium of CC 
2466 69, 173, 71 
Anterior part of 
right thalamic 
radiation and 
genu of CC 
Delayed Story 
Recall Test  
651 103, 112, 105 Body of CC 
P=0.003  
2265 94, 104, 97 Body of CC Symbol Digit 
Modalities 
Test  86 99, 84, 86 Splenium of CC 
P=0.05  
1065 76, 161, 84 Genu of CC 
873 56, 80, 102 Right posterior corona radiata 
456 107, 71, 121 Left posterior corona radiata 
243 91, 135, 95 Body of CC 
Hayling 
Sentence 
Completion 
Task  
177 78, 122, 100 Body of CC 
P=0.003  
 
 
Table 7.2 Neuropsychological test results and comparisons of patient and control groups. 
 
 
7.3.1  White matter FA as predictor 
 
When looking for a significant association between FA across the whole 
skeleton and disability progression, a lower baseline FA in the splenium of the 
corpus callosum (CC) was found to be associated with greater progression of 
disability over five years, as measured by the EDSS step-change (MNI 
coordinates, x=83, y-90, z=92, no. voxels= 8307, p<0.05) (Figure 7.1). 
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Figure 7.1  The callosal regions along the TBSS skeleton, whose FA at study entry was 
associated with progression of physical disability over 5 years, are shown in blue and overlaid 
onto the patients’ mean FA image (p<0.05). 
 
 
With regard to the prediction of cognitive dysfunction, the strongest (and most 
consistent) association between lower FA at baseline and worse cognitive 
performance at five years was found in the CC (see Table 7.3 for cluster sizes 
and coordinates).  
 
In particular:  
(i) lower FA in the splenium and genu of the CC was associated with worse 
immediate verbal memory function, as measured by the immediate SRT 
(p=0.003) (Figure 7.2 A);   
(ii) lower FA in the splenium, body and genu of the CC (with extension into the 
right thalamic radiation) was  associated with worse delayed verbal memory 
function, as measured by the delayed SRT (p=0.003);  
(iii) lower FA in the body and splenium of the CC was associated with worse 
attention and speed of information processing, as measured by the SDMT 
(p<0.05) (Figure 7.2 B);  
(iv) lower FA in the genu and body of the CC (and in the bilateral corona 
radiata) was associated with worse executive functions, as measured by the 
HSCT (p=0.003) (Figure 7.2 C).  
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Figure 7.2  Association between FA values at study entry and cognitive scores at five years. 
The callosal areas, whose FA at study entry were associated with immediate verbal memory 
scores (as measured by SRT, p<0.003), are shown in blue (A), those predicting attention and 
speed of information processing scores (SDMT, p<0.05) at five years in green (B), and those 
whose FA was associated with executive function scores (as measured by HSCT, p<0.003) are 
shown in red (C), and overlaid onto the patients’ mean FA image. 
 
 
When less stringent thresholds for significance were used (p<0.05), 
associations between FA and the immediate and delayed SRT and HSCT were 
also found in multiple areas of the skeleton, including the frontal and parietal 
WM (Figure 7.3), and the brainstem.   
 
 
 
Figure 7.3  White matter regions showing an association between lower baseline FA and 
immediate SRT (voxels in green, A) and HSCT (voxels in yellow, B) scores at five years, when a 
threshold for significance of p<0.05 was used (results overlaid onto patients’ mean FA).  
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No significant gender-related differences in the EDSS and neuropsychological 
tests at five years were seen; no significant interactions between gender and 
EDSS or neuropsychological score were found. 
 
7.3.2  Contribution of WM lesions   
 
When repeating the analyses adjusting for total LL, the association between 
lower FA in the genu and body of the CC and the executive functions (HSCT) at 
five years remained significant (p<0.05), whilst the associations between FA 
and disability progression and the performance on immediate and delayed 
verbal memory tests (SRT) and attention and speed of information processing 
(SDMT) did not.  
 
The mean volume of lesions localised in the CC (the region that showed the 
strongest association with clinical and neuropsychological variables) was 1.3 cc 
(SD1.47). When repeating the analyses adjusting for this CC lesion load, FA in 
the splenium of the CC no longer predicted disability progression, and lower FA 
in the splenium and body of the CC no longer predicted a poorer performance in 
attention and speed of information processing (SDMT).  
 
By contrast, the FA of the splenium of the CC at study entry remained 
significantly associated with a worse performance on immediate and delayed 
verbal memory tests (SRT) (p<0.05), and the FA of the body of the CC was 
associated with a poorer performance on a test of executive function (HSCT) 
(p<0.05) (Figure 7.4) at five years. 
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Figure 7.4  The callosal area, whose FA at baseline significantly correlated with executive 
function scores (HSCT) at five years, after adjusting for corpus callosum T2 lesion load, is 
displayed in pink (p<0.05) and overlaid onto the patients’ mean FA image. 
 
 
7.3.3  Grey matter volume as predictor 
 
Baseline GM volume did not significantly predict EDSS step-change or any 
cognitive impairment at 5 years (with either 8-mm or 12-mm FWHM smoothing 
Kernel). 
 
7.4    Discussion 
 
In the study presented in this Chapter, a combination of TBSS and VBM (after a 
lesion filling procedure) was applied to the baseline FA and volumetric scans of 
patients with early PPMS. The reported data showed that the baseline FA of the 
CC, previously shown to be reduced in the same cohort of patients compared to 
that of healthy controls (see data shown in Chapter III), was significantly 
associated with long-term progression of physical disability, as measured by the 
EDSS step-change, and the occurrence of cognitive dysfunction at five years, in 
the domains of immediate and delayed verbal memory, executive function, and 
attention and speed of information processing, where patients performed 
significantly worse than controls. These findings were interpreted as indicative 
that lower CC FA at baseline was a predictor of both disability progression and 
cognitive dysfunction at five years. Future studies will address the question 
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whether CC FA is also relevant to the progression of cognitive impairment, 
which has been reported in MS (Langdon, 2011). 
 
The CC ensures effective communication between motor and cognitive 
networks in the two brain hemispheres (Bogen et al., 1965); in particular, the 
anterior parts of the CC  (rostrum and genu) connect the orbitofrontal, lateral 
and medial frontal cortices, whereas the body and splenium connect parietal, 
temporal and occipital homotopic regions (Abe et al., 2004). The primary motor 
cortices, necessary for performing highly skilled motor movements, and several 
premotor areas, involved together with the supplementary motor areas in the 
initiation, planning and regulation of movement, are connected between 
hemispheres through the CC (Chao et al., 2009). The disconnection of these 
motor networks has been shown to result in a deterioration of motor function 
and upper limb function (Ozturk et al., 2010; Kern et al., 2010; Srikanth et al., 
2010). In our cohort, it was found that lower FA in the splenium of the CC 
predicted the accumulation of motor disability over the follow-up period and, 
similarly, the raw EDSS at five years (p=0.02; results not shown). The splenium 
of the CC is known to interconnect temporal and occipital cortices (Park et al., 
2008), mainly underlying the transfer of auditory and visual information. 
However, the connections between its superior segment and Brodmann’s area 
5 (Chao et al., 2009), that is implicated in the earliest stages of sophisticated 
movement planning (Andersen and Buneo, 2002), could explain why its early 
damage predicts long-term disability progression in our patients. 
 
Furthermore, the correlation found between a lower baseline FA of the CC and 
a worse cognitive performance at five years, extends previous findings on the 
relevant role of the CC in ensuring effective interhemispheric cooperation, which 
is necessary to perform cognitive tasks that require the activation of cortical 
areas in both hemispheres. In particular, considerable evidence from functional 
neuroimaging studies showed that bilateral temporo-parietal cortices are 
implicated in performing episodic memory tests (Buckner and Wheeler, 2001; 
Rugg et al., 2002), and that complex tasks, such as those related to 
attention/speed of information processing, and executive function, require 
bilateral frontal and parietal involvement (Gazzaniga, 2005; Buchsbaum et al., 
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2005). Evidence from several cross-sectional studies investigating different 
subject populations supports the findings reported here (Jokinen et al., 2007; 
Roosendaal et al., 2009; Voineskos et al., 2012). For example, a reduction in 
the white matter integrity of the splenium correlated with worse age-related 
memory and executive function in a sample of 53 healthy subjects (Voineskos 
et al., 2010), and atrophy of the CC fibres correlated with poor performance in 
tests assessing speed of mental processing, and attention and executive 
functions, in patients with age-related white-matter hyperintensities (Jokinen et 
al., 2007).  
 
Cross-sectional studies have demonstrated that tissue damage localised in the 
CC plays a role in contributing to concurrent motor disability and cognitive 
dysfunction in different phenotypes of MS (Mesaros et al., 2009; Roosendaal et 
al., 2009; Ozturk et al., 2010; Kern et al., 2011). The data presented here 
extend these results by demonstrating that CC damage has an important role in 
predicting long-term disability. The underlying mechanism may be the 
occurrence of a disconnection syndrome (He et al., 2009), whereby damage to 
structural connectivity (either through focal lesions or normal appearing white 
matter (NAWM) pathology) may, in turn, lead to an altered functional 
connectivity between GM regions and, ultimately, to clinical impairment and 
cognitive dysfunction in MS (Dineen et al., 2009). The possibility of a 
disconnection syndrome is further supported by the findings that, when lower 
thresholds for significance were used for the analysis, the association between 
FA and cognitive performance on immediate and delayed verbal memory tests 
(SRT) and executive functions (HSCT) was found to extend to multiple regions 
of the skeleton, including frontal, temporal and parietal WM, which are regions 
involved in memory (Buckner and Wheeler, 2001; Rugg et al., 2002) and 
executive function (Gazzaniga, 2005). The finding of significant association 
between FA of the brainstem and executive function suggests that the 
disruption to brain stem-hemisphere interactions may further contribute to the 
disconnection syndrome, in agreement with reports of cognitive dysfunction in 
patients with isolated brain stem insult (Garrard et al., 2002).  
 
When the association between FA and cognitive performance was corrected for 
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total lesion load, FA in the genu and body of the corpus callosum remained 
significantly associated with performance on a executive function test (HSCT); 
similarly, FA of the body of the CC still predicted performance on the HSCT 
when adjusting for callosal lesion load (LL). Whilst the association between 
genu FA and executive function is expected to remain significant despite 
correction for the total LL, the association between more posterior portions of 
the CC and the performance on the HSCT is less obvious. The HSCT score is 
determined to some extent by general speed, and involves verbal processing 
and word generation. These cognitive functions require an effective 
interhemispheric connection between temporal and parietal cortical areas that 
are connected through more posterior regions of the CC. When adjusting for 
callosal LL, FA in the splenium of the CC predicted performance on immediate 
and delayed verbal memory tests (SRT), confirming that the reduced integrity of 
posterior callosal regions is linked to verbal memory dysfunction independently 
of local lesions. Overall, this persistence of significant correlations between FA 
and cognitive performance after corrections for LL supports the important role 
played by the normal-appearing WM (NAWM) damage in contributing to 
cognitive dysfunction in MS (Mesaros et al., 2009); as previously hypothesised, 
the injury to the NAWM of the CC may result from a degeneration of axons 
transected in local T2 lesions and distal lesions whose related fibres cross the 
CC, through a mechanism of Wallerian degeneration (Coombs et al., 2004; 
Mesaros et al., 2009; Dziedzic et al., 2010). However, as discussed in Chapter 
IV, the contribution of grey matter injury and primary damage to axons (i.e., 
primary axonopathy) (Geurts et al., 2010) to axonal degeneration in the NAWM 
has yet to be conclusively established. 
 
In a previously published work on this same cohort, where the whole WM and 
GM matter histogram metrics and volumes were analysed with a traditional 
approach, it was found that whole brain GM MTR predicted the PASAT score, 
whereas whole brain GM and WM volume predicted performance on the Brixton 
test (Penny et al., 2010). Here, the scores on both the PASAT and the Brixton 
have been excluded from the analysis, as they did not differ significantly 
between patients and healthy controls. Rather surprisingly, in the present study, 
no GM region significantly predicted clinical outcome, when using a VBM 
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approach. Since the extent of the areas being investigated is in principal 
unknown, two different smoothing kernels were used, but the results were 
consistently negative. As discussed previously, the pathological correlates of 
GM atrophy are still unclear, and may reflect demyelination, loss of dendrites, 
axons, and synapses, possibly in combination. Even in early PPMS patients, 
GM atrophy has been identified in the pre- and post-central gyri, and in the 
temporal cortex, and this has been reported to be relevant for concurrent clinical 
disability (Khaleeli et al., 2007b; Bodini et al., 2009).  
 
The lack of correlation between GM atrophy and disability progression is in 
contrast with the results of other studies, performed on patients with other forms 
of MS (Jasperse et al., 2007). This could be a consequence of the regional 
distribution of atrophy in PPMS, which seems to differ from the pattern 
described in other forms of MS when using VBM (Ceccarelli et al., 2008). This 
difference in regional distribution of atrophic GM areas could perhaps help to 
explain the lack of significant association between regional GM volumes at 
baseline and long-term clinical outcomes in the London cohort of PPMS. 
Moreover, in RRMS, it has been reported a significant correlation between early 
changes in regional GM volume and clinical outcome (Jasperse et al., 2007). It 
is possible that looking at regional changes in GM volume, rather than using 
baseline regional GM volumes only, could prove more useful in finding 
significant correlations with long-term clinical outcomes.  
 
Finally, when investigating potential predictive measures of clinical outcome, 
MRI measures other than GM volume, for example those able to explore the 
microstructural damage occurring in the early stage of the disease, such as 
MTR, or sequences that allow detection of GM lesions, may provide significant 
results.  
 
From a technical point of view, in this work a novel approach was employed to 
remove lesion-related segmentation bias before VBM. Preliminary results of the 
applications of this method shows that without region filling the GM volume is in 
general overestimated (because the WM lesions have signal intensity similar to 
that of the cortex) (Chard et al., 2010). Therefore, the application of this method 
194 
Chapter VII: Contribution of WM and GM damage to long-term disability 
 
 
  
195 
should ensure that the segmented GM does not include the lesional tissue.   
 
7.5  Conclusions 
 
In conclusion, in this study the relative contribution of WM and GM damage to 
long-term disability in PPMS has been established, and with the data presented 
in this Chapter the answer to the second question of this thesis has been 
completed. In particular, it has been demonstrated that WM damage localised in 
the CC, both in terms of WM lesions and NAWM, is a relevant determinant of 
progression of motor disability and future cognitive dysfunction, while GM 
regional damage may not be as important. Furthermore, it is possible to 
propose the disconnection of relevant brain regions as a potential mechanism 
underlying clinical progression in MS.  However, it may be important to mention 
that two different regional measures of damage in the WM and in the GM were 
employed in this study: in the first case we used FA, while in the case of GM we 
looked at atrophy, and this relevant difference in the predicting measures may 
explain the surprising lack of predictive value of GM metrics on motor and 
cognitive disability in the results of this study. As a more general consideration, 
the prediction of cognition impairment overall (which can result from the 
damage to multiple brain areas) by the use of regional measures (which also 
differ for WM and GM in the case of this study, as mentioned above) is 
challenging and could potentially provide misleading results. These limitations 
should be taken into account in the interpretation of the data presented in this 
study.  
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In this final Chapter, the conclusions drawn from all the studies presented in this 
thesis will be summarised, and the answer to the two key questions proposed in 
Chapter one will be provided; finally, future research perspectives that could 
originate from the results reported in this thesis will be presented. 
 
8.1 The answer to the two key questions on PPMS 
 
(1) Is there is a spatial and temporal link between the pathological 
processes occurring in the NAWM and in the GM of patients with PPMS? 
In other words, is GM damage secondary to axonal degeneration and 
demyelination in connected WM tracts or alternatively, does it represents 
the initial target of the disease process that leads to subsequent axonal 
degeneration in the WM? 
 
With regard to the spatial link between the pathological processes occurring in 
the NAWM and in the GM of patients with early PPMS, the study presented in 
Chapter III showed that NAWM damage (as detected by DTI) and GM atrophy 
in adjacent areas are interdependent in some specific and clinically eloquent 
brain regions. These data suggest that there might be a spatial link between the 
mechanisms of damage occurring in the two compartments in the early phase 
of progression. However, another possible interpretation of the presented 
results is that the pathological processes affecting the two compartments 
develop independently of each other (as suggested by the evidence in our data 
of NAWM regions where a significant difference between patients and controls 
was found, which was not paralleled by significant changes affecting the 
connected GM areas, and viceversa) reaching a similar (correlated) degree of 
damage in few areas of the brain. 
 
In the study presented in Chapter IV, the temporal sequence of the pathological 
processes affecting NAWM and GM in early PPMS was explored.  The results 
presented in this thesis may suggest that, at least in the early phase of clinical 
progression in this subtype of disease, the tract NAWM could represent the 
initial target of the disease, as described by the “primary WM damage model”. I 
showed that microstructural damage affecting the NAWM, as reflected by MTR, 
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precedes and predicts that occurring in the connected cortical areas. However, 
it is noteworthy to underline the limitations of the hypothesis-driven approach 
employed in this study to test the “primary WM damage” and the “primary GM 
damage” models. In particular, the presented results could simply reflect the 
temporal sequence of the pathological events affecting the two compartments, 
and they do not imply any causal relationship between them. Secondly, this 
study does not exclude the possibility that MS is a “whole brain disease”, where 
WM and GM are affected independently of each other, or where both the two 
models (“primary WM damage” and “primary GM damage”) are valid and can 
accurately describe the temporal sequence of events, each one possibly 
prevailing on the other at different stages of disease and/or in different brain 
areas. 
 
(2) Which regions of WM abnormalities (within lesions and NAWM) and 
GM damage significantly contribute to clinical progression and cognitive 
deterioration?  
 
To answer this question, I first looked at the role of WM lesions, in the study 
presented in Chapter V, which was conducted in patients with well-established 
PPMS who were followed-up for ten years in five different centres. The focal 
WM damage localised in motor and associative tracts (the cortico-spinal tract , 
the bilateral superior longitudinal fasciculus, and the right inferior longitudinal 
fasciculus) was found to be the major determinant of clinical progression, 
independent of spinal cord atrophy.   
 
In the study presented in Chapter VI, where changes in WM tracts over one 
year were investigated, I showed that the short-term accrual of microstructural 
damage in specific WM tracts, such as the cortico-spinal tract, the corpus 
callosum, and the superior and inferior longitudinal fasciculus may contribute to 
clinical impairment in early PPMS. In the study presented in Chapter VII, I 
moved onto examining the relative contribution of WM and GM damage to long-
term motor and cognitive disability in PPMS. I demonstrated that WM damage 
localised in the corpus callosum, both in terms of lesions and NAWM, is a 
relevant determinant of progression of motor disability and future cognitive 
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dysfunction, while GM regional damage may not be as important. However, it 
may be important to mention that two different regional measures of damage in 
the WM and in the GM were employed in this study: in the first case we used 
FA, while in the case of GM we looked at atrophy, and this relevant difference in 
the predicting measures may explain the surprising lack of predictive value of 
GM metrics on motor and cognitive disability in the results of this study. As a 
more general consideration, the prediction of cognition impairment overall 
(which can result from the damage to multiple brain areas) by the use of 
regional measures (which also differ for WM and GM in the case of this study, 
as mentioned above) is challenging and could potentially provide misleading 
results. These limitations should be taken into account in the interpretation of 
the data presented in this study. 
 
In conclusion, the answer to the second question of this thesis is that the WM 
damage plays a key role in contributing to motor and cognitive impairment in 
patients with PPMS and that this appears to be more significant than the 
pathology in GM regions. In particular, damage to strategic WM regions (both in 
terms of lesional change, and abnormalities affecting the NAWM), such as the 
cortico-spinal tract, the corpus callosum, and the associative tracts, could be a 
major determinant of short- and long-term clinical progression in patients with 
this type of disease. It is therefore possible that the mechanisms underlying 
clinical progression in PPMS include the damage in WM tracts, which are 
essential for ensuring the normal neurological functions of the body (such as the 
cortico-spinal tract for the motor function). Additionally, the structural 
disconnection of relevant brain regions may, in turn, result in an abnormal 
functional connectivity between GM regions and, ultimately, lead to motor and 
cognitive impairment in PPMS. 
 
8.2 Future directions 
 
A recent international initiative, the International Collaborative in Progressive 
MS, has highlighted the needs of developing an effective strategy to improve 
the treatments of patients with progressive MS. This strategy includes five keys 
areas and biomarkers discovery is one of them. The studies presented in this 
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thesis show that novel imaging techniques have the potential to serve as 
biomarkers and to improve our understanding of the pathogenesis of 
progression, which is a key step in the development of new opportunities for 
therapeutic intervention. Therefore, to continue along the strategy lines 
proposed by the International Collaborative in Progressive MS, I would propose 
the following research projects. 
 
Firstly, it would be very important to move from the results presented in Chapter 
III, combining the “skeletonized MTR” method described in Chapter VI with 
novel methods to explore regional GM volume changes, such as Tensor Based 
Morphometry (TBM) (Friston et al., 2006), to investigate whether the spatial 
relationship between WM microstructural damage and GM abnormalities in 
PPMS changes over time. 
 
Moreover, it would be extremely interesting to explore whether the “primary WM 
damage model” presented in Chapter IV, which seems to describe accurately 
the temporal sequence of pathological events in PPMS, proves valuable in 
describing the sequence of events in other forms of demyelinating disease, 
such as CIS and RRMS. Should this be the case, it will be of considerable 
interest to establish the relative contribution of WM lesions and NAWM damage 
in determining GM pathology in the other forms of disease.  
 
The results presented in Chapter V and Chapter VII, where specific locations of 
WM damage were demonstrated to be major determinants of long-term motor 
and cognitive disability in PPMS, offer the opportunity to investigate further the 
MRI prognostic factors identified in this thesis, in the attempt to extrapolate the 
results  shown here to individual cases. To this aim, lesion load in the cortico-
spinal tract, the bilateral superior longitudinal fasciculus, and the right inferior 
longitudinal fasciculus, as well as diffusion metrics in the corpus callosum, 
should be included in the MRI features used to train Support Vector Machines 
(SVMs), an innovative computer-based technology which can be applied to 
associate MRI features with clinical outcomes on an individual basis (Ciccarelli 
et al., 2012). This research field could lead to an accurate individual prognosis 
in patients with PPMS, which would be extremely important for appropriate risk 
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stratification when designing clinical trials for this form of disease.  
 
Moreover, to further explore the pathological processes leading to clinical 
progression in PPMS, it would be very interesting to replicate the data 
presented in this thesis using imaging measures which could be more 
pathologically specific than MTR or diffusion-derived parameters. To this aim, a 
great opportunity is offered by molecular imaging with Positron Emission 
Tomography (PET), which allows directly marking and therefore quantifying 
specific components of the central nervous system, such as the myelin 
(Stankoff et al., 2011). Combining PET with advanced MRI imaging could offer 
the unique opportunity to understand in further detail the mechanisms 
underlying clinical progression in PPMS. 
 
Finally, another major challenge which has to be faced in the investigation of 
the pathogenesis of PPMS, as well as in the identification of relevant prognostic 
factors of future motor and cognitive progression in this group of patients, is the 
quantitative assessment in vivo of spinal cord damage. Indeed, novel technical 
approaches in the field of spinal cord imaging, such as the use of combined 
glutamate-glutamine spectroscopy, or the integration of accurate quantification 
of DTI and MTR measures, have the potential to explore in further detail the key 
role played by spinal cord damage in determining clinical progression in MS. 
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Appendix I 
 
 
 
Different cohorts of patients and controls included in the studies 
presented in this thesis 
 
Except for the study presented in Chapter V, which involved a large cohort of 
well-established PPMS patients from the MAGNIMS cohort, all the data 
presented in this thesis come from the investigation of the London cohort of 50 
early PPMS patients, recruited within 5 years of clinical onset and followed-up 
for five years with clinical and radiological assessments. Since all the studies 
presented in this work result from a retrospective analysis performed on 
previously acquired data, not all the MRI sequences were available in all the 
patients at all time-points, and this is the reason why in each study the number 
of patients included is different, although they all belong to the same “early PP” 
cohort. For the same reason, volumetric, MTR and DTI images were not 
available in the same group of healthy controls, and therefore two different 
groups of healthy subjects were included in both the studies presented in 
Chapter III and Chapter IV.  
 
A table summarising the details of the patients and the healthy controls included 
in each study is presented below: 
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Table AI  Patient and healthy control groups included in the studies presented in this thesis 
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